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SCIENTIFIC OPINION 
Scientific Opinion on the risks for human and animal health related to the 
presence of modified forms of certain mycotoxins in food and feed
1
 
EFSA Panel on Contaminants in the Food Chain (CONTAM)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy  
ABSTRACT 
Following a request from the European Commission, the risks to human and animal health related to modified 
forms of the Fusarium toxins zearalenone, nivalenol, T-2 and HT-2 toxins and fumonisins were evaluated. 
Modified (often called “masked”) mycotoxins are metabolites of the parent mycotoxin formed in the plant or 
fungus, e.g. by conjugation with polar compounds. Fumonisins, which are difficult to extract from the plant 
matrix, are also termed modified mycotoxins. The CONTAM Panel considered it appropriate to assess human 
exposure to modified forms of the various toxins in addition to the parent compounds, because many modified 
forms are hydrolysed into the parent compounds or released from the matrix during digestion. For modified forms 
of zearalenone, nivalenol, T-2 and HT-2 toxins and fumonisins, 100 %, 30 %, 10 % and 60 % were added, 
respectively based on reports on the relative contribution of modified forms. The same factors were used for 
animal exposure from feed. In the absence of specific toxicity data, toxicity equal to the parent compounds was 
assumed for modified mycotoxins. Risk characterization was done by comparing exposure scenarios with 
reference doses of the parent compounds. In humans, all lower bound (LB) and upper bound (UB) mean and 
95
th
 percentile exposures to the sum of modified and parent toxins were below the respective provisional 
maximum tolerable daily intakes (PMTDIs) and tolerable daily intakes (TDIs), with two exceptions: for 
zearalenone and modified zearalenone the UB 95
th
 percentile exposure was up to 2.2-fold the TDI. For fumonisins 
and modified fumonisins the exposure of toddlers and other children exceeded the PMTDI at both the LB and the 
UB estimates, which could be of concern. For farm animal species and pets the exposure to the sum of modified 
and parent toxins was in general not of concern. The risk in fish could not be addressed. The CONTAM Panel 
identified several uncertainties and data gaps for modified mycotoxins. 
© European Food Safety Authority, 2014 
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SUMMARY  
Following a request from the European Commission, the EFSA Panel on Contaminants in the Food 
Chain (CONTAM Panel) was asked to deliver a scientific opinion on the risk to human and animal 
health related to the presence of metabolites and the masked or bound forms of fumonisins, zearalenone, 
T-2 and HT-2 toxins and nivalenol in food and feed. Modified forms of deoxynivalenol are covered by a 
separate request. The scientific opinion should comprise the evaluation of the toxicity of these 
metabolites and masked or bound forms of these mycotoxins for animals and humans compared with the 
toxicity of the parent mycotoxins. Furthermore, it should contain an assessment of the co-occurrence of 
the metabolites and masked or bound forms of these mycotoxins in food and feed and an estimation of 
the human dietary exposure and the animal feed exposure compared with the dietary exposure to the 
parent mycotoxins. Finally, an assessment of the human and animal health risks should be performed. 
The Panel has applied the term modified mycotoxins for masked and bound mycotoxins and mycotoxin 
metabolites. Modified mycotoxins have up to recently only occasionally been detected when analysing 
the mycotoxins in their original form, and therefore they have commonly been termed as “masked”. In 
this opinion, the structurally altered forms of mycotoxins covered by the terms of reference are referred 
to as “modified mycotoxins”. The mycotoxins in their unchanged forms are referred to as “parent 
compounds”.  
Modified mycotoxins are found in plants resulting from plant defence reactions after fungal infection or 
are produced by the fungus itself. Modified mycotoxins are metabolites of the parent mycotoxin formed 
in the plant or fungus, e.g. by conjugation with polar compounds. The most common conjugations are 
with glucose and modified glucose but also with other groups such as sulphate and glutathione. For 
fumonisins there is evidence that there are forms that are covalently or non-covalently bound to the 
matrix. Therefore the term modified fumonisins includes both covalently and non-covalently (i.e. 
physically entrapped) bound forms for the purpose of this opinion.  
Protocols for modified mycotoxin analysis are mainly based on water/acetonitrile extraction followed by 
analysis with liquid chromatography–tandem mass spectrometry (LC-MS/MS). Both targeted and 
untargeted methods are used. Immunochemical methods for mycotoxins may not detect modified forms. 
Concerning fumonisins and their entrapped forms, variability due to different extraction strategies is 
high. There is a lack of properly validated routine methods owing to the lack of commercially available 
calibrants and reference materials.  
Modified mycotoxins can be released, hydrolysed, biotransformed and absorbed in the gastrointestinal 
tract, primarily as the parent compound. Although the toxicity of conjugated mycotoxins is not 
addressed in the present opinion, data in the literature shows that conjugates of xenobiotics can be of 
toxicological significance. Based on this the  CONTAM Panel assumed, as a pragmatic approach, that 
all modified forms have the same  toxicity as their parent compounds.  
Bran- and fiber-enriched products are more prone to contamination with mycotoxins, including their 
modified forms. The EFSA occurrence database contains no data on modified mycotoxins covered by 
the present opinion. Therefore, occurrence is based on limited information reported in the literature. 
Literature data shows that modified forms of mycotoxins may add substantially to the overall mycotoxin 
levels, in particular for zearalenone and fumonisins. For fumonisins, the major contribution comes from 
physically entrapped parent compounds, whereas for the other compounds, metabolites are the main 
contributors to modified forms. In order to assess occurrence and exposure, the CONTAM Panel added 
100 %, 30 %, 10 % and 60 % to the levels of the parent compounds to account for  the modified forms 
of zearalenone, nivalenol, the sum of T-2 and HT-2 toxins and fumonisins, respectively.  
Occurrence data about modified mycotoxins in animal products (i.e. milk and dairy, meat, eggs) are not 
available, but occurrence in animal products is expected to be very low, since carry-over of Fusarium 
toxins from feed is considered insignificant for human exposure based on currently available data. 
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The risk characterization for humans is performed by comparing the estimated combined exposure to 
parent and modified forms of mycotoxins with the established health based guidance values (HBGVs) 
for the respective parent compounds. 
Using the lower bound (LB) approach, no consumers with mean or 95
th
 percentile exposure have 
combined exposure to zearalenone and modified zearalenone above the tolerable daily intake (TDI) set 
for zearalenone, indicating no concern. However, if the concentration of modified and parent 
zearalenone in cereals would be closer to the upper bound (UB) level, high consumers (95
th
 percentile) 
may have an exposure up to 2.2-fold the TDI for zearalenone of 0.25 µg/kg body weight (b.w.) per day, 
which would be of concern. 
Exposure to the sum of nivalenol and modified nivalenol is not of concern, as the highest 95
th
 percentile 
UB exposure across studies is less than 20 % of the TDI for nivalenol of 1.2 µg/kg b.w. per day. 
Exposure to the sum of T-2 and HT-2 toxins and their modified forms is considered not to be of 
concern, since all the LB and UB exposures across studies were lower than the TDI of 0.1 µg/kg b.w. 
per day for the sum of T-2 and HT-2 toxins, with the exception of the highest UB exposure derived for 
toddlers’ (≥ 1 year to < 3 years) exposure, which was similar to the TDI.  
The exposure to fumonisins and their modified forms could be of concern, especially in children’s age 
groups.  In toddlers, 0.2-14 % (LB) or 43-66 % (UB) and in other children 0-38 % (LB) to 11-59 % 
(UB) across studies could exceed the provisional maximum TDI (PMTDI) for fumonisins of 2 µg/kg 
b.w. per day. At high (95
th
 percentile) exposure, the maximal exceedance was 2.5-fold (LB) to 3-fold 
(UB) the PMTDI. 
In order to assess occurrence in feed and exposure of animals, the CONTAM Panel added equal factors 
for modified mycotoxins in feed as in food. 
Levels in feed have been compared with guidance values for feed, if established, and estimated 
exposure in animals is evaluated in relation to established NOAELs/LOAELs  for different animals, 
when available. Furthermore, known differences in sensitivities to mycotoxins between different species 
were taken into account when NOAELs/LOAELs were lacking. For fumonisins, contaminated feed has 
been used in the studies used for derivation of NOAELs/LOAELs, with the exception of poultry, for 
which the pure compound has been added to feed. For the other Fusarium toxins, experiments were 
carried out with application of pure compounds. 
For zearalenone and its modified forms, the mean exposure in pigs in general and the 95
th
 percentile 
exposure in piglets is not of concern. Occurrence data were inadequate to conclude on risks for fattening 
pigs and sows receiving feed with a higher than average contamination level. Owing to the lack of either 
occurrence data or NOAELs/LOAELs, the risk for cattle, goats, rabbits and fish cannot be characterised 
fully. Estimated exposure in sheep, horses, poultry, cats and dogs is not of concern.  
For nivalenol and its modified forms, exposure in pigs, ruminants, poultry, horses, rabbits, cats and dogs 
is not of concern. Risk could not be assessed in fish because of the lack of occurrence data in feed.  
For T-2 and HT-2 toxins and their modified forms, the estimated exposure in pigs, ruminants, horses, 
poultry, and dogs is not of concern. Risk could not be assessed in fish because of the lack of occurrence 
data in feed. There is no NOAEL/LOAEL for cats, which are known to be sensitive to T-2 and HT-2 
toxins. A concern cannot be excluded in cats but is unlikely based on low exposure. 
For fumonisins and their modified forms, exposure in pigs, ruminants, poultry, horses, rabbits, cats and 
dogs is not of concern. Risk could not be assessed in fish because of the lack of occurrence data in feed.  
The CONTAM Panel notes that there is a need for more information on the chemical structures of 
modified mycotoxins and for further work to identify modified mycotoxins not yet characterised. The 
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nomenclature, including abbreviations, should be standardised for mycotoxins and their modified forms. 
Furthermore, there is a need for properly validated and sensitive routine analytical methods. The fate of 
modified forms upon food and feed processing needs further investigation. More occurrence data on 
mycotoxins and their modified forms in food and feed need to be generated, in particular for fish and pet 
food. There is also a need for toxicological data on modified mycotoxins. Re-assessments of the animal 
health effects of zearalenone and fumonisins are needed in order to set NOAELs/LOAELs for these 
compounds. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
The Scientific Committee on Food (SCF) has adopted a scientific opinion  
- on 2 December 1999 on deoxynivalenol (DON)
4
.  
- on 17 October 2000 on fumonisin B1 in food
5
, updated on 4 April 2003 as regards fumonisin B2 and 
fumonisin B3
6
 
 
The Scientific Panel on Contaminants in the Food Chain (CONTAM Panel) of the European Food 
Safety Authority (EFSA) adopted an opinion on a request from the Commission  
- on 2 June 2004 on deoxynivalenol as undesirable substance in animal feed
7
 
- on 28 July 2004 on zearalenone as undesirable substance in animal feed
8
 
- on 22 June 2005 on fumonisins as undesirable substance in animal feed
9
 
- on 31 May 2011 on the risks for public health related to the presence of zearalenone in food
10
 
- on 30 November 2011 on the risks for animal and public health related to the presence of T-2 and HT-
2 toxin in food and feed
11
 
- on 17 May 2013 the risks for animal and public health related to the presence of nivalenol in food and 
feed
12
. 
Plants, as living organisms, can alter the chemical structure of mycotoxins as part of their defence 
against xenobiotics. The extractable conjugated or non-extractable bound mycotoxins formed remain 
present in the plant tissue but are currently neither routinely screened for in food nor regulated by 
legislation, thus they may be considered masked. Fusarium mycotoxins (deoxynivalenol, zearalenone, 
fumonisins, nivalenol, T-2 toxin, HT-2 toxin) are prone to metabolisation or binding by plants.  
                                                 
4
  Opinion of the Scientific Committee on Food on Fusarium-toxins Part 1: Deoxynivalenol (DON) , (expressed on 2 December 
1999) http://ec.europa.eu/food/fs/sc/scf/out44_en.pdf 
5
  Opinion of the Scientific Committee on Food on Fusarium-toxins Part 3: Fumonisin B1 (FB1) (expressed on 17 October 
2000) http://ec.europa.eu/food/fs/sc/scf/out73_en.pdf  
6
  Updated opinion of the Scientific Committee on Food on Fumonisin B1, B2 and B3 (expressed on 4 April 2003) 
http://ec.europa.eu/food/fs/sc/scf/out185_en.pdf  
7
  Opinion of the Scientific Panel on contaminants in the Food Chain of the European Food Safety Authority (EFSA) on a 
request from the Commission related to deoxynivalenol as undesirable substance in animal feed, adopted on 2 June 2004. 
8
  Opinion of the Scientific Panel on Contaminants in the Food Chain of the European Food Safety Authority (EFSA) on a 
request from the Commission related to zearalenone as undesirable substance in animal feed, adopted on 28 July 2004. 
9
  Opinion of the Scientific Panel on Contaminants in the Food Chain of the European Food Safety Authority (EFSA) on a 
request from the Commission related to fumonisins as undesirable substance in animal feed, adopted on 22 June 2005. 
10
 EFSA Panel on Contaminants in the Food Chain (CONTAM); Scientific Opinion on the risks for public health related to the 
presence of zearalenone in food. EFSA Journal 2011;9(6):2197. [124 pp.] doi:10.2903/j.efsa.2011.2197 
11
 EFSA Panel on Contaminants in the Food Chain (CONTAM); Scientific Opinion on risks for animal and public health 
related to the presence of T2 and HT2T2 toxin in food and feed. EFSA Journal 2011; 9(12):2481. [187 pp.] 
doi:10.2903/j.efsa.2011.2481.  
12 
 EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain), 2013. Scientific Opinion on risks for animal and 
public health related to the presence of nivalenol in food and feed. EFSA Journal 2013;11(6):3262. 
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In the above mentioned scientific assessments on Fusarium toxins, the toxicity, animal and human 
exposure and the risks for animal and public health for the parent mycotoxin are assessed and  no or 
limited reference is made to the metabolites and the masked or bound form of these Fusarium toxins.  
The Commission has recently requested to EFSA to assess the risks to animal and human health related 
to the presence of deoxynivalenol, metabolites of deoxynivalenol and masked deoxynivalenol in feed 
and food and therefore the metabolites and masked or bound forms of deoxynivalenol have not to be 
addressed in this opinion.  
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Art. 29 (1) (a) of Regulation (EC) No 178/2002 the Commission asks EFSA for a 
scientific opinion on the risks to animal and human health related to the presence of metabolites and the 
masked or bound forms of fumonisins, zearalenone, T-2 and HT-2 toxin and nivalenol in food and feed.  
The scientific opinion should, inter alia, comprise the: 
a) evaluation of the toxicity of the metabolites and masked or bound forms of these mycotoxins for 
animals and humans and this compared to the toxicity parent mycotoxins 
b) assessment of the co-occurrence of the metabolites and masked or bound forms of these mycotoxins 
in food and feed.  
c) estimation of the dietary exposure of the EU population to the metabolites and masked or bound 
forms of these mycotoxins  including the consumption patterns of specific (vulnerable) groups of the 
population (e.g. high consumers, children, people following a specific diet, etc) and this compared to the 
dietary exposure to the parent mycotoxins.  
d) estimation of the exposure of the different animal species to the metabolites and the masked or bound 
forms of these mycotoxins from feed and this compared to exposure to the parent mycotoxins.   
e) assessment of the human health risks for the EU population including for specific (vulnerable) groups 
of the population as the consequence of the estimated dietary exposure to the metabolites and masked or 
bound forms of these mycotoxins and the parent mycotoxins.  
f) assessment of the animal health risks for the different animal species as the consequence of the 
estimated exposure from animal feed to the metabolites and masked or bound forms of these 
mycotoxins and the parent mycotoxins. 
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ASSESSMENT 
1. Introduction 
Food- and feed-related mycotoxins are produced by fungi living on edible plants. The two main defence 
reactions of plants against mycotoxins are chemical modification and compartmentation. Both processes 
can alter the chemical structure of these toxins rendering them (at least in part) extractable conjugated 
and/or non-extractable bound mycotoxins or mycotoxin metabolites. Since these altered mycotoxins are 
usually not detected when analysing the mycotoxins they originated from, they are commonly termed 
“masked”.  
The term “masked mycotoxins” was originally introduced in the early 1990’s (Gareis et al., 1990) and, 
according to the recent literature (Berthiller et al., 2013), refers exclusively to plant metabolites. 
However, mycotoxins can be modified by living organisms other than plants (i.e. fungi, bacteria, 
mammals), and by further processing of the edible plants. All these compounds are not covered by the 
term “masked mycotoxins”. In this opinion, according to Rychlik et al. (2014), the structurally altered 
forms of mycotoxins covered by the terms of reference are referred to as “modified mycotoxins”. 
For fumonisins there is evidence that there are forms that are covalently or not covalently bound to the 
matrix. Therefore the term modified fumonisins includes both covalently (i.e. NDF-FB) and not 
covalently (i.e. physically entrapped) bound forms for the purpose of this opinion.  
Most mycotoxins and their modified forms tend to be mainly concentrated in the bran fractions or outer 
layers of the grains so that other parts of the cereal structure that produce fractions, such as white flour 
or maize grits, are usually contaminated with lower concentrations of mycotoxin than the fractions or 
outer layers that are present in the original whole grain.  
In accordance with the terms of reference in the present opinion, the risks for public and animal health 
related to modified forms of  zearalenone, nivalenol, T-2 and HT-2 toxins and fumonisins are evaluated. 
This evaluation is done in comparison with the mycotoxins in their unchanged forms, which are referred 
to as “parent compounds” throughout the text.  In the present opinion modified mycotoxins occurring in 
edible plants (including forms arising from both plant and fungal metabolism), resulting from food and 
feed processing and from carry-over from contaminated feed to livestock animals are considered. 
Evaluation of modified mycotoxins resulting from mammalian metabolism is outside the scope of this 
mandate.  
2. Legislation 
Article 2 of Council Regulation (EEC) No 315/98
13
 stipulates that food containing a contaminant in an 
amount unacceptable for public health shall not be placed on the market, that contaminant levels should 
be kept as low as can reasonably be achieved and that, if necessary, the EC may establish maximum 
levels for specific contaminants. These maximum levels are laid down in the Annex of Commission 
Regulation (EC) No 1881/2006
14
 and may include limits for the same contaminants in different foods, 
analytical detection limits and reference to the sampling and analysis methods to be used. Modified 
forms of the Fusarium toxins covered by the present mandate are not considered in the Regulation. 
However, maximum levels (MLs) are listed for the parent compounds zearalenone, T-2 and HT-2 toxins 
and fumonisins. Nivalenol is not included in the Annex.  
                                                 
13
  Council Regulation (EEC) No 315/93 of February 1993 laying down Community procedures for contaminants in food . OJ L 
37, 13.2.1993, p. 1-5. 
14
  Regulation (EC) No 1881/2006 of the European Parliament and the Council of 19 December 2006 setting maximum levels 
for certain contaminants in foodstuffs. OJ L 364, 20.12.2006, p. 5-24. 
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Council Directive 2002/32/EC
15
 regulates undesirable substances in feed and the Annex I to it contains a 
list with MLs for certain feed contaminants. Neither the modified  forms of the mycotoxins covered by 
the present mandate nor any of their parent compounds are considered in this Directive. However, 
Commission Recommendation 2006/576/EC
16
 that stipulates data gathering for certain mycotoxins 
provides guidance values for zearalenone and fumonisin B1 (FB1) and FB2 in animal feed. Furthermore, 
indicative levels for T-2 and HT-2 toxins in cereals used for feed are provided in Commission 
Recommendations 2013/165/EU
17
 and 2013/637/EU
18
. 
For the parent compounds of the modified mycotoxins considered in this opinion there are no MLs in 
feed. Instead, the Commission decided to set guidance values as presented in Commission 
Recommendation 2006/576/EC (deoxynivalenol, zearalenone, the sum of fumonisins B1 and B2, and 
more recently for the sum of T-2 and HT-2 toxin). These guidance values are merely set to provide 
orientation to Member States to judge the acceptability of cereals, cereal by-products and compound 
feed for animal feeding. It is unclear what the relationship is to adverse effects observed in animals. 
However, it is also mentioned in Commission Recommendation 2006/576/EC that the guidance values 
for cereals and cereal by-products have been determined for the most tolerant species and should be 
regarded as upper guidance values. 
For zearalenone, guidance values (Commission Recommendation 2006/576/EC) are 0.1 mg/kg for 
compound feed for piglets and gilts, 0.25 mg/kg for sows and fattening pigs and 0.5 mg/kg for dairy 
cattle, sheep (including lambs) and goats (including kids). For cereals and cereal products, a guidance 
value of 2 mg/kg was set, with the exception of maize by-products for which a value of 3 mg/kg was 
set.  
No guidance values have been set for nivalenol. 
For the sum of T-2 and HT-2 toxins, the guidance value (Commission Recommendation 2013/165/EU) 
is 250 µg/kg, except for feed for cats for which a value of 50 µg/kg (Commission Recommendation 
2013/637/EU) was established because they are more sensitive. For oat milling products a value of 
2 000 µg/kg was set and for other cereal products 500 µg/kg. There is also a range of guidance values 
for products for human consumption. 
For the sum of fumonisins B1 and B2, guidance values are 5 mg/kg for compound feed for pigs, horses 
rabbits and pet animals, 20 mg/kg for poultry, calves (< 4 months), lambs and kids, 50 mg/kg for adult 
ruminants (> 4 months) and mink. For maize and maize by-products, a value of 60 mg/kg was set. 
3. Previous evaluations considered for the assessment of modified mycotoxins 
3.1. Human health risk assessments 
No comprehensive risk assessments or health-based guidance values (HBGV) are currently available for 
modified forms of the Fusarium mycotoxins addressed in the present opinion. The terms of reference 
request that the toxicity of the modified forms be compared with the parent compounds. Risk 
assessments and HBGVs for their respective parent compounds (zearalenone, nivalenol, T-2 toxin, HT-
2 toxin and fumonisins) have been presented by EFSA and the Joint FAO/WHO Expert Committee on 
                                                 
15
  Directive 2002/32/EC of the European Parliament and the Council of 7 May 2002 on undesirable substances in animal feed. 
OJ L140, 30.5.2002, p. 10 – 21. 
16
  Commission Recommendation 2006/576/EC of 17 August 2006 on the presence of deoxynivalenol, zearalenone, ochratoxin 
A, T2 and HT2 and fumonisins in products intended for animal feeding. OJ L 229, 23.8.2006, p. 7-9. 
17
  Commission Recommendation 2013/165/EU of of 27 March 2013  on the presence of T2 and HT2T2 toxin in cereals and 
cereal products. OJ L 91, 4.4.2013, p. 12 – 15.  
18 
 Commission Recommendation 2013/637/EU of of 4 November 2013  amending Recommendation 2006/576/EC as regards 
T2 and HT2 toxin in compound feed for cats. OJ L 294, 6.11.2013, p. 44. 
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Food Additives (JECFA) recently. The HBGVs and exposure assessments established in these previous 
opinions will be used for the present assessment. For fumonisins recent EFSA exposure assessments are 
not available. An exposure assessment was carried out therefore for the present opinion. Since no recent 
EFSA HBGV is available for fumonisins, the one established in a recent JECFA evaluation 
(FAO/WHO, 2012) has been used for risk assessment. 
3.1.1. Zearalenone  
The CONTAM Panel has developed a scientific opinion assessing the risks for public health related to 
the presence of zearalenone in food (EFSA CONTAM Panel, 2011a). The Panel concluded that limited 
evidence is available for the carcinogenicity of zearalenone, which acts as an in vivo clastogen. 
Zearalenone exerts oestrogenic activity in mammals, the most sensitive species being the pig. An 
tolerable daily intake (TDI) of 0.25 µg/kg body weight (b.w.) per day was derived from a no observed 
effect level (NOEL) of 10 µg/kg b.w. per day for oestrogenic effects observed in pigs (increased number 
of piglets with swollen and reddened vulva and cervix, increased weight of uteri), applying an 
uncertainty factor (UF) of 40 (4 for inter- and 10 for intra-species differences). An UF of 40 was 
considered to be appropriate by the CONTAM Panel, since it is likely that the human female would not 
be more sensitive to oestrogens in general, or zearalenone or its metabolites in particular, than the 
female pig. Therefore it was considered not necessary to include an additional UF of 2.5 for 
toxicodynamic differences between pigs and humans. 
A total of 13 075 analytical results obtained from food samples and 9 877 results on unprocessed grains 
sampled in 19 European countries between 2005 and 2010 were used as basis for the exposure 
assessment. Zearalenone was reported at quantifiable levels in 15 % of the samples, with highest 
concentrations in wheat bran, corn and products thereof. Grains and grain-based foods, in particular 
grains and grain milling products, bread and fine bakery wares, made the largest contribution to the 
zearalenone exposure in all age classes. Total chronic dietary exposures for adults (≥ 18 years to 
< 65 years old) (minimum lower bound (LB) to maximum upper bound (UB)) ranged from 2.4 to 
29 ng/kg b.w. per day for average consumers and from 4.7 to 54 ng/kg b.w. for high consumers 
(95
th
 percentile consumption in total population).The highest exposure estimates were for toddlers (aged 
≥ 12 months to < 36 months), at 9.3 to 100 ng/kg b.w. per day for average consumers, and 23 to 
277 ng/kg b.w. per day for high consumers. 
Overall, estimates of chronic dietary exposure to zearalenone based on the available occurrence data 
were below or in the region of the TDI of 0.25 µg/kg b.w. per day (250 ng/kg b.w. per day) for all age 
groups. 
3.1.2. Nivalenol 
In 2013, the CONTAM Panel published a scientific opinion aimed at identifying animal and public 
health risks related to the presence of nivalenol in food and feed (EFSA CONTAM Panel, 2013). The 
Panel concluded that nivalenol is unlikely to be genotoxic and that based on the available data 
conclusions could not be drawn on its carcinogenicity. Critical effects in mammals are immunotoxicity 
and haematotoxicity. A TDI of 1.2 µg/kg b.w. per day was established based on a lower 95 % 
confidence limit for a benchmark response of 5 % extra risk (BMDL05) of 350 µg/kg b.w. per day 
derived from reduced white blood cell counts observed in a 90-day rat study and by applying an UF of 
300 to account for inter- and intra-species differences.  
A total of 3 846 data on food and 7 611 data on unprocessed grains reported from 2001 to November 
2011 were used for exposure assessments. A high proportion (90 %) of results was below the limit of 
detection (LOD) or limit of quantification (LOQ) in food. The vast majority of data were on grains and 
grain-based foods. The highest mean concentrations for nivalenol in food and unprocessed grains were 
observed in oats, maize, barley and wheat and products thereof. Higher concentrations were observed in 
unprocessed grains than in grains for human consumption. Total chronic dietary exposures in the adult 
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population (minimum LB to maximum UB) ranged from 0.4 to 75 ng/kg b.w. per day for average 
consumers, to 1.1 to 224 ng/kg b.w. per day for high (95
th
 percentile) consumers. In elderly (≥ 65 years 
to < 75 years old) and very elderly (≥ 75 years old) populations, the chronic dietary exposure to 
nivalenol was slightly lower than in other adults. The highest chronic exposure was estimated for 
toddlers (≥ 1 year to < 3 years old) ranging from 4.3 to 202 ng/kg b.w. per day for average consumers, 
to 12 to 484 ng/kg b.w. per day for high consumers. Grains and grain-based foods made the largest 
contribution to nivalenol exposure. Important contributors were bread and rolls, grain milling products, 
pasta, fine bakery wares and breakfast cereals.  
The CONTAM Panel concluded that residues of nivalenol in products of animal origin could only 
marginally contribute to human exposure. 
All chronic dietary exposures to nivalenol estimated, based on the available occurrence data in food, 
were below the TDI of 1.2 μg/kg b.w. per day, and are therefore not of health concern. 
3.1.3. T-2 and HT-2 toxins 
In 2011, the CONTAM Panel adopted a scientific opinion aimed at assessing the risks incurred with the 
presence of T-2 and HT-2 toxin in food and feed (EFSA CONTAM Panel, 2011b). The Panel concluded 
that T2 and HT2 impair protein and DNA synthesis and induce haematotoxicity and myelotoxicity. In 
view of the rapid metabolism of T-2 to HT-2 toxin a group TDI of 0.1µg/kg b.w. per day was 
established covering both compounds based on a BMDL05 of 10 µg/kg toxin/kg b.w. per day for T-2 
toxin for immunological effects observed in pigs (decreased anti-horse globulin titre, lymphocyte 
stimulation with A-HG/PHA/ConA, leucocytes and t-lymphocytes and histological changes in thymus, 
spleen and lymph nodes) and applying an UF of 100.  
A total of 17 683 analytical results for T-2, 16 536 for HT-2 toxin and 20 519 for the sum of T-2 and 
HT-2 toxin in food, feed and unprocessed grains, collected between 2005 and 2010 from 22 European 
countries were used as a basis for the exposure assessment. HT-2 toxin concentration represents about 
two thirds of the sum of T-2 and HT-2 toxin concentration. Highest mean concentrations for the sum of 
T2 and HT2 were observed in grains and grain milling products. For adults (≥ 18 years to < 65 years 
old), the minimum LB to maximum UB exposure was 3.4 to 18 ng/kg b.w. per day for average 
consumers, and 7.2 to 39 ng/kg b.w. for high consumers (95
th
 percentile consumption in total 
population). The highest chronic dietary exposure estimates are for toddlers (≥ 1 year to < 3 years old), 
at 12 to 43 ng/kg b.w. per day for average consumers, and 23 to 91 ng/kg b.w. for 95
th
 percentile 
consumers. Grains and grain-based foods made the largest contribution to the exposure to the sum of T-
2 and HT-2 toxin.  
Overall, estimates of chronic dietary exposure for populations of all age groups to the sum of T-2 and 
HT-2 toxin based on the available occurrence data are below this group TDI of 100 ng/kg b.w. per day, 
and therefore considered of no health concern. 
3.1.4. Fumonisins 
The most recent comprehensive risk assessment on health effects related to the presence of fumonisins 
in food has been presented by JECFA (FAO/WHO, 2012) and is based mainly on studies carried out 
with FB1. Kidney and liver are the organs most sensitive to fumonisin-mediated toxicity in rats and 
mice. JECFA concluded that fumonisin B1 is not mutagenic but capable of inducing reactive oxygen 
species that could lead to DNA damage and induced kidney and liver tumours in rodents. Based on the 
structural similarities of the different fumonisin derivatives a group provisional maximum TDI 
(PMTDI) for fumonisins B1, B2 and B3 of 2 µg/kg b.w. per day based on a BMDL10 of 165 µg/kg b.w. 
per day for fumonisins B1 for increased incidence of megalocytic hepatocytes observed in a chronic 
study with mice was derived, adding an UF of 100 for inter-species and intra-species differences.  
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Dietary exposure levels were assessed based on occurrence data made available to the JECFA and 
considering the Global Environment Monitoring System (GEMS)/Food consumption cluster diets, 
which provide mean per capita consumption values based on Food and Agriculture Organization of the 
United Nations (FAO) food balance sheet data for raw commodities and some semi-processed 
commodities for 13 clusters of countries. Mean exposure levels estimated for the four clusters covering 
several European countries ranged from 0.5 to 1.5 µg/kg b.w. per day (minimum LB to maximum UB).  
In 2014, EFSA performed an evaluation of the increase in risk for public health related to a possible 
temporary derogation from the maximum level of deoxynivalenol, zearalenone and fumonisins for 
maize and maize products (EFSA, 2014). An exposure assessment was performed considering the EFSA 
Comprehensive European Food Consumption Database. The occurrence data were corresponding to the 
European data that were considered by JECFA in its risk assessment, plus an additional dataset on 
maize and maize products.  
Exposure estimated in these two assessments are not directly comparable to exposure estimated in the 
EFSA assessments available for the other mycotoxins. The consumption data considered by JECFA are 
not the same as the ones considered in the EFSA assessments. The EFSA evaluation performed in 2014 
was considering the exceptional situation of high contamination of maize and maize based products. For 
the sake of comparability with the exposure levels estimated for the other mycotoxins, an exposure 
assessment to total fumonisins was performed (Appendices A – C). 
The dataset used for the exposure assessment of fumonisins contained 3 654 analytical results obtained 
on food samples that were collected between 2000 and 2010 and reported by 11 European countries (the 
European data that were considered by the JECFA in its risk assessment (FAO/WHO, 2012). Around 
44 % of the analytical results corresponded to the sum of fumonisins B1, B2 and B3 whereas the other 
results corresponded to the sum of fumonisins B1 and B2 only. As done in the JECFA evaluation, the 
results corresponding to the sum of fumonisins B1 and B2 were used together with the ones 
corresponding to the sum of fumonisins B1, B2 and B3, without any adjustment. In the children age 
groups, the mean exposure levels range between 0.17 and 1.33 µg/kg b.w. per day at the LB and 
0.47 and 1.69 µg/kg b.w. per day at the UB. The 95
th
 percentile of exposure was between 0.49 and 
3.29 µg/kg b.w. per day at the LB and between 1.53 and 4.21 µg/kg b.w. per day at the UB. In the 
surveys covering adult age groups (including adolescents), the mean exposure levels are below the 
HBGV, being between 0.05 and 0.75 µg/kg b.w. per day at the LB and 0.33 and 1.13 µg/kg b.w. per day 
at the UB. However, the 95
th
 percentile of exposure is in the region of the HBGV for some surveys, 
being between 0.12 and 1.76 µg/kg b.w. per day at the LB and 0.56 and 2.27 µg/kg b.w. per day at the 
UB. Overall, the mean exposure levels estimated are below the PMTDI, but the 95
th
 percentile estimates 
are in the region of the PMTDI for some surveys. 
3.1.5. Summary table of HBGVs derived in previous risk assessments 
In Table 1 a summary of the health-based guidance values derived for zearalenone, nivalenol, T-2 and 
HT-2 toxin and fumonisins is presented. The TDIs are all based on experiments in which pure 
compound was administered. 
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Table 1:  Health-based guidance values (HBGVs) for zearalenone, nivalenol, T-2 and HT-2 toxins 
and fumonisins 
 Compound  Health-based guidance values  Reference 
Zearalenone TDI: 0.25 µg/kg b.w. per day based on a NOEL of 10 µg/kg b.w. per 
day for oestrogenic effects in pigs, UF 40 
EFSA 
CONTAM 
Panel (2011a) 
Nivalenol TDI: 1.2 µg/kg b.w. per day based on a BMDL05 of 350 µg/kg b.w. per 
day for reduced  white blood cell counts in a 90-day rat study, UF 300 
EFSA 
CONTAM 
Panel (2013) 
T-2 and HT-2 
toxins 
Group TDI: 0.1µg/kg b.w. per day based on a BMDL05 of 10 µg//kg 
b.w. per day for  T-2 toxin for immunological/haematological effects 
seen in pigs, UF 100 
EFSA 
CONTAM 
Panel (2011b) 
Fumonisins (FB1, 
FB2, FB3)  
Group PMTDI: 2 µg/kg b.w. per day based on a BMDL10 of 165 µg/kg 
b.w. per day for megalocytic hepatocytes in mice, UF 100 
FAO/WHO 
(2012) 
BMDL05: 95 % lower confidence limit for the benchmark dose response of 5 % extra effect; BMDL10: 95 % lower confidence 
limit for the benchmark dose response of 10 % extra effect; b.w.: body weight; TDI: Tolerable Daily Intake; PMTDI; Provisional 
Maximum Tolerable Daily Intake; NOEL: No Observed Effect Level; UF: Uncertainty Factor. 
3.2. Previous animal health risk assessments of parent compounds 
As for human health, animal health risk assessments of modified forms of zearalenone, nivalenol, T-2 
and HT-2 toxins and fumonisins are lacking. Such evaluations have been made available, however, for 
the parent compounds and will be considered for the present assessment, as presented briefly below.  
3.2.1. Zearalenone  
The CONTAM Panel issued an opinion related to zearalenone as an undesirable substance in animal 
feed (EFSA, 2004). The Panel concluded that in mammals the most prominent effects of zearalenone 
result from its interaction with oestrogen receptors leading to hyperoestrogenism including reduced 
fertility. Female pigs are the most sensitive species. Similarly, sheep are susceptible to 
zearalenone-induced fertility effects while poultry and ruminants show a lower sensitivity to 
zearalenone mediated effects. However, the Panel concluded that it was not possible to derive 
NOAELs/LOAELs , since the data available were inadequate.  
Zearalenone occurs frequently in cereals and grains in particular in maize and maize by-products. 
Contamination of cereals with zearalenone varies considerably. Concentrations ranging from less than 
0.05 mg/kg to a few mg/kg feeding stuff are reported. The Panel concluded in 2004, that due to the great 
variability in diet composition for the major farm animal species a calculation of actual exposure levels 
based on occurrence data of zearalenone in individual feed materials could not be carried out. For the 
current opinion, new data were evaluated showing 1980 acceptable entries (see Appendix E) and these 
were used for a new exposure assessment. In the more recent opinion on zearalenone in food (EFSA 
CONTAM Panel, 2011a), a TDI for human exposure was established based on adverse effects in pigs 
with a NOEL of 10 µg/kg b.w. In addition, also the guidance values set by the EU will be used for 
evaluating the potential contribution of modified forms to the zearalenone level. However, it should be 
stressed that the guidance values are not directly linked to animal health, although they take into 
consideration species differences in sensitivity. 
3.2.2. Nivalenol 
In their scientific opinion on animal and public health risks related to the presence of nivalenol in food 
and feed  (EFSA CONTAM Panel, 2013), the CONTAM Panel established a lowest observed adverse 
effect level (LOAEL) of 100 µg/kg b.w. per day for pigs based on observations of pathological changes 
in the gastrointestinal tract, kidneys and spleen and increased immunoglobulin A levels in plasma. No 
relevant data were available for ruminants, rabbits, fish, horses, dogs and cats. LOAELs of 360 µg/kg 
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b.w. per day were derived from erosion and reduced weights of gizzards and of 53 µg/kg b.w. per day 
from pale and fragile livers and pale kidneys in broiler chicken and laying hens, respectively.  
Animal exposure to nivalenol is primarily from consuming cereal grains and cereal by-products. For 
dairy cows and beef cattle, the estimated LB and UB exposures to nivalenol were between 0.077 and 
0.69 μg/kg b.w. per day. Exceptions to this were dairy cows and beef cattle fed on diets consisting 
predominantly of maize silage. The estimated LB and UB exposures to nivalenol for these were between 
1.9 and 4.6 μg/kg b.w. per day. For small ruminants, the estimated LB and UB exposures to nivalenol 
were between 0.14 and 0.95 μg/kg b.w. per day. The estimated LB and UB exposures for pigs were 
between 0.24 and 1.6 μg/kg b.w. per day, for poultry 0.24 and 1.9 μg/kg b.w. per day, for rabbits 
0.20 and 0.77 μg/kg b.w. per day, and for horses 0.090 and 0.35 μg/kg b.w. per day, respectively. LB 
and UB exposure estimates of 0.054 and 0.21 μg/kg b.w. per day were calculated for farmed fish. For 
companion animals, estimated LB and UB exposure for dogs (0.10 and 0.40 μg/kg b.w. per day, 
respectively) were marginally higher than for cats (0.091 and 0.35 μg/kg b.w. per day, respectively). 
Overall, the exposure estimates based on occurrence data in feed indicated that the risk of adverse health 
effects of feed containing nivalenol was low for pigs and poultry. A health risk assessment for 
ruminants, rabbits, fish, horses, dogs and cats could not be carried out because of a lack of toxicological 
data. The Panel noted, however, that the susceptibility of ruminants to nivalenol-mediated toxicity is 
likely to be low, based on the observed detoxification of the compound by de-epoxidation by rumen 
microorganisms.  
3.2.3. T-2 and HT-2 toxin 
In their opinion on the risks for animal and public health related to the presence of T-2 and HT-2 toxin 
in food and feed (EFSA CONTAM Panel, 2011b) the CONTAM Panel derived a LOAEL of 29 µg/kg 
b.w. per day for pigs on the basis of immunological effects seen with T-2 toxin. Gastrointestinal lesions, 
altered serum proteins and haematological lesions were seen in ruminants (lambs or calves) at 
300 µg/kg b.w. per day of T-2 toxin, which could be considered as a LOAEL according to the Panel. A 
NOAEL could not be established for poultry but LOAELs of 40 µg T-2 toxin/kg b.w. per day were set 
each for broiler chickens, turkeys (lesions in the oral cavity) and ducks (reduction in body weight gain) 
and for laying hens at 120 µg T-2 toxin/kg b.w. per day (infertility and reduced number of eggs). For 
rabbits a NOAEL of 100 µg/kg b.w. per day was identified for T-2 based on moderate signs of 
haematological and hormonal effects at 200 – 500 µg/kg b.w. per day. A NOAEL of 13 µg T-2/kg b.w. 
per day for fish was derived from reduced feed intake, growth and haematocrit and increased mortality 
at higher doses. Based on the data available, no NOAELs/LOAELs could be established for horses, 
dogs and cats. 
The occurrence data used for the exposure assessment of animals to T-2 and HT-2 toxin are already 
described in Section 3.1.5.  
Animal exposure to the sum of T-2 and HT-2 toxin is primarily from consuming cereal grains and cereal 
by-products; levels in forages and oilseed meals are generally low. The animals considered were dairy 
cows, beef cattle, sheep and goats, pigs and piglets, hens, broiler chickens, turkeys, ducks, rabbits, fish, 
dogs, cats and horses. The highest UB exposure based on the available occurrence data in feed was for 
milking goats at 3.3 μg/kg b.w. per day and the lowest was for farmed fish at 0.19 μg/kg b.w. per day. 
Based on estimates of feed intake and the available occurrence data on feeding stuffs, the exposures to 
the sum of T-2 and HT-2 toxin for ruminants are substantially lower than the LOAELs identified, and 
are therefore considered unlikely to be a health concern. For pigs and poultry, comparison of the 
estimates of exposure based on the reported levels of the sum of T-2 and HT-2 toxin in feeds to the 
BMDL05 for pigs indicate that the risk of adverse health effects of feed containing T-2 and HT-2 toxin is 
low for these species. 
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The limited data available for rabbits and farmed fish suggest that the estimated exposures to the sum of 
T-2 and HT-2 toxin in feed at the currently reported concentrations is well below the identified 
NOAELs, and therefore considered unlikely to be a health concern. 
For cats, the health risk from the exposure to the sum of T-2 and HT-2 toxin could not be assessed due 
to the lack of sufficient data. For dogs and horses, the estimates of exposure based on the reported levels 
of the sum of T-2 and HT-2 toxin in feeds indicate that the risk of adverse health effects as a result of 
consuming feed containing T-2 and HT-2 toxin is low for these species. 
3.2.4. Fumonisins  
The CONTAM Panel evaluated toxicity of fumonisins in feed for different animal species of relevance 
(EFSA, 2005). Fumonisin B1 was identified as the most toxic fumonisin derivative. Pigs and horses 
have been identified as the species most sensitive to FB1 -mediated toxicity. A LOAEL of 200 µg/kg 
b.w. per day was derived for pigs based on increased sphinganine/sphingosine ratios in serum and for 
horses based on equine leukoencephalomalacias (a condition also associated with increased 
sphinganine/sphingosine ratios). For adult ruminants, a LOAEL was set at 2400 µg/kg b.w. per day 
derived from observations indicative of liver damage in steers, while in calves a NOAEL of 600 µg/kg 
b.w. per day was observed, based on liver changes and impaired blast genesis at higher dose. For 
poultry, a LOAEL of 2 000 µg/kg b.w. per day was derived from increased liver sphinganine and 
sphinganine/sphingosine ratios. In fish (carp) a LOAEL of 10 mg/kg feed was reported based on 
pathological alterations in pancreas, kidney, heart and brain.  
In general, fumonisins are thus far almost exclusively found in maize with levels ranging from 
0.02 mg/kg to sometimes tens of mg/kg. In most samples, fumonisin B1 is the most prevalent toxin 
which co-occurs with fumonisins B2 and FB3. Maize fractions destined for animal feed can be expected 
to contain higher levels of fumonisins than raw materials. Fumonisins in maize components of animal 
feed averaged 24 mg/kg, 8.1 mg/kg, 5.7 mg/kg and 1.1 mg/kg in maize screenings, maize meal, maize 
germ and maize germ bran respectively. It was assumed in the opinion that maize derived feedingstuffs 
for ruminants and monogastric animals would usually account for less than 20 % of the dry matter 
intake. As regards young pigs, assuming that they would feed exclusively on maize, a maximum intake 
of 0.1 mg/kg b.w. per day of fumonisins was estimated. 
3.2.5. Summary table of NOAELs/LOAELs derived for animals in previous assessments 
In Table 2 a summary of the NOAELs/LOAELs derived for zearalenone, nivalenol, T-2 and HT-2 toxin 
and fumonisins is presented. For fumonisins in the studies used for derivation of NOAELs/LOAELs, 
contaminated feed has been used with the exception of poultry for which pure compound has been 
added to feed. For the other Fusarium toxins, experiments were carried out with application of pure 
compound. 
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Table 2:  NOAELs/LOAELs in animals for zearalenone, nivalenol, T-2 and HT-2 toxins and 
fumonisins  
 Compound  NOAELs/LOAELs  Reference 
Zearalenone No NOAELs/LOAELs set because of inadequate data.  
Pigs and sheep identified as most susceptible species.  
 
Pigs – NOEL: 10 µg/kg b.w. per day (oestrogenic effects) 
This NOEL was used to derive the human TDI. 
 
Guidance values feed (2006/576/EC): 0.1 mg/kg for compound feed for 
piglets and gilts, 0.25 mg/kg for sows and fattening pigs and 0.5 mg/kg 
for dairy cattle, sheep (including lamb) and goats (including kids). 
EFSA (2004) 
 
 
EFSA CONTAM 
Panel (2011a) 
Nivalenol Pigs – LOAEL: 100 µg/kg b.w. per day (gastro intestinal-, kidney-, and 
spleen pathology, ↑ IgA plasma) 
Poultry – LOAEL: 53 µg/kg b.w. per day (liver and kidney effects) 
No NOAELs/LOAELs set for ruminants, rabbits, fish and companion 
animals because of lack of data. No guidance values set. 
EFSA CONTAM 
Panel (2013) 
T-2 and HT-2 
toxins (based 
on T-2 toxin) 
Pigs – LOAEL: 29 µg/kg b.w. per day  (immunological/ 
haematological effects) 
Ruminants – LOAEL: 300 µg/kg b.w. per day (gastro intestinal and 
haematological lesions, altered serum protein) 
Poultry – LOAEL: 40 µg/kg b.w. per day (oral cavity lesions) 
Rabbits – NOAEL: 100 µg/ kg b.w. per day (haematological/hormonal 
effects) 
Fish – NOAEL: 13 µg/kg b.w. per day (↓ feed intake, ↓ growth, 
haematocrit, ↑ mortality) 
No NOAELs/LOAELs derived for companion animals.  
 
Indicative value for feed (2013/165/EU) is 250 µg/kg, and the guidance 
value (2013/637/EU) is 50 µg/kg for cats (2006/576/EC, as amended).  
EFSA CONTAM 
Panel (2011b) 
Fumonisins 
(based on 
fumonisin B1) 
Pigs - LOAEL: 200 µg/kg b.w. per day ( ↑ sphinganine/ sphingosine 
ratios in serum) 
Ruminants – NOAEL: 600 µg/kg b.w. per day (liver changes, 
impaired blastogenesis) 
Poultry – LOAEL: 2000 µg/kg b.w. per day (↑ sphinganine and 
sphinganine/ sphingosine ratios in liver)  
Fish – LOAEL: 10 mg/kg feed (organ pathology) 
 
Horses – LOAEL: 200 µg/kg b.w. per day (equine 
leukoencephalomalacias which are associated with with ↑ 
sphinganine/sphingosine ratios) 
 
Guidance values feed (2006/576/EC): 5 mg/kg for compound feed for 
pigs, horses (Equidae), rabbits and pet animals, 20 mg/kg for poultry, 
calves (< 4 months), lambs and kids, 50 mg/kg for adult ruminants (> 4 
months) and mink. 
EFSA (2005) 
HBGV: Health-Based Guidance Value; b.w.: body weight; TDI: Tolerable Daily Intake; NOAEL: No Observed Adverse Effect 
Level; NOEL: No Observed Effect Level; LOAEL: Lowest Observed Adverse Effect Level; UF: Uncertainty Factor; ↑: 
increased; ↓ decreased. 
4. Chemistry of modified forms of certain mycotoxins 
As will be discussed in more detail in Section 5, modified mycotoxins are usually formed via 
conjugation of the parent fungal metabolite (mycotoxin) in plants. The predominant pathway is 
glycosylation, sometimes followed by subsequent metabolic steps to facilitate compartmentation. These 
pathways are not unique for mycotoxins but are also used by plants to metabolize other xenobiotics, 
e.g. pesticides, or secondary plant metabolites, e.g. flavonoids. 
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In contrast to the chemistry of the parent mycotoxins, which has been thoroughly studied in most cases, 
very little is known about the chemistry of modified forms of mycotoxins to date. In many cases, the 
evidence for the formation of modified mycotoxins is limited to their detection by high-performance 
liquid chromatography–mass spectrometry (HPLC-MS), and structural identification is preliminary and 
mostly based on data obtained by MS and tandem MS (MS/MS). These methods do not provide 
information on the exact structure of the attached mono- or disaccharide group and the regio- and 
stereoisomerism. Only in rare cases have glycosides of mycotoxins been chemically synthesized and 
rigorously identified by methods such as nuclear magnetic resonance (NMR) spectroscopy, e.g. 
deoxynivalenol-3-glucoside and zearalenone-14-glucoside. Therefore, only limited information is 
available at present on the chemistry of the modified forms of most mycotoxins covered in this opinion, 
and it will be given together with the chemical information on the parent (unconjugated) toxins. In 
addition to the chemical composition, data on the ultraviolet (UV) absorbance and, in some cases, 
fluorescence of the toxins is included (Sydenham et al., 1996). UV absorbance of the parent mycotoxin 
is, in general, not affected by conjugation and therefore useful for the analysis of both the parent 
compounds and the modified forms, e.g. by HPLC with UV detection.  
For most monoglycosylated mycotoxins, it is assumed that a ß-D-glucopyranoside group (Figure 1) is 
attached to a hydroxyl group of the parent mycotoxin. In some cases, e.g. for zearalenone, the formation 
of a malonylglucoside and a sulphate (Figure 1) has been demonstrated. However, it should be noted 
that the exact structures of the malonylglucoside has not been proven for modified mycotoxins but is 
inferred from modified pesticides and modified phytochemicals, e.g. flavonoids. In rare cases, e.g. with 
type B trichothecenes, glutathione and cysteine have been identified as conjugate groups. 
 
 
 
                                                                                                                               
 
             ß-D-Glucopyranoside            6’-Malonyl-ß-D-glucopyranoside                  Sulphate 
            (ß-D-Glcp)                              (6’-Malonyl-ß-D-Glcp)    (Sulf) 
Figure 1:  Carbohydrate and sulphate groups attached to mycotoxins to yield the modified forms 
 
4.1. Terminology, abbreviations and synonyms 
Most mycotoxins have complex names. It is common to use abbreviations even for the parent 
compounds. The names of the modified mycotoxins become inevitably more unwieldy due to the 
addition of the conjugate moieties. At present, the abbreviations used in the scientific literature for 
several parent mycotoxins and their modified forms are not consistent. For example, zearalenone is 
abbreviated by some authors and journals as ZEA, while others use ZON or ZEN (Metzler, 2011). 
Glucosides are commonly designated by attaching the abbreviation Glc, Gluc or G. However, the last 
two are sometimes also used for glucuronides. Moreover, different numbering systems are still in place 
for some mycotoxins, which complicates the unambiguous designation of the chemical structures of 
modified mycotoxins, i.e. at which position the conjugate moiety or other chemical groups are attached 
to the parent toxin. An example is again zearalenone with its conjugated and hydroxylated metabolites 
(Metzler, 2011). 
O
HO OH
OHO
OH
2'
1'
3'
4'
5'
6'
O
HO OH
OHO
O OH
O O
6'
O SO3
 Modified mycotoxins in food and feed 
 
EFSA Journal 2014;12(12):3916 19 
An unequivocal system of abbreviations and numbering is proposed below. This system would avoid 
confusion and facilitate the reading of publications from different institutions, and it is expandable to 
meet future demands. 
Table 3 provides a summary of the abbreviations used for parent mycotoxins and their conjugate 
groups. Only mycotoxins dealt with in this opinion are included, and the abbreviations are divided into 
those used in this opinion and others used synonymously in the scientific literature. The abbreviations 
for the parent mycotoxins in this opinion were selected based on their unambuiguity and wide-spread 
use. For conjugates with carbohydrates, a nomenclature is proposed for this opinion which is used in 
carbohydrate chemistry and which clearly designates the specific carbohydrate (e.g. Glc for glucose, 
Man for mannose, Xyl for xylose etc) and its oxidation state (e.g. Glc for glucose, GlcA for glucuronic 
acid). Although at present the number of different carbohydrates found in modified mycotoxins is very 
limited, research on conjugates of secondary plant metabolites (e.g. flavonoids) and pesticides in plants 
leaves little doubt that the diversity of carbohydrates found in conjugated mycotoxins will increase in 
the future. Moreover, it is to be expected that mycotoxins bind covalently to plant cell walls or other 
cellular macromolecules via carbohydrate conjugate groups. The chemical structures of such bound 
mycotoxins can be easily described by the proposed nomenclature, which is suitable to abbreviate even 
very complex polysaccharides. In cases where the specific carbohydrate is unknown, no abbreviation 
should be used and the name should indicate the class of carbohydrate (e.g. hexoside or pentoside). 
In addition to the parent mycotoxin and its conjugate group, the sites of the covalent bonding on both 
moieties and, in the case of carbohydrates, the type of ring (e.g. pyranose or furanose) should be given 
for a complete designation of the modified mycotoxin. So far, only glycosidic bonding, i.e. bonding at 
the C-1 of the carbohydrate molecule, of D-configurated carbohydrates  has been described for modified 
mycotoxins. In many cases, however, the stereochemistry of the glycosidic bond (α or ß), the type of the 
carbohydrate ring (pyranose or furanose), and/or the site of bonding to the mycotoxin are not known. 
The proposed nomenclature can deal with all situations, e.g. ZEN-Glc (glucose conjugate of ZEN with 
unknown site and stereochemistry of bonding and type of ring), ZEN-14-O-Glc (short form ZEN14Glc, 
glucose conjugate with unknown ring type bonded to the 14-hydroxyl group of ZEN), or ZEN-14-O-ß-
D-Glcp (short form ZEN14ßDGlc, D-glucopyranose with a ß-glycosidic bond to the 14-hydroxyl group 
of ZEN). Even non-glycosidic bonding can be indicated by using the style common in carbohydrate 
chemistry, making this abbreviation system highly versatile for future developments in the field of 
modified mycotoxins.  
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Table 3:  Abbreviations and synonyms for parent mycotoxins and their conjugate groups 
Mycotoxin Proposed abbreviation Synonym 
Zearalenone ZEN ZEA, ZON, Z 
Zearalenol ZEL ZOL 
Zearalanone ZAN  
Zearalanol ZAL  
Nivalenol NIV  
Fusarenon-X FUS-X FusX 
T-2 toxin  T2  
HT-2 toxin HT2  
Deoxynivalenol DON D 
Acetyldeoxynivalenol Ac-DON A-DON, ADON 
3-Acetyldeoxynivalenol 
15-Acetyldeoxynivalenol 
Neosolaniol 
3Ac-DON 
15Ac-DON 
NEO 
 
 
NeoSol 
Diacetoxyscirpenol DAS  
Ochratoxin A OTA OA 
Ochratoxin B OTB OB 
Ochratoxin α OTα  
Fumonisin B FB FumB, FUMB 
Hydrolyzed fumonisin B HFB  
Partially hydrolysed fumonisin B PHFB  
N-deoxyfructos-1-yl fumonisin B NDF-FB  
N-carboxymethyl fumonisin B NCM-FB  
Patulin PAT PT 
Glucoside Glc G 
Glucuronide GlcA GA, G 
Sulphate Sulf S 
 
4.2. Zearalenone and other resorcylic acid lactones (RALs)  
Zearalenone was the first mycotoxin for which transformation to the ß-D-glucopyranoside was 
demonstrated in wheat and maize cell cultures (Engelhardt et al., 1988) and the term “masked 
mycotoxin” was coined (Gareis et al., 1990). 
Zearalenone (ZEN, Figure 2) is the trivial name for 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-
1H-2-benzoxacyclotetradecin-1,7(8H)-dione (Chemical Abstracts Service (CAS) No. 17924-92-4, 
C18H22O5, molecular weight (MW) 318). ZEN is a macrocyclic ß-resorcylic acid lactone (RAL) 
produced by Fusarium spp. (reviewed in Chełkowski, 1998). Besides ZEN there are several other 
closely related RALs formed in fungal cultures, e.g α-zearalenol (α-ZEL, Figure 2) and β-zearalenol (ß-
ZEL, Figure 2) (Pfeiffer et al., 2010).  
 
 
 
 
                       ZEN                                                α-ZEL                                            ß-ZEL 
Figure 2:  Zearalenone (ZEN) and the α- and ß-form of zearalenol (ZEL) 
O
OH
HO
O
O
10
1
5
11
3 4
612
7
13
8
15
9
16
H CH3
O
OH
HO
O
7
14
16
H CH3
H
OH
O
OH
HO
O
7
14
16
H CH3
OH
H
 Modified mycotoxins in food and feed 
 
EFSA Journal 2014;12(12):3916 21 
The following UV absorption maxima and molar extinction coefficients were measured by Sydenham et 
al. (1996) for ZEN in methanol: λmax 235 nm (29 200), 274 (13 040), 316 (5 870); for ß-ZEL in 
methanol: λmax 236 nm (26 030), 274 (11 130), 316 (4 620). Fluorescence of ZEN (in methanol): 
Excitation at 315 nm, emission at 460 nm; ß-ZEL (in methanol): Excitation at 315 nm, emission at 
460 nm. 
As ZEN has two hydroxyl groups, i.e. at positions 14 and 16, two regioisomeric monoglucosides can 
theoretically be formed. ZEN-14-O-ß-D-glucopyranoside (ZEN14ßDGlcp, C24H32O10, MW 480) was 
first identified and characterized with 
1
H- and 
13
C-NMR spectroscopy as a transformation product of 
ZEN by Rhizopus spp. (Kamimura, 1986). Chemical synthesis by Zill et al. (1990) and Grabley et al. 
(1992) from ZEN yielded ZEN14ßDGlcp (which was then termed 4-glucoside because a different 
numbering system was used for ZEN) with high yield and purity, and the structure of the Rhizopus 
biotransformation product was confirmed by identical 
1
H-NMR spectra. The occurrence of 
ZEN14ßDGlcp has since been repeatedly demonstrated both in plant cell cultures and other in vitro 
systems as well as a contaminant in moldy cereal products (see Section 8 on Occurrence of modified 
forms of certain mycotoxins in food and feed). 
The regioisomeric ZEN16ßDGlcp (C24H32O10, MW 480) has only very recently been detected in an in 
vitro system, i.e. yeast cells expressing a barley UDP-glucosyltransferase, and the structure confirmed 
by 
1
H- and 
13
C-NMR spectroscopy (Kovalsky Paris et al., 2014).  
The transformation of ZEN to α-ZEL and ß-ZEL (Figure 2) and the subsequent glycosylation of the 
three mycotoxins was observed in maize cell suspension cultures (Engelhardt et al.,1999) and in the 
model plant Arabidopsis thaliana based on HPLC-MS/MS analysis (Berthiller et al., 2006). Using an 
engineered yeast system expressing an Arabidopsis thaliana UDP glucosyltransferase, Berthiller et al. 
(2009) obtained the pure monoglucosides of α-ZEL and ß-ZEL in sufficient amounts for 1H- and 13C-
NMR spectroscopy and established their chemical structures as 14-O-ß-D-glucopyranosides (C24H34O10, 
MW 482). Chemical reduction with sodium borohydride of the keto group at position 7 of 
ZEN14ßDGlcp gave rise to a 1:1 mixture of the 14-O-ß-D-glucopyranosides of α-ZEL and ß-ZEL, 
which were identical in HPLC-MS/MS with the plant metabolites (Berthiller et al., 2009). More 
recently, Mikula et al. (2013) reported on the chemical synthesis of the 14-O-ß-D-glucopyranosides of 
α-ZEL and ß-ZEL by regioselective Königs-Knorr glucuronidation of ZEN followed by reduction of the 
7-keto group with sodium borohydride, which also led to a partial reduction of the protected glucuronic 
acid group. 
In the study of Berthiller et al. (2006) in Arabidopsis thaliana, more than 10 additional conjugated 
metabolites of ZEN, α-ZEL and ß-ZEL were detected by HPLC-MS/MS, including malonylglucosides, 
dihexosides (presumably diglucosides) and pentosylhexosides (presumably xylosylglucosides). 
However, the exact chemical structures of these conjugates still have to be elucidated.  
A sulphate conjugate of ZEN was isolated from a culture of Fusarium graminearum by Plasencia and 
Mirocha (1991). On the basis of fast-atom-bombardment mass spectrometry, 
1
H NMR and UV 
spectroscopy, and chemical and enzymatic reactions, the structure of ZEN14Sulf (C18H21O8S
-
, MW of 
the anion 397) was determined (termed ZEN4Sulf according to the old numbering system). The 
conjugate is soluble in water, methanol, ethanol, and ethyl actetate, slightly soluble in chloroform, and 
insoluble in hexane, benzene and petroleum ether. ZEN14Sulf was also formed in cultures of other 
Fusarium strains (Plasencia and Mirocha, 1991), and of Rhizopus arrhizus (El-Sharkawy et al., 1991). 
ZEN14Sulf appears to be a frequent contaminant of cereal-based food and feed (see Section 5). 
Recently, ZEN14Sulf has also been detected by LC-MS/MS in liquid cultures of two Aspergillus oryzae 
strains and seven Rhizopus species (Brodehl et al., 2014). These fungi are used for food processing, e.g. 
the fermentation of soy products. As a further modified mycotoxin, the sulphate conjugate of α-ZEL 
(C18H23O8S
-
, MW of the anion 399) has been demonstrated in eight out of nine of these cultures by LC-
MS/MS, but the exact position of the sulphate group (C-7, C-14, or C-16) is not known. 
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4.3. Trichothecenes (nivalenol, fusarenon-X, T-2 toxin, HT-2 toxin, diacetylscirpenol, 
neosolaniol) 
Trichothecenes comprise a large group of mycotoxins, which are produced by Fusarium species. 
Approximately 180 congeners have been discovered so far. The chemical structures of the 
trichothecenes discussed in this opinion and of DON are depicted in Figure 3.  
 
 
 
 
 
 T2:  R = COCH3 NIV:  R = H 
               HT2:  R = H FUS-X:  R = COCH3 
 
 
 
 
 
  DON:  R1 = R2 = H  
 DAS:  R = H 3Ac-DON:  R1 = COCH3; R2 = H  
 NEO:  R = OH 15Ac-DON:  R1 = H; R2 = COCH3 
Figure 3:  Chemical structures of the type A trichothecenes T-2 toxin (T2), HT-2 toxin (HT2), 4ß,15-
diacetoxyscirpenol (DAS), neosolaniol (NEO), and the type B trichothecenes nivalenol (NIV), 
fusarenon-X (FUS-X), deoxynivalenol (DON), 3-acetyldeoxynivalenol (3Ac-DON) and 15-
acetyldeoxynivalenol (15Ac-DON) 
Trichothecenes share a tetracyclic sesquiterpenoid 12,13-epoxy-trichothec-9-ene ring system and are 
divided into four groups (A-D) according to different functional groups. Whereas type A and B 
trichothecenes are frequently found as contaminants in cereals and other commodities, type C and D 
trichothecenes occur only rarely in food and feed. Typical type A trichothecenes, which all have either 
no substituent or a functional group other than a ketone at the C-8 position, are T-2 toxin, HT-2 toxin, 
neosolaniol, and 4ß,15-diacetoxyscirpenol (Figure 3). Type B trichothecenes all have a keto group at the 
C-8 position and include nivalenol, fusarenon-X, deoxynivalenol, 3-acetyldeoxynivalenol and 15-
acetyldeoxynivalenol (Figure 3). 
Nivalenol (NIV, Figure 3) is the trivial name for 3α,4β,7α,15-tetrahydroxy-12,13-epoxy-trichothec-9-
en-8-one (CAS  No. 23282-20-4, C15H20O7, MW 312). Nivalenol is a white crystalline powder with a 
melting point of 222-223 °C and its specific rotation has been determined as [α]24D = + 21.54° 
(c = 1.3 mmol/L in ethanol) (Tatsuno et al., 1968). It is soluble in organic solvents of medium to high 
polarity, such as acetonitrile, methanol, ethanol, ethyl acetate and chloroform, and slightly soluble in 
water (Budavari, 1989). In methanol, nivalenol has a maximum UV absorption at 221 nm and a molar 
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absorption coefficient (ε) of 6470 L/mol; after excitation at 240 nm, its fluorescence light is emitted at 
480 nm (Sydenham et al., 1996). 
Fusarenon-X (FUS-X, Figure 3) has the chemical name 3α,7α,15-trihydroxy-4ß-acetoxy-12,13-epoxy-
trichothec-9-en-8-one (CAS No. 23255-69-8, C17H22O8, MW 354)  is a biosynthetic precursor of NIV 
containing an acetyl group at the 4-hydroxy position of NIV. In methanol, FUS-X has a maximum UV 
absorption at 229 nm and a molar absorption coefficient (ε) of 6 920 L/mol; after excitation at 238 nm, 
its fluorescence light is emitted at 480 nm (Sydenham et al., 1996). 
In HPLC-MS/MS studies of wheat grain artificially infected with Fusarium fungi, two compounds were 
detected which were tentatively identified as 3-O-monoglucosides of NIV and FUS-X on the basis of 
accurate mass measurements, characteristic ions and MS/MS fragmentation patterns (Nakagawa et al., 
2011). The elemental formulas and molecular weights are C21H30O12 and 474 for the putative NIV3Glc, 
and C23H32O13 and 516 for FUS-X3Glc, respectively.  
T-2 toxin (T2, Figure 3) is the trivial name for 3α-hydroxy-4β,15-diacetoxy-8α-(3-methylbutoxy)-
12,13-epoxy-trichothec-9-ene (CAS No. 21259-20-1, C24H34O9, MW 466). T2   forms white needles 
with a melting point of 151-152 °C (Bamburg et al., 1968) and has a specific rotation of [α]26 D = +15° 
(c = 2.58 in 95 % ethanol) (Pohland et al., 1982). The structure of HT-2 toxin (HT2, Figure 3) differs 
from that of T2 toxin only by the loss of the acetyl group at the C4-position. Accordingly, HT2 has the 
chemical name 3α,4ß-dihydroxy-15-acetoxy-8α-(3-methylbutoxy)-12,13-epoxy-trichothec-9-ene (CAS 
No 26934-87-2, C22H32O8, MW 424). The melting point of HT2 is similar to that of T2, at 151-152 °C. 
At room temperature HT2 toxin forms white crystals. The solubility of both T2 and HT2 is poor in 
water but good in most organic solvents including methanol, ethanol, acetone, chloroform, ethyl acetate, 
diethyl ether and acetonitrile (Yates et al., 1968). T2 and HT2 have no UV absorption at wavelengths 
above 220 nm (Sydenham et al., 1996). 
Monoglucosides of T2 (C30H44O14, MW 628) and HT2 (C28H42O13, MW 586) were tentatively identified 
in solid and liquid cultures of Fusarium sporotrichioides recently, using HPLC-MS/MS methodology 
(Busman et al., 2011). Based on the availability of hydroxyl groups and in analogy to other 
trichothecenes, the authors proposed that glycosylation has occurred at the 3-hydroxyl group. 
Production of the two glucosides was also observed in kernels from wheat and oat inoculated with F. 
sporotrichioides in the same study and in isolates of Fusarium langsethiae from wheat in Italy 
(Lattanzio et al., 2013). 
Diacetylscirpenol (DAS, Figure 3) is 3α-hydroxy-4ß,15-diacetoxy-12,13-epoxy-trichothec-9-ene (CAS 
No. 2270-40-8, C19H26O7, MW 366).  
Neosolaniol (Figure 3) is 3α,8α-dihydroxy-4ß,15-diacetoxy-12,13-epoxy-trichothec-9-ene (CAS No. 
36519-25-2, C19H26O8, MW 382) and thus the 8α-hydroxylated derivative of DAS. Like other type A 
trichothecenes, DAS and NEO are soluble in moderately polar solvents, such as chloroform, diethyl 
ether, ethyl acetate, and acetone. DAS and NEO have no UV absorption at wavelengths above 220 nm 
(Sydenham et al., 1996). 
Monoglucosides of DAS (C25H36O12, MW 528) and NEO (C25H36O13, MW 544) were identified by 
HPLC-MS/MS in isolates of F. langsethiae from wheat in Italy (Lattanzio et al., 2013).  
Deoxynivalenol (DON) and the isomeric monoacetylated 3-acetyl-DON (3Ac-DON) and 15-acetyl-
DON (15Ac-DON) are type B trichothecences. Their chemical formulas are depicted in Figure 3. 
However, these compounds will not be discussed here since they are covered by a separate request.   
4.4. Fumonisins 
Fumonisins are a group of mycotoxins produced by various Fusarium fungi and are frequently found in 
stored maize worldwide. They are long-chained aliphatic amines carrying methyl and hydroxyl groups 
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at various positions of the aliphatic chain. Two of the hydroxyl groups are esterified with tricarboxylic 
acids. The dominant fumonisins found as food contaminants belong to the B group and comprise FB1 to 
FB4 (Figure 4). FB1 is chemically described as 1,2,3-propanetricarboxylic acid, 1,1’-[1-(12-amino-
4,9,11-trihydroxy-2-methyltridecyl)-2-(1-methylpentyl)-1,2-ethanediyl]ester (CAS No. 116355-83-0, 
C34H59NO15, MW 721). Alkaline treatment leads to partially or fully hydrolyzed fumonisins, in which 
one or both of the tricarboxylic acid moieties are cleaved off. Fumonisins have no UV absorption at 
wavelengths above 200 nm (Sydenham et al., 1996). 
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Figure 4:  Fumonisins of the B group 
Multiple forms of fumonisins occur in food. In addition to free aglycones, the parent compounds are 
physically entrapped into the structure of macromolecular components such as starch or proteins and 
only extractable after hydrolysis of the macromolecules (Dall’Asta et al., 2010). Depending on the 
conditions of the hydrolysis, partially or fully hydrolyzed  fumonisins are released. Owing to the 
presence of an amino group (at C2, see Figure 4) and the carboxyl groups, fumonisins can undergo 
various chemical reactions, e.g. Maillard-type reactions with carbohydrates or ester/amide formation 
with proteins or carbohydrates. Such reactions occur during thermal processing of food (Humpf and 
Voss, 2004) and give rise to a multitude of products, which causes a major analytical problem. 
 The occurrence of fumonisins esterified with fatty acids has only recently been reported (see Section 5). 
The structures of 3-O- and 5-O-linoleoyl-FB1 (C52H89NO16, MW 983), 3-O- and 5-O-oleoyl-FB1 
(C52H91NO16, MW 985), and 3-O- and 5-O-palmitoyl-FB1 (C50H89NO16, MW 959) were proposed for six 
esterified FB1 isomers detected in small amounts in a Fusarium verticillioides-inoculated rice culture 
(Bartók et al., 2013). Even lower amounts of the respective N-acyl-FB1 isomers were found in the same 
culture. 
4.5. Modified forms of other mycotoxins 
There is evidence for the formation of modified forms for a few other mycotoxins, i.e. ochratoxin A 
(Ruhland et al., 1996a, b), destruxin B (Pedras et al., 2001), patulin (Fliege and Metzler, 2000; Baert et 
al., 2007) and the Alternaria toxins alternariol and alternariol-9-O-methylether (Hildebrand et al., in 
press), however data are very limited. As these toxins are not included in the Terms of Reference, they 
will not be discussed in this opinion. 
5. Natural occurrence and environmental fate 
The term “masked mycotoxins” was first introduced by Gareis et al. (1990) to define a mycotoxin 
derivative that may be cleaved during digestion in mammals to release its parent form. After  more than 
a decade, soluble and insoluble conjugates of mycotoxins that can be formed upon chemical or 
biochemical reaction fall under the umbrella of this definition. A tentative comprehensive classification 
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is reported in Figure 5, mainly based on the mechanism of masking (modified from Rychlik et al., 
2014). Compounds deriving from chemical reactions occurring upon processing, as described in Section 
8.4, are also reported in the figure. 
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Figure 5:  Summary table with main modified mycotoxin species and respective pathways  
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Modified mycotoxins are mainly produced by plants via enzymatic transformations related to 
detoxification processes (phase II metabolites) and have been related to a resistance mechanism exerted 
by plants to counteract pathogen invasion (Lemmens et al., 2005; Berthiller et al., 2007, 2013).  
Mycotoxin accumulation in plants mainly occurs in the field, upon fungal infection during the growing 
season. These toxic compounds are able to interact with vital cell functions, thus being a target of the 
plant’s metabolic detoxification processes. Two main detoxification systems are reported for plants: 
chemical modification and compartmentation.  
Chemical modification in plants is commonly exerted via conjugation reactions, involving residues such 
as glucose, malonic acid and glutathione (GSH, -glutamyl-cysteinyl-glycine). Commonly, glycosyl 
residues are added to hydroxyl, thiol, amino and carboxy groups on the parent compound, while 
malonyl residues are added to hydroxyl and amino groups. Electrophilic sites on the parent compounds 
are more prone to conjugation to GSH residues. These phase II reactions, commonly catalyzed by 
glucosyl-, malonyl- and glutathione-S-transferases, generate more water-soluble compounds, which can 
be better eliminated from the cytosol via membrane-bound transporters into the vacuolar or apoplastic 
space. (Marrs, 1996; Berthiller et al., 2013). In general, these conjugates are assumed to be less toxic for 
the generating organism (i.e. plants) than the parent compounds.  
Among detoxification enzymes, the activity of UDP-glucosyl-transferases (UGT) and glutathione-S-
transferases (GSTs) to chemicals have been mainly studied in plants (Dixon et al., 1998; Brazier et al., 
2002). 
Since plants are not able to exert active elimination, compartmentation plays a very important role in the 
detoxification system. Through the sequestration of conjugates into the vacuole or their irreversible 
binding to cell walls, detoxification products are permanently stored in the plant tissue rather than 
excreted. Compounds that are sufficiently polar, can undergo compartmentation in their parent form. 
It has been proven that, upon fungal infection, an intense plant-pathogen cross-talk takes place and 
regulates both fungal infection and mycotoxin accumulation. In response to microbial attack, plants 
activate a complex series of responses that lead to the local and systemic induction of a broad spectrum 
of antimicrobial defenses (Berthiller et al., 2013). At the same time, the pathogen activates similar 
systems, to alter host defense responses, and thus to promote pathogen virulence and disease production. 
Both plant and pathogen signaling systems may involve  different pathways, among those lipid-derived 
compounds (i.e. jasmonates and oxylipins) play a crucial role (Gao et al., 2007, 2009; Tsitsigiannis and 
Keller, 2007; Brodhagen et al., 2008).  
A number of ongoing studies are addressing the role played by the plant-pathogen cross-talk and by the 
plant’s ability to express UGTs and GSTs in the mycotoxin accumulation and masking, but conclusive 
results are still lacking. 
As an example, significant correlations between specific quantitative trait loci (QTLs) in field resistance 
against Fusarium Head Blight disease and ability to convert DON into DON3G have been pointed out 
in soft wheat (Lemmens et al., 2005). Similar studies have also preliminarily addressed the formation of 
DON3G in barley and durum wheat (Gardiner et al., 2010; Cirlini et al., 2014). 
Although, among Fusarium mycotoxins, the conversion of ZEN, DON, T2 and HT2, FUS-X, NIV, 
DAS and NEO to their modified forms has been reported so far (Schneweis et al., 2002; Berthiller et al., 
2005; Nakagawa et al., 2011, 2013; Lattanzio et al., 2013), the occurrence of modified forms in 
naturally infected cereals and products thereof have only been described for DON and ZEN (Berthiller 
et al., 2013; De Boevre et al., 2013). In addition, one recent study reports the occurrence of fatty acid 
esters of fumonisins in naturally infected maize (Falavigna et al., 2013).  
Zearalenone-14-glucoside (ZEN14Glc) was the first modified mycotoxin to be discovered and 
characterized: its formation was indeed demonstrated in maize cell cultures (Engelhardt et al., 1988), 
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and then its fate after ingestion in pigs was described (Gareis et al., 1990).  Its occurrence was later 
described in a wide range of grains  (Schneweis et al., 2002; De Boevre et al., 2013). Deoxynivalenol-3-
glucoside (DON3Glc) (Berthiller et al., 2013; De Boevre et al., 2013) is, however, the most reported 
modified mycotoxin, along with the two acetylated derivatives of DON (15-acetyldeoxynivalenol, 
15Ac-DON and 3-acetyldeoxynivalenol, 3Ac-DON), being proven to frequently occur in naturally 
infected cereals such as wheat, barley and maize. Besides them, zearalenone-14-sulphate (ZEN14Sulf) 
was also described in cereal-based products (Vendl et al., 2010). In addition, polyglycosylated forms 
and glutathione- or cysteyl- conjugates forms have been described mainly for type B trichothecenes 
(Lattanzio et al., 2013; Kluger et al., 2013).  
There is also strong evidence for the compartmentation of fumonisins in plants; occurrence of these 
physically entrapped forms has been proven in raw maize as well as in derived food, although the nature 
of the masking mechanism has not been completely clarified (Dall’Asta et al., 2009a, 2010). Several 
studies demonstrated a good correlation between associative forms of fumonisins (so-called “hidden 
fumonisins”) and the fatty acid profile in maize grown in the field under natural conditions (Dall’Asta et 
al., 2012). Since, fatty acids are strongly implied in the plant-pathogen interaction, such complexation 
may occur as a consequence of the cross-talk with an elicitation of the oxylipin pathways in maize 
(Scala et al., 2013). Very recently, the occurrence of FB1 fatty acid esters in naturally infected corn 
kernels has been described (Falavigna et al., 2013). Although already reported by Bartok et al. (2010) in 
artificially inoculated rice, these compounds have never been described before in corn. In particular, the 
derivatives formed by FB1 esterification with oleic and linoleic acids have been detected. These strongly 
hydrophobic compounds seem to accumulate in at least highly infected kernels, but it is still unclear if 
they are formed by the fungus or by the plant (Falavigna et al., 2012, 2013).  
Similarly, Bartok et al. (2014) reported the occurrence of N-palmitoyl-, N-oleoyl- and N-linoleoyl-FB1 
derivatives in rice cultures of F. verticillioides. However, no data on natural occurrence in maize or 
other cereals are available so far. 
6. Methods of analysis 
Parent mycotoxins in food- and feedingstuffs are commonly analysed by chromatographic methods, 
including thin layer chromatography (TLC), gas-chromatography (GC) or liquid chromatography (LC), 
and immunochemical methods such as enzyme-linked immunosorbent assay (ELISA).  
Commonly two different approaches are reported in the literature to detect modified mycotoxins, 
defined as “direct” and “indirect” methods.  
Direct methods are targeted to determine the conjugated forms as they are. This approach usually is 
based on MS analysis and requires standard calibrants as well as reference materials for validation. 
Besides DON3Glc, direct methods have been developed mainly for ZEN derivatives, since calibrants 
can be rather easily synthesized. Although very reliable, only a few validated direct methods have been 
reported in the literature so far, owing to the common lack of analytical standards. Most of them have 
been recently reviewed by Cirlini et al. (2012) and Berthiller et al. (2013). 
 Indirect methods are commonly based on chemical and/or enzymatic treatments to cleave the 
conjugated forms and release the parent compound. In such a way, the sum of “parent and modified” 
forms will be simultaneously detected in the sample. The indirect approach can be potentially applied to 
all modified forms, it works with all the most common chromatographic or immunochemical techniques 
and it does not requires any specific calibrant, besides the parent compound. In addition, insoluble 
modified forms, such as DON bound to cell walls or matrix-entrapped fumonisins, can be detected only 
by indirect methods. The main drawback is actually due to the efficacy of the cleavage reaction in 
different matrices. Indirect methods are available for fumonisins as well as modified forms of 
trichothecenes and zearalenone. 
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6.1. Sampling and storage 
Concerning the sampling of modified mycotoxins, the strategies commonly used for their parent 
compounds are also suitable for conjugates (Van Egmond et al., 2007). Sampling methods are thus in 
agreement with the current sampling legislation (Commission Regulation (EC) No 401/2006
19
). It must 
be underlined here that the sampling step is a key step for the accurate and reliable determination of 
parent and modified mycotoxins in food and feed. 
Modified mycotoxins are rather stable under laboratory conditions, but no specific study has been 
performed so far to assess their stability during storage (Berthiller et al., 2009).  
6.2. Extraction, sample clean-up and concentration 
Usually, the extraction procedure of modified mycotoxins requires the use of a more polar solvent 
mixture than for their parent compounds; the mostly used solvent mixtures are based on water, methanol 
and/or acetonitrile, in different percentages. It has to be considered, however, that conjugates are usually 
more polar than that used their parents, and that conjugated and parent forms generally co-occur in food. 
The extraction procedure, thus, should allow the simultaneous extraction of both forms with comparable 
recoveries. 
6.3. Modified  forms of zearalenone  
Extraction mixtures for ZEN, αZEL and βZEL and their naturally-occurring modified forms are based 
on acetonitrile and water in different ratios (Cirlini et al., 2012; Berthiller et al., 2013), eventually 
acidified with acetic acid (Sulyok et al., 2006). The pH of the media seems to play a crucial role: since 
the glycosylated conjugates are more polar than their parent compounds, Vendl et al. (2009) studied the 
efficiency of different extraction mixtures in neutral, acidic, neutral polar and acidic polar conditions, 
using maize samples spiked with multi-mycotoxin standard solutions containing ZEN, ZEN14Glc and 
ZEN14Sulf. Results showed that the use of a high water content in the extraction solvent causes lower 
recoveries for ZEN and its derivatives, than in neutral or acid organic mixtures.  
De Boevre and coworkers used a mixture of acetonitrile/water in combination with a hexane defatting 
step, for simultaneous extraction of DON, ZEN, T-2 and 10 metabolites thereof (De Boevre et al., 2012, 
2013). It was reported that neutral and acidic extraction gave similar results for DON3Glc, 3Ac-DON, 
ZEN14Glc, αZELGlc and βZELGlc (Vendl et al., 2009). Using a higher proportion of water reduced the 
recovery of non-polar toxins. Acidic conditions slightly improved the recovery of DON and 
significantly improved the yield of ZEN. 
After sample extraction, the clean up step is usually skipped to avoid further losses, and the extract is 
directly analysed by LC-MS/MS, using the so-called “dilute and shoot” approach (Sulyok et al., 2006).  
Concerning indirect methods, ß-glucosidase, cellulase and cellobiase have been used to cleave 
ZEN14Glc, obtaining an almost quantitative release of ZEN (Beloglazova et al., 2013).  
6.4. Modified forms of trichothecenes 
As reported for ZEN derivatives, the best recovery is obtained also for trichothecenes and their modified 
forms when acetonitrile and water in different ratios are used as the extraction mixture (Lattanzio et al., 
2012; Berthiller et al., 2013), eventually acidified with acetic or formic acid (Sulyok et al., 2006; 
Nakagawa et al., 2013). Since bran and whole grain products are complex matrices, most of the 
                                                 
19  
Commission Regulation (EC) No 401/2006 of 23 February 2006 laying down the methods of sampling and analysis for the 
official control of the levels ofmycotoxins in foodstuffs. OJ L 70, 9.3.2006, p. 12. 
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intereferences affecting the further steps of the analysis were avoided by using a preliminary defatting 
step with hexane. Final recovery was consequently increased (De Boevre et al., 2012, 2013).  
After sample extraction, the extracts are filtered and analysed with or without prior clean-up, which is 
generally based on the use of multifunctional column, immunoaffinity column (IAC), solid-phase 
extraction (SPE) etc., and is usually aimed at enhancing signal to noise ratio for extracts obtained by 
complex matrices with heavy matrix effects (Malachova et al., 2011; Lattanzio et al., 2013).  
Commercially available clean-up columns for mycotoxins, including SPE and  IACs, are often less 
suitable for conjugated derivatives, since these forms are more polar than their parents. On account of 
the very good sensitivity of mass spectrometry equipment available nowadays, extracts obtained from 
the acetonitrile/water/acetic acid mixture were suitable for analysis without further clean-up, using the 
so-called “dilute and shoot” approach (Sulyok et al., 2006). De Boevre tested four SPE cartridges and 
showed that no acceptable recoveries were obtained for modified mycotoxins (De Boevre et al., 2012). 
Flow-through cartridges were also checked for their applicability to multianalyte purification in a 
certain polarity range (Lattanzio et al., 2013). Results showed that these systems, in the vast majority of 
cases, did not permit efficient recovery of modified mycotoxins.  
Recently, the application of a QuEChERS-like (Quick, Easy, Cheap, Effective, Rugged and Safe) 
approach was reported by Zachariasova et al. (2010) for parent and modified forms of trichothecenes in 
wheat. Although Zachariasova et al. (2010) did not report satisfactory recovery for DON3Glc owing to 
its higher polarity than DON, a different result was obtained by Dall’Asta et al. (2013), by lowering the 
polarity of the solvent mixture. Indirect methods are not often applied to analysis of modified forms of 
trichothecenes, since the enzymatic cleavage has been proven to lead to a lower yield than those 
obtained for ZEN derivatives (Berthiller et al., 2011). This is mainly due to the nature of the glucosidic 
bond that involves, in this case, an alcoholic and not a phenolic group.  
Enzyme treatments with amylolytic (α-amylase, amyloglucosidase), proteolytic (papain) or cell wall 
degrading (cellulase, xylanase) enzymes have been proposed for releasing DON from bran (Zhou et al., 
2008); although never tested so far, a similar approach could be followed for other modified 
mycotoxins. This is in agreement with the higher content of modified mycotoxins (DON3Glc) released 
upon malting in the brewing process (Lancova et al., 2008; Vendl et al., 2009), as described in Section 
8.4.3. 
6.5.  Modified forms of fumonisins 
Fumonisins will lose their conjugated side chains upon treatment with strong bases. As sugar, starch, 
peptide or protein conjugates are also attached to the side chains, fumonisins can be liberated by this 
treatment and measured (Dall’Asta et al., 2009a, 2010). In particular, it has been observed that 
performing alkaline hydrolysis of contaminated corn products leads to an often higher amount of 
released hydrolysed fumonisins than that stoichiometrically derived by the conversion of the fumonisins 
detectable by routine analytical methods.  
The general approach to the evaluation of modified fumonisin forms is based on an alkali treatment of 
the sample that induces the loss of the tricarballylic side chains of fumonisins, releasing the hydrolysed 
fumonisins (HFBs), which can be easily quantified by LC–MS. Indeed, comparing the results obtained 
after the hydrolysis step (amount of total fumonisins) with the amount of fumonisins determined by the 
normal approach (parent fumonisins), it is possible to evaluate the amount of bound or physically 
entrapped forms. For the extraction of total fumonisins, the sample undergoes a hydrolysis step with 
2 N KOH for 60 minutes at room temperature. The aqueous phase is then extracted with acetonitrile, 
dried under a nitrogen stream and redissolved in water/methanol before LC-MS/MS analysis. The 
estimated recovery for HFB1, HFB2 and HFB3 ranged from 92 % to 98 % with a low quantification limit 
(70 µg/kg for HFB1, HFB2 and HFB3).  
 Modified mycotoxins in food and feed 
 
EFSA Journal 2014;12(12):3916 31 
A QuEChERS-like approach was also reported for determination of physically entrapped fumonisins 
(Dall’Asta et al., 2010). This approach, originally developed for pesticides, is based on the use of a 
mixture of salts in combination with aqueous-organic solvents allowing for protein precipitation and 
matrix disaggregation. When primary amines are avoided, both parent and physically entrapped forms 
of fumonisins are efficiently recovered from the samples. 
Among the conjugated forms of fumonisins, NDF-FB1 and NCM-FB1 have been described in processed 
food (Castelo et al., 2001; Seefelder et al., 2001; Voss et al., 2001). These forms are extracted with the 
same methods used for FB1, mainly based on the use of water/methanol or water/acetonitrile mixture. 
The clean up step is usually avoided. 
Fatty acid esters of FB1 have been recently reported in rice and maize (Bartok et al., 2010; Falavigna et 
al., 2013). These rather apolar compounds are commonly extracted from the matrix using 
water:methanol (25/75, v/v), then the sample is directly analysed by LC-MS/MS. 
6.6. Chromatographic methods 
Mass spectrometry based techniques are the method of choice for masked mycotoxin analysis. The 
selectivity of this detection approach allows avoiding clean-up steps, being particularly useful for the 
simultaneous determination of multiple mycotoxins and multiple metabolites.  
Those methods aimed at detecting a specific target analyte (or a group of analytes) are defined targeted 
methods and are mainly based on LC-MS/MS. These protocols should be validated and usually allow a 
reliable and accurate quantification of the target analytes. Quantification mainly involve multiple 
reaction monitoring (MRM) analysis, while identification and characterization of metabolites are 
commonly based on enhanced product ion (MS/MS) and multiple MS (MS3) modalities.  
Most of the LC-MS/MS methods published so far for masked mycotoxins have been reviewed by Cirlini 
et al. (2012) and Berthiller et al. (2013).  
The method of choice for the identification of unknown masked mycotoxins in processed or 
unprocessed food is high-resolution MS, mainly used as untargeted analysis. Unknown mycotoxin 
conjugates, indeed, occur often in naturally contaminated samples at low amounts. Isolation and 
characterization by means of traditional spectroscopic techniques, such as NMR, is thus very 
challenging and high resolution MS can act as a good alternative, since additional information such as 
the structure of the parent compound and its general fragmentation pathways are usually available.  
The most used MS methods are those based on soft ionization modes such as electrospray (ESI) or 
atmospheric pressure chemical ionization (APCI). In particular, collision-induced dissociation (CID) 
experiments with MS/MS can be used for analysing the dissociation of the pseudo-molecular ions 
preferentially generated by the soft ionization methods. The equipment mainly used for structure 
elucidation are triple-quadrupoles and ion traps, together with hybrid instruments such as combinations 
of quadrupole and linear ion trap, quadrupole and time-of-flight (Q-TOF), linear ion trap and Fourier 
transform ion-cyclotron resonance (FT-ICR).  
For the screening of unknown compounds, full scans over a wide mass range are often used. TOF and 
Fourier transform (e.g. Orbitrap) instruments are superior to quadrupole mass spectrometers in terms of 
full-scan sensitivity, mass accuracy and resolving power. Besides the acquisition of accurate masses of 
analytes, other additional post-data acquisition mathematical tools can be applied to help the molecular 
identification.  
6.7. Targeted methods for modified forms of zearalenone and trichothecenes 
Most of the methods reported in the literature so far involve a separation on C18 column using gradient 
elution with a mixture of water/methanol or water/acetonitrile in different proportions as eluent (Cirlini 
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et al., 2012; Berthiller et al., 2013; De Boevre et al., 2013). Detection is mainly performed by ESI 
source, utilizing the MRM mode in both positive and negative polarity according to the analyte. Eluents 
are commonly modified upon addition of formic or acetic acid or by addition of cationisation agents 
such as ammonium acetate. The use of slightly acidic conditions allows control of the pH of the eluent, 
as this is often a critical point, as some mycotoxins such as fumonisins may otherwise show peak tailing 
and low efficiency in chromatographic separations.  
The majority of the methods reported in the literature so far are focused on the simultaneous detection 
of ZEN and its modified forms as well as DON and its modified forms (Sulyok et al., 2006; Berthiller et 
al., 2007; Vendl et al., 2009; De Boevre et al., 2012). Often other minor trichothecenes can be also 
detected. This multitoxin approach is often based on a compromise in terms of recovery and accuracy. 
Specific conditions are reported in Table 4. 
Although conjugated forms of T2 and HT2, as well as NIV and DAS glucosides, have been reported in 
the literature, there is a lack of validated protocols for these compounds. Data are based, indeed, on a 
rough comparison of the analyte peak area with the one obtained for the parent compound. Furthermore, 
the extraction strategy is very generic, without any evaluation of the recovery (Lattanzio et al., 2013). 
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Table 4:  Overview of analytical procedures reported in the literature for ZEN and its modified forms 
Target analyte Matrix Extraction mixture Clean up Separation Detection Recovery References 
ZEN, ZEN14Glc, 
ZEN14Sulf 
Arabidopsis 
thaliana 
ACN/H2O (75/25) None HPLC (RP-C18): MeOH 
+ 5 mM aqueous ammonium acetate  
 
QTrap-MS/M:  
ESI source,  
MRM mode 
100 % Berthiller et 
al. (2006) 
DON, 3Ac-DON, 
15Ac-DON, 
DON3Glc, ZEN, 
ZEN14Glc, 
ZEN14Sulf, HFB1 
Cereals  ACN/H2O/AcOH None HPLC (RP-C18): ACN/H2O/AcOH   
+ 5 mM aqueous ammonium acetate 
QTrap-MS/M:  
ESI source,  
MRM mode  
Not reported Sulyok et al. 
(2006); 
Berthiller et 
al. (2007); 
Dall’Asta et 
al. (2009a) 
DON, ZEN, 
DON3Glc, 3Ac-
DON, ZEN14Glc, 
ZEN14Sulf 
Cereal-based 
food 
ACN/H2O/AcOH None   Not 
specified 
Vendl et al. 
(2010) 
DON3Glc,  
α-, βZEL14Glc,  
ßZEL14Glc,  
ZEN14Glc, 
ZEN14Sulf 
Maize/wheat/oats
/bread/cornflakes 
ACN/H2O/AcOH 
79:20:1 
Hexane 
defatting 
   De Boevre et 
al. (2012) 
ACN: acetonitrile; AcOH: acetic acid; MeOH: methanol. 
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6.8. Targeted methods for modified forms of fumonisins 
For the separation and detection of physically entrapped fumonisins, a very useful approach is to 
convert the molecules into their hydrolysed counterparts by chemical or enzymatic hydrolysis before the 
chromatographic analysis. This approach allows for the detection of the sum of parent and bound 
fumonisins (often referred as “total fumonisins”) as hydrolysed forms. The main drawback is that where 
the concentration of parent compound is needed, two different determination should be performed to 
obtain data for parent and total fumonisins, thus increasing the method uncertainty.  
Kim et al. (2003) separated HFB1 and HFB2 on a C18 column, in an LC–MS system, using 0.1 % 
aqueous formic acid and methanol/acetonitrile as mobile phase and positive ESI as detection mode. 
More recently, a method for the detection of physically entrapped fumonisins after alkaline hydrolysis 
in the forms of HFB1, HFB2 and HFB3 was validated by Dall’Asta et al. (2008). A LC–MS/MS system 
was used, where LC was coupled with a triple quadrupole mass spectrometer equipped with an ESI 
interface (positive ion mode). The chromatographic conditions used water and methanol as eluents, both 
added with 0.1 % of formic acid. Detection of the analytes was achieved by multiple reaction 
monitoring (MRM) mode. The method allowed to determine parent and modified fumonisins without 
any clean up step. 
N-deoxy-fructosyl fumonisin B1 (NDF-FB1) and N-carboxymethyl-fumonisin B1 (NCM-FB1) are 
usually analysed by LC-MS/MS using the same extraction procedures commonly applied for the parent 
compounds (Seefelder et al., 2003) 
Firstly identified by Bartok et al. (2010), fatty acid esters of FB1 have been also reported in corn by 
Falavigna et al. (2013). Bartok et al. (2010) developed two methods, based on RP-HPLC/ESI-ITMS and 
RP-HPLC/ESI-TOFMS, for the identification of palmitoyl-, oleoyl- and linoleoyl-O-derivatives of FB1 
in fungal cultures. Starting from these methods, Falavigna et al. (2013) proposed a LC-ESI-MS/MS 
method for the determination of these compounds in corn kernels, involving a solid-liquid extraction 
followed by a dilute and shoot approach. 
Very recently, a LC-ESI-MS/MS based method for N-acyl fatty acid derivatives of FB1 has been 
proposed by Bartok et al. (2013). The method was developed for fungal cultures of F. verticillioides and 
involved a SPE purification step before chromatographic analysis. 
Similar compounds were found in fried tortillas and corn-based food, using thermal treatments (Park et 
al., 2013). The authors suggested an apolar extraction followed by SPE purification. Afterwards, the 
eluate was further hydrolysed under alkaline conditions to get hydrolysed fumonisins. After another 
SPE-C18 purification step, HFBs were detected by LC-FLD with derivatisation with ortho-
phthalaldehyde (OPA). 
The specific conditions of analysis are reported in Table 5. 
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Table 5:  Overview of analytical procedures reported in the literature for fumonisins and their modified forms 
Target 
analyte 
Matrix Extraction mixture Clean up Separation Detection Recovery References 
HFB1, 
PHFB1, 
PHFB2 
Corn flakes Ethyl acetate after a 
hydrolysis step 
C18 and 
FumoniTest
TM
 
column 
HPLC (RP-C18):  
1 % HOOH/ACN/MeOH  
Fluorescence 
detection/ESI-
MS/MS : positive 
ionization, SIM 
mode 
63–86 % Kim et al. (2003) 
HFB1, HFB2, 
HFB3 
Corn and 
corn-based 
food 
ACN after a hydrolysis step None HPLC (RP-C18):  
1 % HOOH//MeOH 
ESI-MS/MS: 
positive ionization, 
MRM mode 
92–98 % Dall’Asta et al. 
(2009b, 2010, 
2012) 
Fatty acid 
esters of 
fumonisins 
Corn and 
rice 
H2O/MeOH 25/75 None HPLC (RP-C18):  
1 % HOOH//MeOH 
ESI-MS/MS: 
positive ionization, 
MRM mode 
Not reported Falavigna et al. 
(2012, 2013) 
NDF- FB1 Corn-based 
products 
H2O/MeOH/ACN 50/25/25  None LC-ESI-MS/MS ESI-MS/MS: 
positive ionization, 
MRM mode 
Not reported Voss et al. (2001); 
Seefelder et al. 
(2003) 
Matrix bound 
fumonisins 
Corn grits 
or extruded 
products 
H2O/MeOH/ACN 50/25/25 
followed by KOH 
hydrolysis 
OASIS
TM 
HLB 
column 
HPLC (RP-C18):  
1 % HOOH//MeOH 
Fluorescence 
detection 
Not reported Bullerman et al. 
(2008); Jackson et 
al. (2011) 
N-acyl fatty 
acid 
derivatives of 
FB1 
Fungal 
cultures 
H2O/ACN 1/1 None HPLC (RP-C18):  
1 % HOOH//MeOH 
ESI-MS/MS: 
positive ionization, 
MRM mode 
Not reported Bartok et al. 
(2013) 
N-acyl fatty 
acid 
derivatives of 
FB1 
Retail fried 
corn foods 
Hexane/Chloroform 
extraction, KOH hydrolysis 
Bond Elut 
silica SPE, 
OASIS
TM
 HLB  
  72 – 85 % Park et al. (2013) 
ACN: acetonitrile; AcOH: acetic acid; MeOH: methanol. For the purposes of this opinion the term modified fumonisins includes both covalently (i.e. NDF-FB) and not covalently (i.e. physically 
entrapped) bound forms. 
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6.9. Immunochemical methods 
ELISA methods continue to be widely used for fast screening of commodities and foods for mycotoxins 
owing to their relatively low cost and easy application (Berthiller et al., 2013). However, the application 
of antibody-driven systems to modified mycotoxin detection is still poor. Antibodies developed against 
the parent mycotoxin can potentially cross-react with modified forms if the epitope is not sterically 
hindered by the metabolism (Köppen et al., 2010). Only a few studies on the evaluation of ELISA for 
the recognition of modified mycotoxins have been performed, probably on account of the unavailability 
of analytical standards from the market (Dzuman et al., 2014). To date, only two attempts at developing 
antibodies for modified forms have been reported, one being focused on ZEN14Glc determination 
(Beloglazova et al., 2013) and the other one on T2 glucoside detection (Maragos et al., 2013). 
For accurate data interpretation, a deep knowledge on cross-reactivity of ELISA kits is crucial. 
However, owing to the lack of commercially available calibrants for modified mycotoxins, cross-
reactivity studies are lacking, with the exception of DON3Glc (Tangni et al., 2010; Veršilovskis et al., 
2011; Dzuman et al., 2014).  
6.10. Conclusions on methods of analysis 
Protocols for modified mycotoxin analysis are mainly based on water/acetonitrile extraction followed by 
a dilute and shoot analysis by LC-MS/MS. There is, however, a general lack of analytical standards and 
reference materials. Since the development of fit-for-purpose validated methods is based on the use of 
proper calibrants and naturally incurred reference materials, a very low number of properly validated 
methods for modified mycotoxins are available.   Modified mycotoxins such as ZEN14Glc, ZEN14Sulf 
or T2Glc are in-house chemically or enzymatically synthesized for research purposes, or isolated from 
naturally contaminated samples (McCormick et al., 2012; Mikula et al., 2013) and are not commercially 
available so far. Also biosynthetic methods for glucosylation are known (Berthiller et al., 2009). In this 
case, the storage of in-house standards should carefully consider the stability of the compound under 
storage conditions. Soluble conjugated mycotoxins are prone to hydrolysis to their parent toxins in 
aqueous or methanolic solutions (i.e. ZEN14Sulf to ZEN). The use of aprotic solvents (i.e. acetonitrile) 
is thus strongly recommended (Berthiller et al., 2013). 
Concerning physically entrapped fumonisins, recovery is strongly affected by the efficiency of the 
analytical protocol, the critical steps being the sample preparation (i.e. particle size) and extraction. An 
optimal recovery could be obtained when a suitable protocol, involving proper grinding and using 
extracting mixtures able to disrupt physical complexation, is implemented. 
7. Hazard identification and characterisation  
7.1. Bioavailability of modified mycotoxins 
Little is known about bioavailability of masked forms of mycotoxins other than DON and to some 
extent ZEN. Therefore, below studies on DON are also presented to exemplify the principles for the 
bioavailability of modified mycotoxins.  
A rather important discussion with respect to modified mycotoxins, is whether they can be hydrolysed 
and absorbed in the gastrointestinal (GI) tract. In one of the first studies on modified mycotoxins, Gareis 
et al. (1990) treated a young pig (27 kg) for 14 days with about 600 µg/day of the 14-glucoside
20 
of 
ZEN spiked to the feed. Both ZEN and its oestrogenic metabolite α-ZEL were detected in urine and 
faeces in varying daily amounts. Highest amounts were observed on day 6 with an estimated excretion 
in urine around 70 and 90 µg/day for ZEN and α-ZEL, as compared with 80 and 40 µg/day in the 
                                                 
20
  Termed 4-glucoside in  original paper. 
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faeces. This study implies that substantial amounts of the glucoside are hydrolysed and subsequently 
absorbed, thus contributing to the overall exposure to this mycotoxin. 
This observation was supported by a recent paper by Veršilovskis et al. (2012), who exposed rats by 
oral gavage to a mixture of the ZEN14Glc, DON3Glc and fully 
13
C-labelled ZEN and DON (each at a 
dose of 25 µg). Rats were killed after 55 minutes and various tissues and parts of the GI tract (tissue 
plus content) were analysed. No parent mycotoxins, the glucosides or glucuronides were detected in 
liver or bladder, potentially related to the short exposure. Highest amounts of both ZEN14Glc but also 
parent unlabelled ZEN (one quarter to one third of the glucoside) were detected in the stomach, 
confirming the hydrolysis of this glucoside in the upper part of the GI tract as shown by Gareis et al. 
(1990). Levels in the small intestine and the colon were much lower with relatively higher levels of the 
parent form. Also the glucuronide was detected in the stomach (small amounts) and intestines. The 
situation for DON3Glc was very different with hardly any hydrolysis in the stomach and non-detectable 
levels in the intestines.  
The relative resistance to degradation of DON3Glc is in line with results from in vitro studies by 
Berthiller et al. (2011), showing no hydrolysis under acidic conditions or in the presence of various 
digestive enzymes. However, the glucoside was substantially hydrolysed by a number of bacteria that 
can be present in the lower part of the GI tract, such as Enterococcus mundtii and Lactobacillus 
plantarum.  
In a follow-up study, Nagl et al. (2012) exposed rats to 2.0 mg/kg b.w. of DON or 3.1 mg/kg b.w. of 
DON3Glc. In the case of DON, about equal amounts of DON plus known metabolites (15 and 13 %) 
were recovered in urine and faeces, in the urine primarily as the glucuronide and in the faeces as the de-
epoxide, DOM-1. In the case of the glucoside, most of the compound was recovered in the faeces 
(17 %) as DON and DOM-1, and a small amount of the glucoside. The urine contained much lower 
amounts (4 %) and indicates that the glucoside is probably hydrolysed at the lower part of the GI tract, 
resulting in a much lower but possibly not negligible bioavailability of the parent mycotoxin. Overall 
recovery of the administered compounds was rather low, being 28 % for the parent compound and 21 % 
for the glucoside. 
Using an in vitro digestion model, De Nijs et al. (2012) showed similar results to Berthiller et al. (2011), 
i.e. that DON3Glc is not hydrolysed under conditions typical of the upper parts of the human GI tract. 
Furthermore, DON3Glc was not absorbed or metabolized by CaCo-2 intestinal cells, an in vitro model 
to study intestinal absorption. 
Nagl et al. (2014) also treated piglets orally with DON or DON3Glc. It was shown that the major part of 
the applied DON (85 %) was excreted in the urine over 24 hours, primarily within the first 8 hours. 
Most of the DON was excreted as the parent compound (51 %) but also the 3-glucuronide (19 %) and 
15-glucuronide (15 %) were detected at substantial amounts. In the case of DON3Glc, less than half of 
the dose was recovered (42 %), most of it in the urine (40 %) and in this case most of it in the urine 
collected between 8 and 24 hours, suggesting a delayed absorption. Since no urine was collected after 
24 hours, a major part of the dose might have been missed. Only a minor amount in the urine was 
present as DON3Glc and most of it was DON and to some extent the two glucuronides. When 
DON3Glc was injected in the blood of piglets, almost all of the dose was excreted within 8 hours in the 
urine, almost completely as DON3Glc. This study shows that in pigs DON can be released from 
DON3Glc, probably in the distal part of the GI tract. At least half of the dose should as such be taken 
into account, but based on the delayed absorption, this fraction might be even higher. 
Dall’Erta et al. (2013) also used a human in vitro model mimicking different steps of the digestive 
process  to study the fate of  DON3Glc, ZEN14Glc, ZEN14Sulf and the parent compounds. The applied 
model consists of a sequence of three incubation steps, reproducing salivary juice (pH 6.8-7, 5 minutes; 
main enzyme: α-amylase), gastric juice (pH 2 - 3, 2 hours; main enzyme: pepsine), and duodenal juice 
and bile (pH 6.5 - 7, 2 hours; main enzymes: pancreatine, lipase) (Versantvoort et al., 2005).   
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While the findings of Dall’Erta et al. (2013) on DON are in line with previous studies, for the 
ZEN14Glc this seems contradictory with the results of Veršilovskis et al. (2012). When the glucosides 
were incubated with human intestinal bacteria, both the glucoside and sulphate of ZEN were completely 
degraded within 30 minutes, partly resulting in the parent mycotoxin (61 % after 30 minutes, 40 % after 
24 hours) and a large number of unknown metabolites. In the case of DON3Glc, the degradation was 
much slower but complete after 24 hours with DON as the major metabolite (90 %). Only traces of 
DOM-1 were detected. Results in complete agreement were described by Gratz et al. (2013) for DON 
and DON3Glc. The authors incubated the modified compound with a fecal suspension obtained by 
volunteers. While DON3Glc was efficiently cleaved to DON in four to six hours in all the samples, only 
one out of five volunteers was able to convert DON into DOM-1. Besides the expected inter-individual 
variability, the possible microbiome-specificity of this detoxification mechanism was thus pointed out.  
The same in vitro digestion model was used to investigate the nature of modified mycotoxins of 
fumonisins, being either covalently bound to food components or hidden owing to entrapment in the 
food matrix. The presence of such modified fumonisins has been shown after alkaline treatment of corn 
and corn products, resulting in much higher levels than after normal extraction (Dall’Asta et al., 2010; 
Falavigna et al., 2012). Alkaline hydrolysis results in the formation of hydrolysed FBs (HFBs) and 
cannot reveal whether the mycotoxins are bound or physically entrapped. The same authors showed that 
incubation of corn and corn-based products in the digestion model resulted in higher levels of parent 
fumonisins than normally extracted (on average about two-fold). This strongly indicates that the 
modified fumonisins in corn were physically entrapped rather than bound, but also that they can be 
released in the GI tract of humans and thus contribute to the exposure. Furthermore, Dall’Asta et al. 
(2010) showed that an extraction according to the QuEChERS - technique results in fumonisin levels 
similar to those obtained after alkaline hydrolysis or incubation in the in vitro digestion system. 
Concerning modified fumonisins, Cirlini et al. (2014) showed that NDF-FB1 can be partially cleaved 
under digestive conditions, while it is rather stable when incubated with human intestinal bacteria. An 
opposite behaviour was reported for HFB1 that is partially degraded to unknown compounds by gut 
microbiota. These results are in agreement with data reported by Hahn et al. (in press) about the 
toxicokinetic and the toxicity in rats of orally administered FB1, HFB1 and NDF-FB1.  
In particular, the study performed by Hahn et al. (in press) demonstrated that the administration of HFB1 
and NDF-FB1 does not increase the Sa/So ratio in rats, thus indicating a poor absorption or a lack of 
toxicological activity compared with the parent compound. 
Overall these data show that there is limited information on the bioavailability of modified mycotoxins, 
with varying results for different toxins. However, release and absorption of the parent mycotoxin is 
certainly possible and, as such, modified mycotoxins may contribute to the overall exposure. 
7.2. Toxicity of modified forms of certain mycotoxins in experimental animals  
Unlike their parent compounds for which health HBGVs have been derived both for humans and 
animals on the basis of in most cases relatively abundant information on their toxic properties, no 
toxicological data are available to date for the modified forms of ZEN, NIV, T2, HT2 and fumonisins. 
Metabolic conjugation with polar molecules such as carbohydrates and sulphate, also known as phase II 
metabolism, is commonly considered as an inactivation reaction, because the aglycone usually loses its 
biological activity and is eliminated from its site of action. However, there are exceptions to this general 
rule, and conjugates may still be of toxicological significance through various mechanisms, e.g. (a) by 
retaining or even acquiring biological activity after conjugation, (b) through subsequent hydrolysis of 
the conjugate and release of the parent aglycone, or (c) by improving the absorption of the bioactive 
agent. For mycotoxins, studies on the toxicity of the masked forms are not available. Therefore, the 
mechanisms outlined above will be briefly illustrated with conjugates of other xenobiotics. 
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Although glucuronidation of numerous drugs or phytochemicals is associated with the loss of biological 
activity, a recent study by Ruotolo et al. (2014) with the major mammalian metabolites of the weak 
phytoestrogen quercetin (QUER, Figure 6) showed that QUER-3-O-glucuronide, but not QUER-3’-O-
sulphate, exhibited about the same oestrogenic activity as parent QUER in yeast and in human breast 
cancer cells in vitro. Using the same cell systems, trans-resveratrol (RES, Figure 6), its major plant 
metabolite RES-3-O-glucoside, and the main mammalian metabolites RES-3-O-sulphate, RES-3-O-
glucuronide, and RES-4’-O-glucuronide were assayed for oestrogenic and anti-oestrogenic activity. 
Whereas none of the compounds was oestrogenic, a fairly strong anti-estrogenic activity was observed 
for RES-3-O-sulphate but not for the other substances (Ruotolo et al., 2013).  
In a study with daidzein (DAI, Figure 6) and genistein (GEN, Figure 6), which are the major 
phytoestrogens present in many soy food items, Zhang et al. (1999) found that DAI-7-O-glucuronide 
and GEN-7-O-glucuronide still had a significant affinity for oestrogen receptors present in mouse 
uterine cytosol, albeit by a factor of about 10 and 50 less than the unconjugated DAI and GEN, 
respectively. Moreover, DAI-7-O-glucuronide and GEN-7-O-glucuronide were shown to activate 
human natural killer cells in vitro at nutritionally relevant concentrations, with both glucuronides being 
more potent than unconjugated GEN (Zhang et al. 1999). 
GEN and DAI were also used by Pugazhendhi et al. (2008) to study the effect of conjugation with 
sulphate on their oestrogenicity in cultured MCF-7 human breast cancer cells. Competition with 
17ß-estradiol for binding to the oestrogen receptors, induction of a stably transfected oestrogen-
responsive reporter gene, and stimulation of cell growth were used as endpoints. In no case did 
sulphation abolish oestrogenic activity. For the 4’-O-sulphates of GEN and DAI, a modest reduction of 
oestrogenicity was observed, whereas opposing effects were disclosed for the 7-O-sulphates: the 
oestrogenic activity was substantially reduced for GEN-7-O-sulphate but increased for DAI-7-O-
sulphate in comparison with the unconjugated phytoestrogens. Thus, conjugation may even enhance the 
biological activity, and inverse effects may occur between structurally related compounds. 
  
 
 
 
                   Quercetin                                 Resveratrol                            Daidzein 
 
 
 
 
                    Genistein                               Ketoprofen                        1’-Hydroxysafrol 
Figure 6:   Examples of aglycones forming conjugates with different biological properties 
In some instances, the formation of glucuronides and sulphates can render a non-reactive aglycone 
chemically reactive. Examples for the “metabolic activation” via glucuronidation are the so-called acyl 
glucuronides of carboxylic acids, amply known from non-steroidal anti-inflammatory agents such as 
ketoprofen (Figure 6). Such acyl glucuronides are electrophilic and can rearrange by intramolecular acyl 
migration, hydrolyze to the parent carboxylic acid, or alkylate proteins (Bailey and Dickinson, 2003). 
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Basically the same behaviour might be expected from acyl glucuronides and acyl glucosides of 
mycotoxins bearing carboxyl groups, such as ochratoxin A and citrinin, but acyl conjugates of 
mycotoxins have not been reported to date. Formation of  sulphates is a well-known metabolic 
activation pathway of allylic alcohols (such as 1’-hydroxy-safrole, Figure 6), because the sulphate ion is 
a good leaving group and favors formation of electrophilic carbocations (Rietjens et al., 2005). 
Although most glucosides, glucuronides and sulphates are chemically stable, they are prone to 
enzymatic hydrolysis by glucosidases, glucuronidases and sulphatases, respectively. Such enzymes are 
present in various compartments of the mammalian organism and also in the gut microflora. For 
example, most dietary flavonoids, which exist in planta predominantly as ß-glycoside conjugates, are 
hydrolyzed in the small intestine by the enzyme lactase phloridzin hydrolase in the brush-border of the 
epithelial cells, followed by passive diffusion into these cells (Manach and Donovan, 2004). An 
alternative hydrolytic step is mediated by a cytosolic ß-glucosidase within the epithelial cells after 
uptake of the polar glucosides via the active sodium-dependent glucose transporter SGLT1; conjugated 
flavonoids reaching the distal regions of the small intestine are hydrolyzed by bacterial glucosidases 
(Manach and Donovan, 2004). Likewise, glucuronidated metabolites of the flavonoid aglycones 
excreted via the bile are hydrolyzed in the intestine and undergo enterohepatic circulation. 
It is generally assumed that the free aglycone has a higher bioavailability than the conjugate form owing 
to its higher lipophilicity and ability for passive diffusion through cell membranes. However, there are 
reported cases where the opposite is true. When equivalent doses of the soy isoflavone DAI were orally 
administered to male volunteers either as free aglycone or as DAI-7-O-ß-D-glucoside, the systemic 
bioavailability, maximum plasma concentration and cumulative recovery of DAI metabolites in urine 
were three to six times higher after the ingestion of the glucoside than after ingestion of free DAI (Rüfer 
et al., 2008). The greater bioavailability of the conjugate form is believed to be mostly due to its higher 
water solubility, which increases its diffusion through the aqueous boundary layer as well as the mucous 
layer of the intestine as compared with the more lipophilic aglycone.  
These few examples illustrate the complex mechanisms by which conjugates may exert toxic effects. At 
least four different molecular mechanisms may render the masked form of a mycotoxin toxicologically 
active: (1) the conjugation may not abolish the activity of the parent compound; (2) conjugation may 
infer activity to the parent compound which is not present before; (3) the modified form may facilitate 
absorption of the mycotoxin; and (4) the modified form may be hydrolysed in the gastrointestinal tract 
and the released parent mycotoxin may be absorbed. The last mechanism is probably the most frequent 
one. However, as there are virtually no data on the toxicokinetics and toxicity of modified mycotoxins, 
the contribution of the modified form to the effects of the parent mycotoxin cannot be quantified at 
present.  
Based on the few data currently available, and following a pragmatic approach, the modified forms of a 
mycotoxin are assumed to exert the same toxicity as the parent compound.  
8. Occurrence of modified forms of certain mycotoxins in food and feed 
Masked forms have been identified so far for DON, NIV, FUS-X, T2, HT2, ZEN, NEO, and OTA. 
Moreover, there is some evidence for the compartmentation of fumonisins in plants.  
Up to now, the occurrence of  masked forms in naturally infected cereals and products thereof have been 
described only for DON and ZEN (Berthiller et al., 2013; De Boevre et al., 2013). In addition, one 
recent study reports the occurrence of fatty acid esters of fumonisins in naturally infected maize 
(Falavigna et al., 2013). 
Occurrence data for the masked forms are commonly expressed as relative percentage with respect to 
the parent compounds. Following data are given accordingly. 
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8.1. Modified forms of zearalenone 
The masked forms of ZEN and its derivatives α- and β-ZELs have been studied in food and feed. The 
identification of ZEN-conjugated forms has been performed using A. thaliana or cell cultures of cereals, 
demonstrating the formation of a wide number of extractable compounds such as glucosides, 
malonylglucosides, dihexosides and pentosylhexosides (Berthiller et al., 2006). 
A survey of 10 wheat grain samples revealed the relative proportion of ZEN14Glc to ZEN to be up to 
30 % (Schneweis et al., 2002), as reported in Table 6. Low amounts of ZEN14Sulf were found in 
different commodities (wheat flour, whole-meal wheat bread, maize meal, biscuits, wheat flakes, bran 
flakes, muesli, crackers, cereal snack bars and polenta), with the highest concentration being 6.1 µg/kg 
in bran flakes, reaching a concentration up to 20 % in respect of the parent compound (Vendl et al., 
2009).  However, in a survey of extractable conjugated Fusarium mycotoxins in cereal-based raw 
materials and finished products, none of the 84 cereal-based products analysed contained ZEN14Glc, α- 
or β-ZEL and their glucosides αZEL14Glc  and βZEL14Glc (Vendl et al., 2010). The method used for 
these analyses showed a good sensitivity with LOD in the range 1 – 10 µg/kg for ZEN and its 
derivatives. 
Streit et al. (2013) analysed 83 samples of feed and feed raw materials for the co-occurrence of  
mycotoxins. A multi-mycotoxin approach was followed, also including the determination of DON3Glc, 
ZEN14Glc and ZEN14Sulf forms. All of them were found to contain 7 to 69 mycotoxins and their 
masked forms. Although ZEN14Glc was not detected, DON3Glc and ZEN14Sulf were frequently found 
with 75 % and 49 % positive samples, respectively. ZEN14Sulf accounted for up to 30 % of its 
precursor. 
To date, the most comprehensive survey about ZEN and its conjugated forms has been performed by 
DeBoevre et al. (2012, 2013). In this study, cereal-based food products (n = 174) were analysed for the 
occurrence of DON, ZEN, T2 and HT2 together with their conjugated forms. The applied method was 
fully validated according to the EU requirements, obtaining a LOQ between 10 and 26 µg/kg for all the 
analysed matrices (maize, wheat, oats, breakfast cereals, bread). 
Among the products analysed within the study, all purchased from the Belgian market in 2011, fibre-
enriched bread samples (44 %) were significantly contaminated with ZEN, seven of them being above 
the EU maximum limit of 50 µg/kg. ZEN occurred also in the bran-enriched samples (39 %) and in 
more than half of the breakfast cereal samples (52 %), but the highest incidence (62 %) was observed 
for oatmeal. Together with ZEN, α- and β-ZELs were also detected in most of the samples.  
The incidence of ZEN in food and feed matrices was 80 %. α-ZEL and β-ZEL occurred in 53 and 63 % 
of the samples, respectively. Data are reported in Table 6. ZEN14Glc, ZEN14Sulf, αZEL14Glc and 
βZEL14Glc occurred on average in 29 %, 8 %, 10 % and 19 %, respectively, of the fibre-enriched bread 
samples. When the total sum of the masked forms is considered, concentration up to 100 % of the parent 
compound is obtained. In the bran-enriched bread samples ZEN14Sulf occurred in 6 % of the samples, 
while the glucosylated forms were found in 6 % (ZEN14Glc), 3 % (αZEL14Glc) and 6 % (βZEL14Glc). 
In general, ZEN derivatives occurred at an overall concetration up to 74 % of the parent compound. 
Concerning the breakfast cereal samples, αZEL14Glc, βZEL14Glc and ZEN14Sulf occurred at the same 
level of incidence (26 %, 29 % and 27 %), while ZEN14Glc was observed in 40 % of the samples. 
ZEN14Glc appeared in 38 % of the oatmeal samples (De Boevre et al., 2012, 2013). Furthermore, in the 
case of oatmeal and breakfast cereals, the overall concentration of masked forms exceed the 
concentration of ZEN. 
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Table 6:  Occurrence of ZEN conjugates in raw cereals and cereal-based products 
Matrix Conjugates 
n 
(pos) 
% with 
respect to 
ZEN 
Reference 
Raw 
cereals 
Maize  ZEN14Sulf 41 Up to 30 % Streit et al. (2013) 
 Wheat ZEN14Glc 10 Up to 30 % Schneweis et al. 
(2002) 
Food Wheat flour ZEN14Sulf 3 Up to 20 % Vendl et al. (2010) 
 Crackers ZEN14Sulf 3 Up to 20 % Vendl et al. (2010) 
 Breakfast cereals 
– bran flakes 
ZEN14Sulf 3 Up to 15 % Vendl et al. (2010) 
 Fibre enriched 
bread 
ZELs, ZEN14Glc, ZEN14Sulf, 
βZEL14Glc, αZEL14Glc 
52 As the sum, up 
to 100 % 
De Boevre et al. 
(2012, 2013) 
 Bran enriched 
bread 
ZELs, ZEN14Glc, ZEN14Sulf, 
βZEL14Glc, αZEL14Glc 
36 As the sum, up 
to 74 % 
De Boevre et al. 
(2012, 2013) 
 Breakfast cereals ZELs, ZEN14Glc, ZEN14Sulf, 
βZEL14Glc, αZEL14Glc 
62 As the sum, up 
to 110 % 
De Boevre et al. 
(2012,2013) 
 Popcorn ZELs, ZEN14Glc, ZEN14Sulf, 
βZEL14Glc, αZEL14Glc 
12 As the sum, up 
to 22 % 
De Boevre et al. 
(2012,2013) 
 Oatmeal ZELs, ZEN14Glc, ZEN14Sulf, 
βZEL14Glc, αZEL14Glc 
13 As the sum, up 
to 100 % 
De Boevre et al. 
(2012,2013) 
  
8.2. Modified forms of trichothecenes 
Most of the studies carried out so far on modified mycotoxins deal with DON3Glc natural occurrence, 
while other modified trichothecenes are currently still not addressed quantitatively. The reason can be 
found mainly in the lack of analytical standards and reference material, but it must also be considered 
that DON3Glc was discovered almost a decade ago, while other modified compounds have been more 
recently identified. Since DON and modified DON are covered by a separate request, data concerning 
the occurrence of modified forms of DON are not considered herein. 
Among modified trichothecenes, FUS-XGlc and NIVGlc have been reported for the first time in wheat 
grain that was artificially infected with Fusarium fungi. According to the authors, more than 15 % of 
FUS-X and NIV were converted into their respective glucosides (Nakagawa et al., 2011). It should be 
underlined that FUS-XGlc was not reported in natural infected samples so far. 
Recently, the occurrence of NIVGlc was reported in wheat by Yoshinari et al. (2014), at a concentration 
ranging from 12 % to 27 %. 
Recently, the 3-O-glucosides of T2 and HT2 have also been reported in wheat and oats inoculated with 
Fusarium sporotrichiodes (Busman et al., 2011). Similarly, their occurrence in naturally infected wheat 
and oats was described by Lattanzio et al. (2012). Levels of the HT2 and T2 parent forms were up to 
85 µg/kg and 23 µg/kg, respectively, in wheat, and to 834 µg/kg and 377 µg/kg, respectively, in oats, 
corresponding to approximately 12 % of the parent form. Data are reported in Table 7. 
Using an approach based on peak area ratio between glucoside derivatives and parent T2 and HT2, less 
than 1 % peak area ratio was obtained in fungal cultures tested, whereas higher glucosides values were 
estimated in naturally contaminated wheat and oat samples (peak area ratio up to 24 % and 2 7 % for 
T2Glc and HT2Glc, respectively). The latter data were similar to those reported for DON3Glc in wheat, 
that is up to approximately 30 % of the total DON contamination (Berthiller et al., 2005, 2009; Cirlini et 
al., 2013). 
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A very recent study demonstrates the occurrence of monoglucosides of HT2, NEO and DAS in cultures 
of F. langsethiae isolate at levels that could be roughly estimated in vitro to account up to 37 % of the 
relevant unconjugated toxin (Lattanzio et al., 2013). However, the natural occurrence in cereals of these 
compounds has never been reported so far. 
Table 7:  Occurrence of T2 and HT2 conjugates in raw cereals  
Matrix Conjugates n (pos) % with respect to T2/HT2 Reference 
Raw cereals Wheat  T2Glc, HT2Glc 9 Up to 12 %
(a)
 Lattanzio et al. (2012) 
 Oat T2Glc, HT2Glc 9 2 %
(a)
 Lattanzio et al. ( 2012) 
(a): evaluated on the basis of the area ratio, owing to the lack of analytical standards 
8.3. Modified forms of fumonisins 
Several studies have reported the presence of bound fumonisins in food, which can be determined only 
after application of a hydrolysis step (Dall’Asta et al., 2008, 2009a,b). In particular, it has been observed 
that, after performing alkaline hydrolysis of contaminated corn products (e.g. extruded products such as 
cornflakes), the amount of hydrolysed fumonisins released was higher than the amount expected if all 
the fumonisins detected with the routine method were quantitatively hydrolysed. 
This could be ascribed to a masking phenomenon, based on a probable physical entrapment of the 
mycotoxins into the structure of macromolecular components (such as starch) (Kim et al., 2002, 2003; 
Park et al., 2004). Although this phenomenon could be considered as an analytical issue, recent studies 
reported a strong relation with corn genotype and agronomical factors (Dall’Asta et al., 2012). 
The occurrence of bound fumonisins in commercial cornflakes was first reported in 2003 (Kim et al., 
2003). Samples of retail corn flakes were analysed for both free fumonisins and protein-bound 
fumonisins, which were extracted with sodium dodecyl sulphate and measured as hydrolyzed fumonisin 
B1 (FB1) after alkaline hydrolysis. On average, a 2.6 fold higher content of FB1 was found after 
hydrolysis. A similar approach was applied to 30 retail samples of heat-processed corn foods, revealing 
bound FB1 in all samples at significant levels (Park et al., 2004).  
The occurrence of bound fumonisins in 21 gluten-free products, at concentration levels comparable or 
higher than those found for the parent forms, has also been reported (Dall’Asta et al., 2008). Ninety-
seven maize samples collected in Italy were analysed for free and total fumonisins just after harvesting 
(Dall’Asta et al., 2010). Free FBs were found in all samples at concentration levels ranging from 0.05 to 
40 mg/kg, with a median value of 3.52 mg/kg after correction for moisture content. Total FBs obtained 
after alkaline hydrolysis were in the range 0.05 to 69 mg/kg, being significantly higher than free 
fumonisins in 82 of 97 samples. 
Similar results were reported by Bryla et al. (2014), who found physically entrapped fumonisins in 
gluten-free bread up to 80 % of the parent forms. Breads were prepared exclusively with corn flour, 
while both yeast- and sourdough bread-making processes were considered in the study.  
Among the covalent bound conjugates of fumonisins, fatty acid esters were identified in rice cultures 
inoculated with F. verticillioides – these substances are, however, most likely to have been fungal 
metabolites (Bartok et al., 2010). These compounds have been recently found in naturally infected corn 
at levels up to 5 % of the fumonisin concentration (Falavigna et al., 2013). 
Table 8 below presents the occurrence of physically entrapped fumonisins and fumonisin conjugates in 
raw maize and corn-based products. 
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Table 8:  Occurrence of physically entrapped fumonisins and fumonisin conjugates in raw maize and 
corn-based products
(a)
 
Matrix Forms n (pos) 
% with respect to 
FB1/FB2/FB3 
Reference 
Raw 
maize 
 Physically entrapped 
fumonisins 
31 Up to 100 % Dall’Asta et al. (2009a) 
  Physically entrapped 
fumonisins 
97 Up to 60 % Dall’Asta et al. (2010) 
  Physically entrapped 
fumonisins 
120 Up to 60 % Dall’Asta et al. (2012) 
  Fatty acid esters of FB1 5 5 – 6 % Falavigna et al. (2013) 
Food Corn flakes Physically entrapped 
fumonisins 
4 Up to 100 % Dall’Asta et al. (2009a) 
 Corn-based 
products 
Physically entrapped 
fumonisins 
6 Up to 60 % Dall’Asta et al. (2009a) 
 Gluten-free 
products 
Physically entrapped 
fumonisins 
21 Up to 100 % Dall’Asta et al. (2009b) 
 Gluten-free 
bread 
Physically entrapped 
fumonisins 
- Up to 80 % Bryla et al. (2014) 
(a):  For the purposes of this opinion the term modified fumonisins includes both covalently (i.e. NDF-FB) and not covalently 
(i.e. physically entrapped) bound forms.  
8.4. Impact of food and feed processing 
8.4.1. Effect of sorting and milling 
The primary food/feed processing steps consists of selection and pre-milling. No significant thermal 
breakdown of mycotoxins would be expected at this stage, but moulds and mycotoxins are often 
concentrated in dust and broken grains which are more susceptible to fungal infection and toxin 
contamination. Sorting, cleaning, dehulling and debranning prior to milling may reduce the mycotoxin 
contamination in the grains by removing the kernels with extensive mould growth, broken kernels, fine 
materials and dust (Kushiro, 2008; Cheli et al., 2013). Whole grains are milled to produce flour and 
other fractions, then these fractions are the raw materials used to prepare the final products. 
Most mycotoxins and their modified forms tend to be mainly concentrated in the bran fractions or outer 
layers of the grains (Edwards et al., 2011). Studies on modified forms have been addressed only for 
DON and DON3Glc, while no specific information has been collected for other modified forms 
(Blandino et al., 2014). However, owing to their comparable chemical behaviour, a similar trend is also 
likely for other toxins. Concerning modified mycotoxins,  Kostelanska et al. (2011a) studied the 
fractionation of DON3Glc and DON in milling fractions, observing that their trend was similar, and 
white flours contained only approximately 60 % of the content of DON3Glc and DON in unprocessed 
wheat grains. Similar findings have been reported by Simsek et al. (2012).  
8.4.2. Impact food and feed production including thermal treatment 
Thermal treatment may have a significant impact in mycotoxin mitigation, but it can also lead to side 
reactions resulting in the formation of products with altered chemical structures (neogenesis). 
This phenomenon has been mainly studied for DON and fumonisins. Hence, conversion of DON to 
isomeric and/or further demethylated forms is described here for illustration. Four main products called 
norDON A, B, C and D, together with the isomeric form isoDON, have been isolated and characterized 
by NMR so far (Bretz et al., 2006). Since these forms are not commonly detected in the analytical 
methods, their formation can result in an apparent decrease of the initial DON levels. These compounds 
were found in cereal-based food samples from the market at concentrations in the range 3 – 15 µg/kg.  
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Since the hydroxy group in position C-3 is not involved in the reaction during the formation of isomeric 
and demethylated products, similar rearrangements might also occur for DON3Glc, as reported by 
Kostelanska et al. (2011b). Nothing is known so far about possible rearrangements involving 
trichothecenes other than DON, but it is probably due to structural similarity.  
Concerning fumonisins, the main reaction described upon thermal treatments involves reducing sugars 
via Maillard-type reactions and further rearrangement. The main products are N-carboxymethyl (NCM) 
fumonisin and N-deoxyfructosyl (NDF) fumonisin (see Figure 7). In addition, the hydrolysed form 
created by the cleavage of both carballylic moieties is commonly obtained upon alkali treatment (Humpf 
and Voss, 2004).  
 
Figure 7:  Formation of HFB1, NCM-FB1 and NDF-FB1 from FB1 upon processing 
A study provided by De Girolamo et al. (2001) investigated the stability of fumonisins FB1 and FB2 
during the production of corn flakes from raw corn flour by extrusion and roasting, finding 
approximately 60 to 70 % reduction in fumonisin content during the entire process. In this case, only 
30 % of those losses were attributed to the extrusion step, where the material was subjected to 70 to 
170 °C for two to five minutes. 
In general, the studies available in the scientific literature indicate that the greatest reduction of 
fumonisins occurs at temperatures of 160 °C or more and in the presence of glucose (Humpf and Voss, 
2004). Extrusion of corn grits with 10 % added glucose resulted in a 75 to 85 % decrease in FB1 levels. 
Amounts of degradation products such as HFB1 and NDF fumonisins in extruded grits depend on the 
type and amount of sugar added, as found by Seefelder et al. (2001) and Castelo et al. (2001). Extrusion 
is often associated with alkali treatment to obtain masa flour and/or tortillas. Chips obtained from masa 
flour contained HFB1 at low concentrations, but almost no NCM-FB1 and NDF-FB1 were detected 
(Voss et al., 2001). 
Concerning physically entrapped fumonisins, Bryla et al. (2014) reported a decrease in both parent and, 
to a lesser extent, entrapped forms during bread making. In particular, the baking process induced a 
30 % reduction in parent forms for both yeast-fermented and sourdough breads, while the reduction for 
entrapped fumonisins was about 19 and 10 %, respectively. 
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The authors stated that entrapped fumonisins were less affected by baking owing to a matrix 
stabilization effect. 
Among treatments for food and feed production, baking, bread making, extrusion and brewing have 
often been studied in recent years. Again, little information is available for other modified mycotoxins 
other than those originating from DON.  
Baking is the most studied food process so far. Vidal et al. (2014) studied the fate of DON and 
DON3Glc during the bread making: DON increased from the unkneaded mix to fermented dough and 
decreased during baking, depending on the initial concentration in the flour. These observations were 
also in agreement with other previous studies, such as that performed by Wolff et al. (2004), in which 
DON decreased up to 25 % in the baked bread. DON3Glc content increased during fermentation as 
suggested by Zachariasova et al. (2012), and also during baking, most likely owing to the glycosylation 
of DON in the initial stages of baking before enzyme inactivation. Kostelanska et al. (2011a) noted that 
when so-called bread improver enzyme mixtures (i.e. xylanase and protease) were employed as a dough 
ingredient, a distinct increase (up to 145 %) of DON3Glc occurred in fermented dough, whereas some 
decrease in both DON3Glc and DON (10 % and 13 %, respectively, compared with fermented dough, 
and mainly in the crust) took place during baking. A similar trend was observed by Young et al. (1984) 
and recently in the study by Simsek et al. (2012). 
Brewing and beer-making has gained great attention in recent years for the possible formation and 
transfer of DON and DON3Glc from barley and malt to beer (Lancova et al., 2008; Kostelanska et al., 
2011b), while no specific studies have been performed for other modified mycotoxins. In particular, a 
very high increase of DON and DON3Glc - even up to 536 % and 210 %, respectively – was reported 
during the malting step and their total transfer into wort during the mashing step was described 
(Kostelanska et al., 2009).  
8.5. Carry-over  
In general the carry-over of ZEN, NIV, T2, and HT2 from feed to animal derived products is rather low 
(EFSA, 2005; EFSA CONTAM Panel, 2011a, b, 2013). As such it is not considered relevant for human 
exposure. Also the  exposure from plant-derived products is much higher.  
No data are available for the carry-over of modified forms of these mycotoxins but it can be assumed 
that the above-mentioned considerations are also applicable for the modified forms of these mycotoxins, 
in particular since hydrolysis in the GI tract leads to the release of the parent compounds. 
8.6. Conclusions on occurrence 
An increasing amount of occurrence data on modified mycotoxins is currently available from the 
literature. However, owing to the lack of analytical calibrants and reference materials, the majority of 
surveys are targeted to DON and DON3Glc, followed by ZEN and its large group of structurally related 
compounds. Very few data, on the contrary, are available for the modified forms of minor 
trichothecenes such as NEO, DAS, FUS-X, as well as for the regulated T2 and HT2. 
Covalently modified forms of fumonisins have been reported in maize at low concentrations: N-acyl 
derivatives can be formed both in the field or during processing, while O-acyl forms have been 
recovered only in the field. Non-covalently bound fumonisins have been reported at concentrations 
comparable to the parent compounds.  
Data about processing indicate that modified forms of DON and ZEN are mainly located in the outer 
part of the cereal kernels and are concentrated during bran and fiber-enriched flour production. On the 
other hand, there is a lack of data about possible transformation upon processing of trichothecenes other 
than DON and its modified forms. 
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Concerning fumonisins, N-acyl derivatives are formed upon extrusion in the presence of reducing 
sugars (i.e. cornflakes). 
Occurrence data on modified mycotoxins in animal products (i.e. milk and dairy, meat, eggs) are not 
available, although the carry-over of Fusarium toxins and their structurally related compounds has never 
been reported so far. 
According to the data reported so far, bran- and fiber-enriched products are more prone to modified 
mycotoxin contamination.  
Modified forms of ZEN often co-occur with parent ZEN and may account for a total concentration up to 
110 % of the parent compound. 
Concerning NIV, its modified forms are reported in cereals amounting up to 30 % of their parent form, 
while modified T2 and HT2 are reported in cereals amounting to 10 % of their parent form. 
Physically entrapped fumonisins have been extensively reported in maize at levels comparable to 
fumonisins (60 – 100 %). Covalently bound fumonisins, on the contrary, are present only at very low 
concentrations. 
9. Exposure assessment in animals and humans 
9.1. Previously reported exposure assessments to modified mycotoxins in humans 
De Boevre et al. (2013) reported exposure to ZEN and its modified forms based on occurrence in cereals 
on the Belgian market (see Section 8.1) and consumption data from adults in the Belgian National Food 
Consumption Survey of 2004. In deterministic analysis, the mean exposure to the sum of ZEN 
(ZEN14Glc, ZEN14Sulf, αZEL, βZEL, αZEL14Glc and βZEL14Glc) LB (UB) exposure was 0.107 
(0.122) µg/kg b.w. per day, whereas the 95
th
 percentile exposure was LB (UB) 0.243 (0.277) µg/kg b.w. 
per day. Other data describing exposure to modified mycotoxins were not found. 
9.2. Human exposure to modified forms of certain mycotoxins in comparison with exposure 
to their parent compounds 
Human exposure to the parent mycotoxins together with their modified forms was derived by using the 
overall exposure levels established in recent EFSA opinions on ZEN (EFSA CONTAM Panel, 2011a), 
NIV (EFSA CONTAM Panel, 2013) and T2 and HT2 (EFSA CONTAM Panel, 2011b) adding a certain 
factor accounting for respective modified forms based on levels reported in the literature, as outlined 
below. For fumonisins recent EFSA exposure assessments were not available. An exposure assessment 
to fumonisins was carried out and is presented in detail in Appendices A - C. Also for fumonisins a 
factor was added to the exposures estimated for the parent compound to account for the modified forms 
of fumonisins.  
9.2.1. Exposure to zearalenone and its modified forms 
According to the latest occurrence papers (see De Boevre et al. 2013), the modified forms of ZEN 
(ZELs, ZEN14Glc, ZEN14Sulf, βZEL14Glc, αZEL14Glc) commonly occur together with their 
precursor in cereal-based food, mainly in bran- and fibre-enriched products. The percentage of 
occurrence with respect to ZEN ranges from 15 to 110 %, expressed as the sum of all the co-occurring 
modified forms in each sample (see Section 8, Table 6). At least one of these forms was present in about 
50 % of the considered samples. With the exception of popcorn, the contamination was comparable in 
all the tested samples (n = 175) in terms of type and relative percentage of occurring forms. 
 Occurrence of  modified forms of ZEN appear to be in the range of an addition of 100 % to the 
concentration of the parent compound (see Section 8.1).  
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Table 9 presents exposure assessments for ZEN for the different age groups (mean and 95
th
 percentile 
exposures) as established in EFSA CONTAM Panel (2011a). The chronic dietary exposure to ZEN was 
higher in younger consumers than in adults. Also, there was a relatively high variation between the 
exposure estimates across European countries and dietary surveys within each age class. A similar 
variation is seen by the addition of 100 % (Table 10) to the parent compound. 
Table 9:  Summary statistics of chronic dietary exposure to ZEN (ng/kg b.w. per day) as provided in 
EFSA CONTAM Panel (2011a) 
Age class 
Summary statistics of exposure (ng/kg b.w. per day) 
Minimum Median Maximum 
LB UB LB UB LB UB 
Mean dietary exposure in total population 
Infants
(a)
 3.3 87 6.4 87 9.4 88 
Toddlers 9.3 51 13 83 23 100 
Other children 5.7 29 11 44 22 75 
Adolescents 3.6 17 6.1 26 12 42 
Adults 2.4 14 4.3 18 7.2 29 
Elderly 2.0 13 3.4 16 6.4 26 
Very elderly 2.3 12 2.9 16 7.1 29 
95
th
 percentile exposure in total population
(b)
 
Infants 33
(c)
 -
(d)
 -
(d)
 -
(d)
 -
(d)
 217
(c)
 
Toddlers 24 104 31 182 50 277 
Other children 9.9 59 22 80 42 124 
Adolescents 7.5 38 15 53 26 76 
Adults 4.7 28 9.5 35 14 54 
Elderly 3.5 25 7.5 31 12 42 
Very elderly 7.0 26 7.7 35 13 47 
b.w.: body weight; LB: lower-bound; UB: upper-bound.  
(a):  Estimates based on only two dietary surveys. 
(b): The 95th percentile estimates obtained on dietary surveys/age classes with fewer than 60 observations may not be 
statistically robust (EFSA, 2011) and therefore they should not be considered in the risk characterisation. Those estimates 
were not included in this table. 
(c):  Estimates are based on only one dietary survey. 
(d):  Not calculated.  
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Table 10:  Scenarios* of chronic dietary exposure to ZEN and modified ZEN, derived by adding 100 % 
to the exposure derived in EFSA CONTAM Panel (2011a) in order to account for modified forms of 
ZEN (ng/kg b.w. per day). 
Age class Summary statistics of exposure (ng/kg b.w. per day) 
 Minimum Median Maximum 
 LB UB LB UB LB UB 
Mean dietary exposure in total population 
Infants
(a)
 6.6 174 12.8 174 18.8 176 
Toddlers 18.6 102 26 166 46 200 
Other children 11.4 58 22 88 44 150 
Adolescents 7.2 34 12.2 52 24 84 
Adults 4.8 28 8.6 36 14.4 58 
Elderly 4.0 26 6.8 32 12.8 52 
Very elderly 4.6 24 5.8 32 14.2 58 
95
th
 percentile exposure in total population
(b)
 
Infants 66 
(c)
 -
(d)
 -
(d)
 -
(d)
 -
(d)
 434
 (c)
 
Toddlers 48 208 62 364 100 554 
Other children 19.8 118 44 160 84 248 
Adolescents 15 76 30 106 52 152 
Adults 9.4 56 19 70 28 108 
Elderly 7.0 50 15 62 24 84 
Very elderly 14 52 15 70 26 94 
*Values given in this table are rough estimates of exposures to ZEN together with modified ZEN. The values have been derived 
by adding 100% to the exposure values derived for ZEN (see Table 9), based on similar percentages of the ratio of contents of 
ZEN with respect to its modified forms in foodstuffs reported in the literature. Precise figures have been retained but should not 
imply spurious accuracy. 
(a):  Estimates based on only two dietary surveys. 
(b):  The 95th percentile estimates obtained on dietary surveys/age classes with fewer than 60 observations may not be 
statistically robust (EFSA, 2011) and therefore they  should not be considered in the risk characterisation. Those estimates 
were not included in this table. 
(c):  Estimates are based on only one dietary survey. 
9.2.2. Exposure to nivalenol and its modified forms 
The glycosylated form of NIV has only recently been identified and no occurrence data are available in 
the literature. However, NIV shows a structural similarity to DON, and modified forms of NIV may be 
expected to occur to a similar extent as that for DON. For the same reason, food processing may 
significantly affect the levels of NIV3Glc, i.e. thus causing the release of glycosylated forms from the 
cell walls as already described for DON (Kostelanska et al., 2011b; Simsek et al., 2012; Zachariasova et 
al., 2012). In consideration of this, an additional 30 % is considered for NIV for exposure assessment 
(see also Section 8.2). 
Table 11 presents exposure assessments for NIV for  the different age groups (mean and 95
th
 percentile 
exposures), as derived in EFSA CONTAM Panel (2013). The highest chronic exposure was estimated in 
toddlers and was higher in younger age groups than in adults (≥ 18 years to < 65 years old). A relatively 
high variation between the exposure estimates across the dietary surveys within each age class was 
observed. There is a large difference between the LB and UB exposure estimates. The same is reflected 
by adding 30 % to the parent compound in order to account for exposure to modified forms of NIV 
(Table 12). 
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Table 11:  Summary statistics of chronic dietary exposure to NIV (ng/kg b.w. per day) across 
European countries as established by EFSA CONTAM Panel (2013) 
Age class 
Summary statistics of exposure (ng/kg b.w. per day) 
Minimum Median Maximum 
LB UB LB UB LB UB 
 Mean dietary exposure in total population 
Infants 2.4 136 -
(a)
 -
(a)
 4.4 140 
Toddlers 4.3 81 6.3 152 8.8 202 
Other children 1.3 56 5.5 97 12 132 
Adolescents 1.0 45 2.1 60 6.4 80 
Adults 0.4 37 1.6 56 4.8 75 
Elderly 0.81 31 1.7 49 4.7 55 
Very elderly 0.80 43 1.6 49 3.9 58 
 95
th
 percentile dietary exposure in total population
(b)
 
Infants 16 -
(c)
 -
(c)
 -
(c)
 -
(c)
 389 
Toddlers 12 203 15 317 23 484 
Other children 3.0 121 12 179 22 259 
Adolescents 3.0 99 6.0 124 15 147 
Adults 1.1 89 4.0 112 10 224 
Elderly 2.3 60 3.5 102 11 127 
Very elderly 1.9 79 3.8 100 7.8 111 
b.w.: body weight; LB: lower-bound; UB: upper-bound. 
(a):  Not calculated; estimates available from only two dietary surveys. 
(b):  The 95th percentile estimates obtained on dietary surveys/age classes with fewer than 60 observations may not be 
statistically robust (EFSA, 2011) and therefore they  should not be considered in the risk characterisation. Those estimates 
were not included in this table. 
(c): Not calculated; estimates available from only one dietary survey. 
Table 12:  Scenarios* of chronic dietary exposure to NIV and modified NIV (ng/kg b.w. per day) 
derived by adding 30 % to the exposure derived in EFSA CONTAM Panel (2013) in order to account 
for modified forms of NIV 
Age class 
Summary statistics of exposure (ng/kg b.w. per day) 
Minimum Median Maximum 
LB UB LB UB LB UB 
 Mean dietary exposure in total population 
Infants 3.1 177 -
(a)
 -
(a)
 5.7 182 
Toddlers 5.6 105 8.2 19 11 263 
Other children 1.7 73 7.2 126 16 172 
Adolescents 1.3 56 2.7 78. 8.3 104 
Adults 0.5 48 2.1 73 6.2 98 
Elderly 1.1 40 2.2 64 6.1 72 
Very elderly 1.0 56 2.1 64 5.1 76 
 95
th
 percentile dietary exposure in total population
(b)
 
Infants 201 -
(c)
 -
(c)
 -
(c)
 -
(c)
 506 
Toddlers 16 264 20 412 30 630 
Other children 3.9 157 16 233 29 337 
Adolescents 3.9 129 7.8 161 20 192 
Adults 1.4 116 5.2 146 13 291 
Elderly 3.0 78 4.6 133 14 165 
Very elderly 2.5 103 4.9 130 10 144 
*The vlues given in this table are rough estimates of exposures to NIV together with modified NIV. The values have been 
derived by adding 30 % to the exposure values derived for NIV (see Table 11), based on similar percentages for the ratio of 
contents of NIV with respect to its modified forms in foodstuffs reported in the literature. Precise figures have been retained but 
should not imply spurious accuracy.  
b.w.: body weight; LB: lower-bound; UB: upper-bound. 
(a): Not calculated; estimates available from only two dietary surveys. 
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(b): The 95th percentile estimates obtained on dietary surveys/age classes with fewer than 60 observations may not be 
statistically robust (EFSA, 2011) and therefore they  should not be considered in the risk characterisation. Those estimates were 
not included in this table. 
(c): Not calculated; estimates available from only one dietary survey. 
9.2.3. Exposure to T-2 and HT-2 toxin and their modified forms 
Modified forms of T2 and HT2 have only recently been reported in the literature; thus, very few 
occurrence data collected under natural infection conditions have been reported so far (see Section 5). 
According to Lattanzio et al. (2013), glucosylated forms of T2 and HT2 may naturally occur in both 
wheat and oats at concentration up to 12 % with respect to the parent compounds.  
Accordingly, exposure assessment is performed considering an addition of 10 % to the exposure to the 
parent compounds. Due to the very low number of samples (n = 9), these data have to be considered as 
very preliminary. 
Table 13 presents exposure assessments T2 and HT2 in the different age groups (mean and 
95
th
 percentile exposures) as derived in EFSA CONTAM Panel (2011b). The dietary exposure to the 
sum of T2 and HT2 is higher in younger consumers than in adults. In addition, there is a relatively high 
variation between the exposure estimates across the dietary surveys within each age class. The same is 
reflected when a 10 % additional exposure to modified forms of T2 and HT2 is added to the exposure to 
the parent compound (Table 14). 
Table 13:  Summary statistics of chronic dietary exposure to the sum of T2 and HT2 as derived in 
EFSA CONTAM Panel (2011b) (ng/kg b.w. per day) across European countries 
Age class 
Summary statistics of exposure (ng/kg b.w. per day) 
Minimum Median Maximum 
LB UB LB UB LB UB 
 Mean dietary exposure in total population 
Infants 5.9 11 
-(a) -(a) 
6.2 16 
Toddlers 12 30 16 34 28 43 
Other children 10 26 14 31 16 39 
Adolescents 4.4 13 7.9 19 9.2 24 
Adults 3.4 10 5.6 14 9.0 18 
Elderly 3.3 10 4.2 13 5.8 14 
Very elderly 2.8 10 4.0 12 6.4 15 
 95
th
 percentile dietary exposure in total population
(b)
 
Infants 19 
-(c) -(c) -(c) -(c) 
51 
Toddlers 23 48 33 62 65 91 
Other children 21 44 31 58 44 71 
Adolescents 12 29 19 38 25 47 
Adults 7.2 20 14 26 25 39 
Elderly 6.7 21 10 23 14 26 
Very elderly 5.3 17 7.0 19 12 25 
b.w.: body weight; LB: lower-bound; UB: upper-bound.  
(a):  Not calculated; estimates available only from two dietary surveys. 
(b):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011) and therefore they  should not be considered in the risk characterisation. Those estimates 
were not included in this table. 
(c):  Not calculated; estimates available only from one dietary survey. 
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Table 14:  Scenarios* of chronic dietary exposure to the sum of T2 and HT2 + 10 % (ng/kg b.w. per 
day) across European countries 
Age class 
Summary statistics of exposure (ng/kg b.w. per day) 
Minimum Median Maximum 
LB UB LB UB LB UB 
 Mean dietary exposure in total population 
Infants 6.5 12 
-(a) -(a) 
6.8 18 
Toddlers 13 33 18 37 31 47 
Other children 11 29 15 34 18 43 
Adolescents 4.8 14 8.7 21 10 26 
Adults 3.7 11 6.2 15 10 20 
Elderly 3.6 11 4.6 14 6.4 15 
Very elderly 3.1 11 4.4 13 7.0 17 
 95
th
 percentile dietary exposure in total population
(b)
 
Infants 21 
-(c) -(c) -(c) -(c) 
56 
Toddlers 25 53 36 68 72 100 
Other children 23 48 34 64 48 78 
Adolescents 13 32 21 42 28 52 
Adults 7.9 22 15 29 28 43 
Elderly 7.4 23 11 25 15 29 
Very elderly 5.8 19 7.7 21 13 28 
*Values given in this table are rough estimates of exposures to the sum of T2 and HT2 together with the sum of modified T2 
and HT2. The values have been derived by adding 10 % to the exposure values derived for the sum of T2 and HT2 (see Table 
13), based on similar percentages  for the ratio of contents of the sum of T2 and HT2 with respect to its modified forms in 
foodstuffs reported in the literature. Precise figures have been retained but should not imply spurious accuracy. 
b.w.: body weight; LB: lower-bound; UB: upper-bound.  
(a):  Not calculated; estimates available only from two dietary surveys. 
(b):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011) and therefore they should not be considered in the risk characterisation. Those estimates 
were not included in this table. 
(c):  Not calculated; estimates available only from one dietary survey. 
9.2.4. Exposure to fumonisins and their modified forms 
According to the literature summarized in Section 8.3, the modified forms of fumonisins (both 
covalently and not covalently bound) commonly occur together with their precursor in corn and maize-
based products. The percentage of occurrence with respect to FB1 is ranging from 60 % up to 100 %, 
expressed as the sum of all the co-occurring modified forms in each sample. The presence of modified 
forms is very dependent on the growing season (occurrence ranging between 25 % and 100 % of the 
considered samples), even if general criteria are still to be defined (Dall’Asta et al., in press). However, 
according to the latest reports (Dall’Asta et al., 2012, in press), the ratio of modified fumonisins is 
higher when the overall contamination is low, while it is lower in highly contaminated samples. In 
consideration of this fact, the exposure assessment is performed considering an additional 60 % of 
modified fumonisins to the parent compound. 
Table 15  presents summary statistics of the chronic dietary exposure to fumonisins across the different 
age groups (mean and 95
th
 percentile exposures) as derived in this opinion (Appendix C). Higher 
exposure is seen in younger  age groups than in adults, and maximum LB exposure is seen in surveys of 
“other children”. The same is observed when 60 % additional exposure to modified forms of fumonisins 
are added to the exposure to the parent compound (Table 16). 
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Table 15:  Summary statistics of chronic dietary exposure to fumonisins (μg/kg b.w. per day) across 
European countries as established in the present opinion (Appendix C) 
Age class 
Summary statistics of exposure (μg/kg b.w. per day) 
Minimum Median Maximum 
LB UB LB UB LB UB 
Mean dietary exposure in total population 
Infants 0.04 0.34 
-(a)
 
-(a)
 0.12 0.63 
Toddlers 0.18 0.93 0.43 1.32 0.82 1.65 
Other children 0.14 0.71 0.38 1.13 1.17 1.77 
Adolescents 0.08 0.43 0.20 0.60 0.69 1.04 
Adults 0.05 0.33 0.11 0.40 0.33 0.63 
Elderly 0.05 0.31 0.07 0.35 0.28 0.53 
Very elderly 0.04 0.31 0.07 0.35 0.13 0.46 
95
th
 percentile exposure in total population
(b)
 
Infants 0.53 1.99 
-(c)
 
-(c)
 0.53 1.99 
Toddlers 0.58 2.32 1.33 2.41 1.61 3.26 
Other children 0.24 1.43 0.98 2.01 3.14 4.05 
Adolescents 0.14 0.87 0.59 1.29 1.58 2.19 
Adults 0.09 0.59 0.29 0.81 0.83 1.25 
Elderly 0.08 0.53 0.21 0.67 0.53 0.99 
Very elderly 0.13 0.55 0.18 0.64 0.34 0.84 
b.w.: body weight; LB: lower-bound; UB: upper-bound. 
(a):  Estimates based on only two dietary surveys. 
(b):  The 95th percentile estimates obtained on dietary surveys/age classes with fewer than 60 observations may not be 
statistically robust (EFSA, 2011) and therefore they should not be considered in the risk characterisation. Those estimates 
were not included in this table. 
(c):  Estimates are based on one dietary survey only. Note: in order to avoid the impression of too high precision, the numbers 
for all exposure estimates are rounded to three figures.  
Table 16:  Scenarios* of chronic dietary exposure to fumonisins μg/kg b.w. per day) as established in 
the present opinion, derived by adding 60 % to account for modified fumonisins 
Age class 
Summary statistics of exposure (μg/kg b.w. per day) 
Minimum Median Maximum 
LB UB LB UB LB UB 
Mean dietary exposure in total population 
Infants 0.06 0.54 
-(a)
 
-(a)
 0.19 1.01 
Toddlers 0.28 1.49 0.68 2.12 1.31 2.63 
Other children 0.23 1.14 0.61 1.81 1.87 2.82 
Adolescents 0.12 0.69 0.32 0.96 1.11 1.66 
Adults 0.08 0.53 0.17 0.64 0.54 1.01 
Elderly 0.07 0.50 0.12 0.56 0.45 0.84 
Very elderly 0.07 0.49 0.11 0.56 0.21 0.74 
95
th
 percentile exposure in total population
(b)
 
Infants 0.84 3.19 
-(c)
 
-(c)
 0.84 3.19 
Toddlers 0.93 3.71 2.12 3.85 2.58 5.21 
Other children 0.39 2.28 1.57 3.22 5.03 6.49 
Adolescents 0.22 1.39 0.95 2.07 2.53 3.50 
Adults 0.15 0.94 0.47 1.30 1.33 2.01 
Elderly 0.13 0.84 0.34 1.07 0.84 1.59 
Very elderly 0.21 0.89 0.28 1.03 0.54 1.34 
*Values given in this table are rough estimates of exposures to fumonisins together with modified fumonisins. The values have 
been derived by adding 60 % to the exposure values derived for fumonisins (see Table 15), based on similar percentages  for 
the ratio of contents of fumonisins with respect to its modified forms in foodstuffs reported in the literature. Precise figures 
have been retained but should not imply spurious accuracy. 
(a):  Estimates based on only two dietary surveys. 
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(b):  The 95th percentile estimates obtained on dietary surveys/age classes with fewer than 60 observations may not be 
statistically robust (EFSA, 2011) and therefore they should not be considered in the risk characterisation. Those estimates 
were not included in this table. 
(c):  Estimates are based on one dietary survey only. Note: in order to avoid the impression of too high precision, the numbers 
for all exposure estimates are rounded to three figures.  
9.3. Animal exposure to modified forms of certain mycotoxins in comparison with exposure 
to their parent compounds 
Since no recent animal exposure assessments are available for ZEN and fumonisins, new assessments 
have been carried out in the present opinion based on the analysis of available occurrence data as 
presented in Appendix E to this opinion. Occurrence data on NIV and T2 and HT2 were presented by 
EFSA recently (EFSA CONTAM Panel, 2011b, 2013). Occurrence data of the parent compounds were 
used to estimate the average exposure of various animal species to ZEN (Table 17), NIV (Table 19), 
T2/HT2 (Table 21) and fumonisins (Table 23), and the potential increase in the exposure due to the 
presence of modified forms (Tables 18, 20, 22, 24). This was done using default values for feed 
consumption previously established and used for T2/HT2 and NIV (EFSA CONTAM Panel 2011b, 
2013). The assessment is based on a similar percentage addition of modified mycotoxins in animal feed 
as that in human food (100 % for ZEN, 30 % for NIV, 10 % for T2 and HT2 and 60 % for fumonisins). 
Where available data for compounds feeds for specific species were used. This is contrary to the method 
applied for NIV and T2/HT2 (EFSA CONTAM Panel 2011b, 2013), where exposure was based on data 
on ingredients and their contribution to compound feed, also due to the limited datasets for compound 
feeds. However, regarding the well-known differences in sensitivity between species, as also reflected in 
the guidance values provided in Commission Recommendation 2006/576/EC21, in practice the less 
contaminated ingredients may be used for the more sensitive species and data on species-specific 
compound feeds seem to be more relevant. Where too few data were available on compound feed, 
estimations for pigs, poultry and rabbits were based on the levels in the category “Cereal grains and 
cereal by-products”, using relative contributions to the feed of 74, 72 and 75 % for piglets, pigs for 
fattening and sows, respectively, 74, 65, 65 and 72 % for chickens for fattening, laying hens, turkeys for 
fattening and ducks, respectively, and 36 % for rabbits. Further details will be provided below under the 
sections on the different mycotoxins. 
Also depending on the season, cows receive fresh grass, silage of grass, or maize and maize silage, in 
addition to compound feed. Consequently, the exposure differs depending on the type of feeding, the 
season and also the quantity of milk produced. For the present opinion the focus was on cows fed with 
maize and maize silage since data show that this material may in general contain the higher mycotoxin 
levels. A body weight of 650 kg and milk production of 40 kg/day were considered the default. The 
daily feed consumption and the relative contribution of different ingredients for such cows was 
estimated to be 15.0 kg of maize silage, 9.5 kg of maize grain and 2.8 kg of soybean meal, amounting to 
27.3 kg in total  (EFSA CONTAM Panel, 2011b, 2013). 
For fattening beef cattle, a body weight of 400 kg was considered as the default, and for estimating the 
exposure to ZEN, NIV and fumonisins, a daily feed intake of 10.5 kg consisting of 9.5 kg maize silage 
and 1.0 kg soybean meal was applied. So again this refers to cattle fed primarily with maize silage. In 
the case of T2/HT2, beef cattle fed with cereals had the highest exposure, and these animals received a 
daily ration of 7.1 kg non-forage feed (in addition to 1.4 kg forage which normally makes no 
contribution to T2/HT2 intake). The non-forage feed was assumed to contain 60 % barley, 5 % rapeseed 
meal, 5 % sunflower meal, 10 % maize gluten feed, 4 % wheat feed, 10 % sugar beet pulp, 3 % 
molasses, 1 % vegetable oils and 3 % vitamins/minerals.  
                                                 
21
  Commission Recommendation 2006/576/EC of 17 August 2006 on the presence of deoxynivalenol, zearalenone, ochratoxin 
A, T2 and HT2T2 and fumonisins in products intended for animal feeding. OJ L 229, 23.8.2006, p. 7-9. 
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For lactating sheep, a body weight of 80 kg was applied and a feed intake of 2.8 kg per day, of which 
50 % was compound feed with 55 % cereals and cereal by-products. For lactating and fattening goats 
body weights of 60 and 40 kg, respectively, were applied, feed intakes of 3.4 and 1.5 kg/day and relative 
contributions for compound feed of 65 and 40 % with 60 and 70 % from cereals and cereal by-products.  
For estimating exposure of horses, a body weight of 450 kg and feed intake of 9 kg/day was applied, of 
which 4.5 kg was feed with a relative composition of 40 % oats, 10 % beans, 30 % wheat feed, 12 % oat 
feed, 5 % molasses and 3 % minerals/vitamins. For NIV, the mean levels for cereals and cereal by-
products were used for oats, wheat feed and oat feed, and for T2/HT2 toxins the levels in oat, oat 
middling and wheat middling were used. 
For estimating the exposure of cats, a body weight of 4 kg was applied and a feed intake of 60 g/day, for 
dogs a body weight of 25 kg and feed intake of 360 g/day. In the absence of specific data on cat and dog 
feed, it was assumed that potential exposure would come from the cereals in the feed with relative 
contributions of 55 and 65 % for cats and dogs, respectively (EFSA CONTAM Panel, 2011a, 2013).   
No occurrence data were available for fish feed, consequently no exposure assessments could be carried 
out. 
The Panel also noted that animals may occasionally be exposed to much higher levels owing to specific 
contaminations of ingredients of compound feed but also silage. This is demonstrated by the data for 
ZEN and fumonisins in Appendix E, showing values for the P99 values that are often more than 10-fold 
higher than those at the P50. In particular in such cases the presence of modified forms may contribute 
to adverse effects on animal health. Based on the turn-over of compound feed or silage such high 
exposure may last for periods of weeks up to several months. However, the current database contains in 
general too few data to evaluate the higher end exposure of specific animal species. Where permitted by 
the available data, the Panel estimated the high exposure based on the P95 levels.  
9.3.1. Exposure to zearalenone and its modified forms 
Table 17 shows the estimated exposure of various different species based on newly retrieved occurrence 
data shown in Appendix E on compound feed, or in the case of cows and horses, ingredients of the 
rations provided to them. For lactating sheep data on compound feed were applied, taking into account 
that this contributes 50 % to the diet. For lactating and fattening goats data on compound feed were 
limited or missing, and calculations were applied as for nivalenol, i.e. based on levels in cereals and 
cereal-based products, using the relative contribution to compound feed and the relative contribution of 
compound feed to the overall diet. For dogs and cats, estimated levels and exposure were based on the 
levels in “Cereal grains and cereal by-products” and the relative contribution to feed. Where permitted 
by available data, the high exposure was also estimated based on P95 values. Table 18 shows the 
estimated exposure to ZEN and its modified forms based on an average contribution of 100 % of these 
modified forms. 
Cows showed the highest exposure due to the high levels in maize silage. Cows fed on grass or grass 
silage are likely to have a lower exposure, although some high levels of ZEN were reported to EFSA 
(see Appendix E). 
 Modified mycotoxins in food and feed 
 
EFSA Journal 2014;12(12):3916 56 
Table 17:  Mean and P95 levels of ZEN in feed (LB/UB) and estimated exposure of various animal 
species to the parent compound alone 
Animal species  
Live 
weight 
(kg) 
Feed intake 
(kg per day) 
Level (µg/kg) 
Exposure  (µg/kg b.w. 
per day) 
LB UB LB UB 
Based on mean levels       
Piglets 20 1 14 19 0.7 1.0 
Pigs for fattening 100 3 18 31 0.6 0.9 
Sows 200 6 72 82 2.2 2.5 
Chickens for fattening 2 0.12 37 46 2.2 2.8 
Laying hens 2 0.12 55 64 3.3 3.8 
Turkeys for fattening 12 0.4 44 57 1.5 1.9 
Ducks
(a)
 3 0.14 28 43 1.3 2.0 
Rabbits 2 0.15 50 68 3.8 5.1 
Fattening cows (corn) 400 10.5 200 218 5.3 5.7 
Dairy cows 650 27.3 150 163 6.3 6.8 
Sheep lactating 80 2.8 7 9 0.2 0.3 
Goats lactating 60 3.4 17 20 0.9 1.1 
Goats fattening 40 1.5 12 14 0.4 0.5 
Horses
(b)
 450 9.0 4 6 0.1 0.1 
Cats 4 0.06 23 28 0.4 0.4 
Dogs 25 0.36 27 33 0.4 0.5 
Based on P95 levels 
Piglets 20 1 48 48 2.4 2.4 
Pigs for fattening 100 3 (c) (c) (c) (c) 
Sows 200 6 (c) (c) (c) (c) 
Chickens for fattening 2 0.12 128 128 7.7 7.7 
Laying hens 2 0.12 183 183 11.0 11.0 
Turkeys for fattening 12 0.4 (c) (c) (c) (c) 
Ducks
(a)
 3 0.14 
(c) (c) (c) (c) 
Rabbits 2 0.15 
(c) (c) (c) (c) 
Fattening cows (corn) 400 10.5 720 720 18.9 18.9 
Dairy cows 650 27.3 555 556 23.3 23.4 
Sheep lactating 80 1.4 37 37 1.3 1.3 
Goats lactating 60 2.2 64 64 3.6 3.6 
Goats fattening 40 0.6 46 46 1.7 1.7 
Horses
(b)
 450 9.0 
(c) (c) (c) (c) 
Cats 4 0.06 90 90 1.4 1.4 
Dogs 25 0.36 107 107 1.5 1.5 
(a): Data for feed for ducks were included in a miscellaneous group of feeds in Appendix E 
(b): Because there were no data on oat middling, the values for wheat middling were used. 
(c): Too few data to calculate P95 values and no exposures could be calculated. 
 
Table 18 shows the estimated exposure to ZEN and its modified forms based on an average contribution 
of 100 % of these modified forms. 
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Table 18:  Scenario of mean and P95 levels of ZEN in feed (LB/UB) and estimated exposure of 
various animal species including an additional 100 % contribution of modified forms
(a)
 
Animal species  
Live 
weight 
(kg) 
Feed intake 
(kg per day) 
Level 
(µg/kg) 
Exposure  
(µg/kg b.w. per day) 
LB UB LB UB 
Based on mean levels       
Piglets 20 1 29 38 1.4 1.9 
Pigs for fattening 100 3 37 62 1.1 1.8 
Sows 200 6 145 164 4.3 4.9 
Chickens for fattening 2 0.12 73 92 4.4 5.5 
Laying hens 2 0.12 110 128 6.6 7.7 
Turkeys for fattening 12 0.4 89 114 3.0 3.8 
Ducks 3 0.14 56 86 2.6 4.0 
Rabbits 2 0.15 100 135 7.5 10.1 
Fattening cows (corn) 400 10.5 401 437 10.5 11.5 
Dairy cows 650 27.3 300 326 12.6 13.7 
Sheep lactating 80 2.8 14 17 0.5 0.6 
Goats lactating 60 3.4 33 40 1.9 2.3 
Goats fattening 40 1.5 24 28 0.9 1.1 
Horses 450 9.0 7 12 0.1 0.2 
Cats 4 0.06 46 56 0.7 0.8 
Dogs 25 0.36 55 66 0.8 1.0 
Based on P95 levels 
Piglets 20 1 96 96 4.8 4.8 
Pigs for fattening 100 3 
(b) (b) (b) (b) 
Sows 200 6 
(b) (b) (b) (b) 
Chickens for fattening 2 0.12 256 256 15.4 15.4 
Laying hens 2 0.12 366 366 22.0 22.0 
Turkeys for fattening 12 0.4 
(b) (b) (b) (b) 
Ducks 3 0.14 
(b) (b) (b) (b) 
Rabbits 2 0.15 
(b) (b) (b) (b) 
Fattening cows (corn) 400 10.5 1439 1441 37.8 37.8 
Dairy cows 650 27.3 1111 1112 46.6 46.7 
Sheep lactating 80 2.8 73 73 2.6 2.6 
Goats lactating 60 3.4 128 128 7.3 7.3 
Goats fattening 40 1.5 92 92 3.4 3.4 
Horses 450 9.0 
(b) (b) (b) (b) 
Cats 4 0.06 180 180 2.7 2.7 
Dogs 25 0.36 213 213 3.1 3.1 
(a): Values given in this table are rough estimates of exposures to ZEN together with modified ZEN. The values have been 
derived by adding 100 % to the exposure values derived for ZEN (see Table 17), based on similar percentages of the ratio 
of contents of ZEN with respect to its modified forms in foodstuffs reported in the literature. Precise figures have been 
retained but should not imply spurious accuracy. 
(b): Too few data were available for the parent compound to calculate P95 values and no P95 scenario exposures could be 
provided. 
9.3.2. Exposure to nivalenol and its modified forms 
In line with the recent opinion on nivalenol (EFSA CONTAM Panel, 2013), levels in feed and related 
exposure of the various species was based on the levels in feed ingredients, for most species only the 
group “Cereal grains and cereal by-products”, and was done according to the contribution described 
under Section 9.2.2. Average and P95 levels (LB/UB) in this category were 11/43 and 66/66 µg/kg. For 
cows levels in maize silage, maize grain and soybean meal were used to calculate the average and P95 
levels in the diet, and for horses the levels in oats, wheat feed and oat feed were used, in both cases 
according to the relative contribution to the diet. For sheep and goats it is assumed that the forage part 
does not contribute to the exposure (EFSA CONTAM Panel, 2013). Cows showed again the highest 
exposure owing to relatively high levels in maize silage. 
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Table 19:  Mean and P95 levels of NIV in feed (LB/UB) and estimated exposure of different animal 
species to the parent compound alone 
Animal species  
Live 
weight 
(kg) 
Feed intake 
(kg per day) 
Level 
(µg/kg) 
Exposure  
(µg/kg b.w. per day) 
LB UB LB UB 
Based on mean levels       
Piglets 20 1 8.1 31.8 0.41 1.59 
Pigs for fattening 100 3 7.9 31.0 0.24 0.93 
Sows 200 6 8.3 32.3 0.25 0.97 
Chickens for fattening 2 0.12 8.1 31.8 0.49 1.91 
Laying hens 2 0.12 7.2 28.0 0.43 1.68 
Turkeys for fattening 12 0.4 7.2 28.0 0.24 0.93 
Ducks 3 0.14 7.9 31.0 0.37 1.44 
Rabbits 2 0.15 4.0 15.5 0.30 1.16 
Fattening cows (corn) 400 10.5 72.4 157.4 1.90 4.13 
Dairy cows 650 27.3 47.8 110.6 2.01 4.64 
Sheep lactating 80 2.8 3.0 11.8 0.11 0.41 
Goats lactating 60 3.4 4.3 16.8 0.24 0.95 
Goats fattening 40 1.5 3.1 12.0 0.12 0.45 
Horses 450 9 4.1 16.1 0.08 0.32 
Cats 4 0.06 6.1 23.7 0.09 0.35 
Dogs 25 0.36 7.2 28.0 0.10 0.40 
Based on P95 levels 
Piglets 20 1 48.8 48.8 2.44 2.44 
Pigs for fattening 100 3 47.5 47.5 1.43 1.43 
Sows 200 6 49.5 49.5 1.49 1.49 
Chickens for fattening 2 0.12 48.8 48.8 2.93 2.93 
Laying hens 2 0.12 42.9 42.9 2.57 2.57 
Turkeys for fattening 12 0.4 42.9 42.9 1.43 1.43 
Ducks 3 0.14 47.5 47.5 2.22 2.22 
Rabbits 2 0.15 23.8 23.8 1.78 1.78 
Fattening cows (corn) 400 10.5 368.2 368.2 9.67 9.67 
Dairy cows 650 27.3 246.6 246.6 10.36 10.36 
Sheep lactating 80 2.8 18.2 18.2 0.64 0.64 
Goats lactating 60 3.4 25.7 25.7 1.46 1.46 
Goats fattening 40 1.5 18.5 18.5 0.69 0.69 
Horses 450 9 24.8 24.8 0.50 0.50 
Cats 4 0.06 36.3 36.3 0.54 0.54 
Dogs 25 0.36 42.9 42.9 0.62 0.62 
 
Table 20 shows the estimated exposure to NIV and its modified forms based on an average contribution 
of 30 % of these modified forms. 
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Table 20:  Scenario of mean and P95 levels of NIV in feed (LB/UB) and estimated exposure of 
different animal species including an additional 30 % contribution of modified forms
(a)
 
Animal species  
Live 
weight 
(kg) 
Feed intake 
(kg per day) 
Level 
(µg/kg) 
Exposure  
(µg/kg b.w./day) 
LB UB LB UB 
Based on mean levels       
Piglets 20 1 10.6 41.4 0.53 2.07 
Pigs for fattening 100 3 10.3 40.2 0.31 1.21 
Sows 200 6 10.7 41.9 0.32 1.26 
Chickens for fattening 2 0.12 10.6 41.4 0.63 2.48 
Laying hens 2 0.12 9.3 36.3 0.56 2.18 
Turkeys for fattening 12 0.4 9.3 36.3 0.31 1.21 
Ducks 3 0.14 10.3 40.2 0.48 1.88 
Rabbits 2 0.15 5.1 20.1 0.39 1.51 
Fattening cows (corn) 400 10.5 94.1 204.7 2.47 5.37 
Dairy cows 650 27.3 62.1 143.7 2.61 6.04 
Sheep lactating 80 2.8 3.9 15.4 0.14 0.54 
Goats lactating 60 3.4 5.6 21.8 0.32 1.24 
Goats fattening 40 1.5 4.0 15.7 0.15 0.59 
Horses 450 9 5.5 21.0 0.11 0.42 
Cats 4 0.06 7.9 30.7 0.12 0.46 
Dogs 25 0.36 9.3 36.3 0.13 0.52 
Based on P95 levels 
Piglets 20 1 63.5 63.5 3.17 3.17 
Pigs for fattening 100 3 61.8 61.8 1.85 1.85 
Sows 200 6 64.4 64.4 1.93 1.93 
Chickens for fattening 2 0.12 63.5 63.5 3.81 3.81 
Laying hens 2 0.12 55.8 55.8 3.35 3.35 
Turkeys for fattening 12 0.4 55.8 55.8 1.86 1.86 
Ducks 3 0.14 61.8 61.8 2.88 2.88 
Rabbits 2 0.15 30.9 30.9 2.32 2.32 
Fattening cows (corn) 400 10.5 478.7 478.7 12.57 12.57 
Dairy cows 650 27.3 320.6 320.6 13.46 13.46 
Sheep lactating 80 2.8 23.6 23.6 0.83 0.83 
Goats lactating 60 3.4 33.5 33.5 1.90 1.90 
Goats fattening 40 1.5 24.0 24.0 0.90 0.90 
Horses 450 9 32.2 32.2 0.64 0.64 
Cats 4 0.06 47.2 47.2 0.71 0.71 
Dogs 25 0.36 55.8 55.8 0.80 0.80 
(a) Values given in this table are rough estimates of exposures to NIV together with modified NIV. The values have been 
derived by adding 30 % to the exposure values derived for NIV (see Table 19), based on similar percentages for the ratio 
of contents of NIV with respect to its modified forms in foodstuffs reported in the literature. Precise figures have been 
retained but should not imply spurious accuracy. 
9.3.3. Exposure to the sum of T-2 toxin and HT-2 toxin and their modified forms 
In line with the opinion on T2 and HT2 (EFSA CONTAM Panel, 2011b), levels in feed and related 
exposure of the various species were based on the levels in feed ingredients. This was not based on the 
combined group “Cereal grains and cereal by-products”, but on average and P95 levels in wheat, barley, 
oats, maize, soybean, rapeseed and lucerne meal, wheat feed, sunflower meal, sugar beet pulp, beans 
and maize gluten feed and according to the respective contribution described previously (EFSA 
CONTAM Panel, 2011b). For sheep and lactating and fattening goats, the relative contribution of non-
forage feed to the total ration was also taken into account, being 35, 75 and 40 %, respectively. For 
cows levels in maize silage, maize grain and soybean meal were used to calculate the average and P95 
levels in the diet, and for horses the levels in oats, wheat feed and oat feed were used, in both cases 
according to the relative contribution to the diet. 
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Goats showed the highest estimated exposure owing to relatively high levels in oats that can contribute 
significantly to feed for goats. Rabbits also showed a relatively high exposure owing to higher levels in 
wheat feed. 
Table 21:  Mean and P95 levels of T2 and HT2 in feed (LB/UB) and estimated exposure of various 
animal species to the parent compound alone 
Animal species  
Live 
weight 
(kg) 
Feed intake 
(kg per day) 
Level 
(µg/kg) 
Exposure  
(µg/kg b.w. per day) 
LB UB LB UB 
Based on mean levels       
Piglets 20 1 5.4 25.3 0.27 1.27 
Pigs for fattening 100 3 9.4 29.0 0.28 0.87 
Sows 200 6 9.9 27.9 0.30 0.84 
Chickens for fattening 2 0.12 15.8 29.2 0.95 1.75 
Laying hens 2 0.12 14.1 25.8 0.85 1.55 
Turkeys for fattening 12 0.4 8.1 27.6 0.27 0.92 
Ducks 3 0.14 7.6 26.1 0.35 1.22 
Rabbits 2 0.15 12.1 20.2 0.91 1.51 
Fattening cows (corn) 400 7.1 5.5 38.8 0.10 0.69 
Dairy cows 650 27.3 16.6 39.6 0.70 1.67 
Sheep lactating 80 2.8 3.9 7.5 0.13 0.26 
Goats lactating 60 3.4 47.4 58.9 2.68 3.34 
Goats fattening 40 1.5 27.9 33.8 1.05 1.27 
Horse 450 9.0 55.3 59.8 0.55 0.60 
Cats 4 0.06 13.5 17.1 0.20 0.26 
Dogs 25 0.36 15.9 20.2 0.23 0.29 
Based on P95 levels 
Piglets 20 1 22.9 42.1 1.15 2.10 
Pigs for fattening 100 3 52.6 70.9 1.58 2.13 
Sows 200 6 62.8 80.2 1.88 2.41 
Chickens for fattening 2 0.12 104.2 116.0 6.25 6.96 
Laying hens 2 0.12 92.2 102.3 5.53 6.14 
Turkeys for fattening 12 0.4 31.2 47.8 1.04 1.59 
Ducks 3 0.14 42.0 59.7 1.96 2.79 
Rabbits 2 0.15 73.8 78.8 5.53 5.91 
Fattening cows (corn) 400 7.1 32.7 51.5 0.58 0.91 
Dairy cows 650 27.3 106.6 118.3 4.48 4.97 
Sheep lactating 80 2.8 22.9 25.7 0.80 0.90 
Goats lactating 60 3.4 159.7 164.1 9.05 9.30 
Goats fattening 40 1.5 92.9 94.8 3.48 3.55 
Horse 450 9.0 167.0 167.0 1.67 1.67 
Cats 4 0.06 68.3 74.9 1.03 1.12 
Dogs 25 0.36 80.8 88.6 1.16 1.28 
 
Table 22 shows the estimated exposure to T2 and HT2 and their modified forms based on an average 
contribution of 10 % of these modified forms. 
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Table 22:  Scenario of mean and P95 levels of the sum of T2 and HT2 in feed (LB/UB) and estimated 
exposure of various animal species including an additional 10 % contribution of modified forms
(a)
  
Animal species  
Live 
weight 
(kg) 
Feed intake 
(kg per day) 
Level 
(µg/kg) 
Exposure 
(µg/kg b.w. per day) 
LB UB LB UB 
Based on mean levels       
Piglets 20 1 5.9 27.8 0.30 1.43 
Pigs for fattening 100 3 10.3 31.9 0.31 0.96 
Sows 200 6 10.9 30.7 0.33 0.92 
Chickens for fattening 2 0.12 17.4 32.1 1.05 1.98 
Laying hens 2 0.12 15.5 28.4 0.54 1.76 
Turkeys for fattening 12 0.4 8.9 30.4 0.30 1.05 
Ducks 3 0.14 8.3 28.7 0.39 1.32 
Rabbits 2 0.15 13.3 22.2 1.00 1.67 
Fattening cows (corn) 400 7.1 6.1 42.7 0.11 0.76 
Dairy cows 650 27.3 18.3 43.6 0.77 1.83 
Sheep lactating 80 2.8 4.2 8.2 0.15 0.29 
Goats lactating 60 3.4 52.1 64.8 2.95 3.67 
Goats fattening 40 1.5 30.7 37.2 1.15 1.39 
Horses 450 9.0 60.8 65.8 0.61 0.66 
Cats 4 0.06 14.8 18.8 0.22 0.28 
Dogs 25 0.36 17.5 22.2 0.25 0.32 
Based on P95 levels 
Piglets 20 1 25.2 46.3 1.26 2.31 
Pigs for fattening 100 3 57.9 78.0 1.74 2.34 
Sows 200 6 69.1 88.2 2.07 2.65 
Chickens for fattening 2 0.12 114.6 127.6 6.88 7.66 
Laying hens 2 0.12 101.4 112.5 6.09 6.75 
Turkeys for fattening 12 0.4 34.4 52.6 1.15 1.75 
Ducks 3 0.14 46.2 65.7 2.15 3.07 
Rabbits 2 0.15 81.2 86.7 6.09 6.50 
Fattening cows (corn) 400 7.1 36.0 56.7 0.64 1.01 
Dairy cows 650 27.3 117.2 130.2 4.92 5.47 
Sheep lactating 80 2.8 25.2 28.2 0.88 0.99 
Goats lactating 60 3.4 175.7 180.5 9.96 10.23 
Goats fattening 40 1.5 102.2 104.3 3.83 3.91 
Horses 450 9.0 183.7 183.7 1.84 1.84 
Cats 4 0.06 75.2 82.4 1.13 1.24 
Dogs 25 0.36 88.8 97.4 1.28 1.40 
(a): Values given in this table are rough estimates of exposures to the sum of T2 and HT2 together with the sum of modified 
T2 and HT2. The values have been derived by adding 10 % to the exposure values derived for the sum of T2 and HT2 (see 
Table 21), based on similar percentages for the ratio of contents of the sum of T2 and HT2 with respect to its modified 
forms in foodstuffs reported in the literature. Precise figures have been retained but should not imply spurious accuracy. 
9.3.4. Exposure to fumonisins and their modified forms 
Table 23 shows the estimated exposure of various different species based on newly retrieved occurrence 
data shown in Appendix E on compound feed in the case of pigs, or in the case of cows and horses, 
ingredients of the rations provided to them. For sheep and goats, the levels in cereals and cereal based 
products were also applied to estimate the level in compound feed and subsequently in the total diet, 
using the relative contributions described under Section 9.2.4. For dogs and cats, estimated levels and 
exposure were based on the level in “Cereal grains and cereal by-products” and the relative contribution 
to feed (see Section 9.3). As a similar approach was taken  for chickens, turkeys and ducks for fattening, 
for laying hens and for rabbits since no specific data were available on compound feed for these species. 
Where permitted by available data, the high exposure was also estimated based on P95 values. Highest 
exposure was estimated for chickens and laying hens, owing to their relatively high consumption of 
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cereals, relative to their body weight. Dairy cows receiving maize silage were also estimated to have a 
relatively high exposure. 
Table 23:  Mean and P95 levels of fumonisins in feed (LB/UB) and estimated exposure of various 
animal species to the parent compound alone 
Animal species  
Live 
weight 
(kg) 
Feed intake 
(kg per day) 
Level 
(µg/kg) 
Exposure  
(µg/kg b.w. per day) 
LB UB LB UB 
Based on mean levels       
Piglets 20 1 73 205 3.7 10.3 
Pigs for fattening 100 3 246 369 7.4 11.1 
Sows 200 6 152 395 4.6 11.9 
Chickens for fattening 2 0.12 210 306 12.6 18.3 
Laying hens 2 0.12 185 268 11.1 16.1 
Turkeys for fattening 12 0.4 185 268 6.2 8.9 
Ducks 3 0.14 204 297 9.5 13.9 
Rabbits 2 0.15 102 149 7.7 11.2 
Fattening cows (corn) 400 10.5 23 313 0.6 8.2 
Dairy cows 650 27.3 194 421 8.2 17.7 
Sheep lactating 80 2.8 78 114 2.7 4.0 
Goats lactating 60 3.4 111 161 6.3 9.1 
Goats fattening 40 1.5 80 116 3.0 4.3 
Horses
(a)
 450 9.0 2 52 0.0 1.0 
Cats 4 0.06 156 227 2.3 3.4 
Dogs 25 0.36 185 268 2.7 3.9 
Based on P95 levels 
Piglets 20 1 353 449 17.6 22.5 
Pigs for fattening 100 3 
(b) (b) (b) (b) 
Sows 200 6 970 1070 29.1 32.1 
Chickens for fattening 2 0.12 1117 1224 67.0 74.6 
Laying hens 2 0.12 981 1093 58.9 65.6 
Turkeys for fattening 12 0.4 981 1093 32.7 36.4 
Ducks 3 0.14 1086 1210 50.7 56.5 
Rabbits 2 0.15 543 605 40.7 45.4 
Fattening cows (corn) 400 10.5 
(b) (b) (b) (b) 
Dairy cows 650 27.3 
(b) (b) (b) (b) 
Sheep lactating 80 2.8 415 462 14.5 16.2 
Goats lactating 60 3.4 589 656 33.3 37.2 
Goats fattening 40 1.5 423 471 15.8 17.7 
Horses
(a)
 450 9.0 
(b) (b) (b) (b) 
Cats 4 0.06 830 925 12.4 13.9 
Dogs 25 0.36 981 1093 14.1 15.7 
(a): because their were no data on oat middling, the values for wheat middling were used. 
(b): too few data to calculate P95 values and no exposures could be calculated 
 
Table 24 shows the estimated exposure to fumonisins and their modified forms based on an average 
contribution of 60 % of these modified forms. 
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Table 24:  Scenarios of  mean and P95 levels of fumonisins in feed (LB/UB) and estimated exposure 
of various animal species including an additional 60 % from modified forms
(a)
 
Animal species  
Live 
weight 
(kg) 
Feed intake 
(kg per day) 
Level 
(µg/kg) 
Exposure  
(µg/kg b.w. per day) 
LB UB LB UB 
Based on mean levels       
Piglets 20 1 117 328 5.9 16.4 
Pigs for fattening 100 3 394 590 11.8 17.7 
Sows 200 6 243 632 7.3 19.0 
Chickens for fattening 2 0.12 336 489 20.2 29.3 
Laying hens 2 0.12 295 430 17.7 25.8 
Turkeys for fattening 12 0.4 295 430 9.8 14.3 
Ducks 3 0.14 327 476 15.3 22.2 
Rabbits 2 0.15 164 238 12.3 17.8 
Fattening cows (corn) 400 10.5 38 501 1.0 13.2 
Dairy cows 650 27.3 311 674 13.1 28.3 
Sheep lactating 80 2.8 125 182 4.4 6.4 
Goats lactating 60 3.4 177 258 10.0 14.6 
Goats fattening 40 1.5 127 185 4.8 6.9 
Horses 450 9.0 3 83 0.1 1.7 
Cats 4 0.06 250 363 3.7 5.5 
Dogs 25 0.36 295 430 4.3 6.2 
Based on P95 levels 
Piglets 20 1 562 718 28.1 35.9 
Pigs for fattening 100 3 (b) (b) (b) (b) 
Sows 200 6 1552 1712 46.6 51.4 
Chickens for fattening 2 0.12 1787 1990 107.2 119.4 
Laying hens 2 0.12 1569 1748 94.2 104.9 
Turkeys for fattening 12 0.4 1569 1748 52.3 58.3 
Ducks 3 0.14 1738 1937 81.1 90.4 
Rabbits 2 0.15 869 968 65.2 72.6 
Fattening cows (corn) 400 10.5 
(b) (b) (b) (b) 
Dairy cows 650 27.3 
(b) (b) (b) (b) 
Sheep lactating 80 2.8 664 740 23.2 25.9 
Goats lactating 60 3.4 942 1049 53.4 59.4 
Goats fattening 40 1.5 676 753 25.4 28.2 
Horses 450 9.0 
(b) (b) (b) (b) 
Cats 4 0.06 1328 1479 19.9 22.2 
Dogs 25 0.36 1569 1748 22.6 25.2 
(a): Values given in this table are rough estimates of exposures to fumonisins together with modified fumonisins. The values 
have been derived by adding 60 % to the exposure values derived for fumonisins (see Table 23), based on similar 
percentages  for the ratio of contents of fumonisins with respect to its modified forms in foodstuffs reported in the 
literature. Acute figures have been retained but should not imply spurious accuracy. 
(b):  Too few data were available for the parent compound to calculate P95 values and no P95 scenario exposures could be 
provided 
 
10. Risk characterisation  
10.1. Human health risk characterisation  
There are no toxicity data on modified forms of ZEN, NIV, T2, HT2, and fumonisins. However, there 
are studies indicating that glycosides of several mycotoxins and also sulphates of mycotoxins are 
hydrolysed in the stomach or lower in the GI tract and then absorbed. Furthermore, mycotoxins that are 
modified by sequestration in the plant matrix are also to a large extent released by digestion in the GI 
tract. Therefore, toxicity, similar to that of the parent compound can be assumed for modified 
mycotoxins in both animals and humans, as a pragmatic approach. The risk characterization is 
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performed by comparing the estimated combined exposure of parent and modified forms of mycotoxins 
with the established TDIs for the respective parent compounds. 
Based on the few data currently available and taking a pragmatic approach, the modified forms of a 
mycotoxin are assumed to exert the same toxicity as the parent compound.  
10.1.1. Zearalenone  
The TDI for ZEN is 0.25 µg/kg b.w. per day (250 ng/kg b.w. per day). The exposure estimates with the 
scenario adding 100 % modified ZEN to the exposure estimates of the parent compound resulted in a 
mean dietary exposure ranging across age groups and surveys between 4.0 (lowest LB, in the elderly) to 
200 ng/kg b.w. per day (highest UB, in toddlers). High exposure amounted to between 7.0 and 
554 ng/kg b.w. per day (lowest LB to highest UB). There was, however, a relatively large difference 
between LB and UB exposure; the highest LB 95
th
 percentile in toddlers was 100 ng/kg b.w. per day, 
which is more than five-fold lower than the UB. Again, the highest exposure was estimated for toddlers 
with a maximum mean exposure of 57 (LB) and 250 (UB) ng/kg b.w. per day, and a maximum high 
exposure of 125 to 692 ng/kg b.w. per day. 
Using the LB approach even high consumers will not have a combined exposure to ZEN and modified 
ZEN above the TDI set for ZEN, indicating no concern. However, if the true concentration of modified 
and parent ZEN in cereals is closer to the UB level, high consumers may have an exposure up to 2.7-
fold the TDI, which would be of concern. 
10.1.2. Nivalenol  
The TDI for NIV is 1.2 µg/kg b.w. per day (1 200 ng/kg b.w. per day). Estimated mean dietary exposure 
to NIV with the addition of 30 % modified NIV ranged between 0.5 (lowest LB) ng/kg b.w. per day to 
262.6 (highest UB) ng/kg b.w. per day, whereas the highest LB and UB high 95
th
 percentile)  exposure 
was 29.9 and  629.2 ng/kg b.w. per day, respectively. None of these estimated exposures were close to 
the TDI, and estimated exposure to nivalenol and modified nivalenol is not of concern.  
10.1.3. T-2 and HT-2 toxin 
The group TDI for the sum of T2 and HT2 is 0.1 µg/kg b.w. per day (100 ng/kg b.w. per day). The 
mean dietary exposure to T2 and HT2 with the addition of 10 % modified forms ranged from 3.1 
(lowest LB) to 47.3 (highest UB) ng/kg b.w. per day across age groups and surveys. The high 
(95
th
 percentile) exposure was highest in toddlers, where the LB and UB exposures were 71.5 and 
100.1 ng/kg b.w. per day, respectively. This high UB level is similar to the TDI, but since the UB is a 
conservative estimate, the exposure to the sum of T2 and HT2 with the addition of  modified forms is 
not considered to be of concern. 
10.1.4. Fumonisins 
The group PMTDI for fumonisins is 2 µg/kg b.w.per day. The calculated exposure to fumonisins as 
parent compounds in European countries showed that mean LB and UB exposure across age class and 
surveys was lower than the PMTDI, whereas the 95
th
 percentile exposure in toddlers and other children 
was above the PMTDI in several surveys. In other children, 0 to 18 % (LB) and up to 35 %  (UB) had 
an exposure above the PMTDI, whereas in toddlers up to 27 % had an exposure above the PMTDI 
(Appendix C, Table C2).  This indicates a concern for fumonisin exposure in toddlers and other children 
with high consumption at the present level of parent fumonisins in food, without the additional exposure 
from modified forms of fumonisins. However, the unexpectedly high contribution from wheat based 
products to the total exposure is associated with high uncertainty due to the low number of quantified 
results. This uncertainty also affects exposure estimates for their modified forms.  
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The amount of modified fumonisins that comes in addition to the parent compounds can be expected to 
be 60 %. With the addition of  60 % modified fumonisins, a 95
th
 percentile LB exposure up to 5.0 µg/kg 
b.w. per day was seen in other children, which is 2.5-fold the PMTDI. The 95
th
 percentile UB estimates 
indicated a three-fold exceedance of the PMTDI. 
With the addition of 60 % modified fumonisins, 0 to 38 % (LB) of other children and 0.2 to 14 % (LB) 
of toddlers exceeded the PMTDI, whereas the UB estimates indicate that 11 to 59 % of other children 
and 43 to 66 % of toddlers exceed the PMTDI (Table 25).  
Table 25:  Percentage above the PMTDI across surveys in the total population with 60 % extra 
contribution from modified fumonisins 
Age class 
Percentage above the PMTDI in total population 
Minimum Median Maximum 
LB UB LB UB LB UB 
Infants (< 1 year old) 0.3 22 -
(a)
 -
(a)
 0.3 22 
Toddlers (≥ 1 year to < 3 years old) 0.2 43 5.3 51 14 66 
Other children (≥ 3 years to < 10 years old) 0.0 11 2.6 32 38 59 
Adolescents (≥ 10 years to < 18 years old) 0.0 0.2 0.5 5.7 12 29 
Adults (≥ 18 years to < 65 years old) 0.0 0.0 0.1 0.8 0.7 5.3 
Elderly (≥ 65 years to < 75 years old) 0.0 0.0 0.0 0.3 0.0 1.3 
Very elderly (≥ 75 years old) 0.0 0.0 0.0 0.0 0.2 0.9 
(a):  Estimates based on only two dietary surveys. 
This indicates that the total fumonisin exposure including modified forms may be of concern, especially 
in children’s age groups. 
10.2. Animal health risk characterization 
The animal health risk characterisation is performed as for humans, by estimating exposure to the sum 
of parent and modified mycotoxins in comparison with the NOAELs/LOAELs for the respective parent 
compounds (see Table 2). The assessment is based on a similar percentage addition of modified 
mycotoxins in animal feed as that in human food (100 % for ZEN, 30 % for NIV, 10 % for the sum of 
T2 and HT2 and 60 % for fumonisins).  
Peak exposures may occur in certain feed commodities and cause an increased exposure of animals of 
several weeks to months. As such, the higher end of the distribution is also of interest to evaluate the 
risks for animals. High percentile (P95) exposures have been included when adequate feed data were 
available. 
10.2.1. Zearalenone and its modified forms 
No NOAELs/LOAELs for ZEN in animals were derived by EFSA in 2004, since the data available were 
considered inadequate. However, pigs and sheep were found to be the most susceptible species. In the 
human ZEN risk assessment from EFSA in 2011, the human TDI was based on a NOEL of 10 µg/kg 
b.w. per day for oestrogenic effects in pigs.  
Pigs 
Guidance values for ZEN in feed have been established in Commission Recommendation 2006/576/EC. 
These values are, in compound feed for piglets and gilts, 0.1 mg/kg feed, and for sows and fattening 
pigs, 0.25 mg/kg feed. These values can be used for comparison with the reported occurrence of 
zearalenone in compound feed (Appendix E). The reported mean and P95 values for pig feed were 
below the guidance values.  
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Exposure of pigs to ZEN is seen in relation to the NOEL of 10 µg/kg b.w. per day for oestrogenic 
effects in pigs in the present risk characterization. The mean estimated exposure of pigs to  ZEN 
together with an added 100 % modified ZEN was below the above-mentioned NOEL of 10 µg/kg b.w. 
per day. In piglets, too, the exposure based on the 95
th
 percentile occurrence in feed was below the 
NOEL.  
Based on available data in feed, there is no concern for exposure to ZEN and modified ZEN in piglets. 
Exposure in fattening pigs and sows receiving feed with average levels is also not of concern. 
Occurrence data were inadequate to draw conclusions regarding fattening pigs and sows receiving feed 
with higher than average contamination levels. 
Ruminants 
The guidance value for ZEN in feed as established in Commission Recommendation (2006/576/EC) is 
0.5 mg/kg feed for dairy cattle. The occurrence data for ZEN as parent compound are well below 
0.5 mg/kg feed for dairy cattle. However, in maize silage, a major feed source, the P95 value exceeds 
the guidance value. The addition of 100 % modified ZEN to the occurrence would lead to an even 
higher fraction exceeding this guidance value.  
EFSA has not derived a NOAEL/LOAEL for cattle, but cattle are considered to be less sensitive to ZEN 
than pigs (EFSA, 2004). 
The estimated exposure after feeding with mixed feed (maize silage, maize grain and soy bean meal) at 
the 95
th
 percentile concentration of ZEN and modified ZEN was for fattening cows 38 µg/kg b.w. per 
day and for dairy cows 47 µg/kg b.w. per day (i.e. being four to five-fold the NOEL derived for pigs). 
However, in the absence of a NOAEL/LOAEL, the risk for cattle cannot be characterised fully.  
According to EFSA (2004) next to pigs sheep are rather sensitive to ZEN toxicity. Estimated exposure 
in sheep is lower than in pigs, and therefore not of concern.  
Estimated exposure in goats is considerably lower than in cows but, owing to the lack of an effect level, 
the risk for goats cannot be characterised fully. 
Poultry 
There are neither NOAELs/LOAELs nor guidance values for poultry. The mean exposure in poultry to 
ZEN together with its modified forms is between 4 and 8 µg/kg b.w. per day whereas the P95 exposures 
are between 15 and 22 µg/kg b.w. per day. According to EFSA (2004) poultry is less susceptible to ZEN 
induced toxicity than pigs. The CONTAM Panel therefore consideres exposures of poultry to ZEN and 
its modified forms not to be of concern. 
Horses  
There are neither NOAELs/LOAELs nor guidance values for horses. Estimated exposure to ZEN and 
modified ZEN based on mean occurrence in horse feed is 0.2 µg/kg b.w. per day, thus far below the 
NOEL derived for pigs of 10 µg/kg b.w. per day and considered not to be of concern.   
Rabbits 
There are neither NOAELs/LOAELs nor guidance values for rabbits. Estimated exposure to ZEN and 
modified ZEN based on mean occurrence in rabbit feed is 10 µg/kg b.w. per day, thus similar to the 
NOEL derived for pigs. In the absence of information on susceptibility of rabbits to ZEN a concern 
cannot be excluded. 
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Fish 
No occurrence data were available for fish feed, consequently no exposure assessment and risk 
characterisation could be carried out. 
Cats and dogs 
There are neither NOAELs/LOAELs nor guidance values for cats and dogs. However, estimated 
exposure to ZEN and modified ZEN based estimated mean and 95
th
 percentile occurrence in grains 
possibly used for pet food is maximally 3 µg/kg b.w. per day and thus far below the NOEL of 10 µg/kg 
b.w. per day derived for pigs (sensitive to ZEN) and thus not of concern.  
10.2.2. Nivalenol and its modified forms 
Pigs 
For NIV the CONTAM Panel established a LOAEL of 100 µg/kg b.w. per day for pigs (EFSA 
CONTAM Panel, 2013). The estimated exposure to NIV with the addition of 30 % modified NIV to the 
parent compound results in a mean exposure which is maximally 2 % (mean exposure level) to 3 % 
(95
th
 percentile exposure) of the LOAEL, and is therefore not of concern.  
Ruminants 
No NOAELs/LOAELs have been set for NIV in ruminants. Dairy cows had the highest 95
th
 percentile 
exposure of 13 µg/kg b.w. per day. In EFSA CONTAM Panel (2013) the CONTAM Panel noted that 
the susceptibility of ruminants to nivalenol mediated toxicity is likely to be low based on evidence of 
detoxification of the compound by de-epoxidation by rumen microorganisms. Based on this, exposure 
of ruminants to NIV and its modified forms is not of concern.  
Poultry 
For NIV the CONTAM Panel established a LOAEL of 53 µg/kg b.w. per day for poultry (EFSA 
CONTAM Panel, 2013). The highest mean and 95
th
 percentile exposure to NIV with additional 30 % 
modified NIV, which was estimated for fattening chicken, was  2.5 and 3.8 µg/kg b.w. per day, 
respectively. This is only 5 to 7 % of the LOAEL and therefore not of concern.  
Fish 
As regards fish no occurrence data were available, consequently no exposure assessment and risk 
characterisation could be carried out. 
Other livestock and companion animals 
Since no NOAELs/LOAELs have been set for NIV in horses, rabbits, cats and dogs no risk 
characterisation can be carried out. However, 95
th
 percentile exposures in these species ranged between 
0.6 and 2.3 µg/kg b.w. per day. This is much lower than the LOAEL of 53 µg/kg b.w. per day derived 
for poultry, the most sensitive species for which a NOAEL/LOAEL has been derived (EFSA CONTAM 
Panel, 2013). Therefore exposure to NIV and its modified forms is not of concern. 
10.2.3. T-2 and HT-2 toxin and their modified forms 
Pigs 
In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 29 µg/kg b.w. per day for pigs. The 
highest mean exposure was calculated for piglets and sows (about 1.0 µg/kg b.w. per day) after adding 
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10 % modified T2 and HT2 to the exposure of the parent compound. At the 95
th
 percentile the exposure 
was estimated to be 2.3 µg/kg b.w. per day for piglets and 2.7 µg/kg b.w. per day for sows. This is up to 
9 % of the LOAEL and not of concern.  
Ruminants 
In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 300 µg/kg b.w. per day for ruminants. 
In ruminants the highest 95
th
 percentile exposure to T2 and HT2 with addition of 10 % modified forms 
was estimated in lactating goats at 10.4 µg/kg b.w. per day. This is 3.4 % of the LOAEL and not of 
concern. 
Poultry 
In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 40 µg/kg b.w. per day for poultry. The 
highest estimated exposure to T2 and HT2 toxin with addition of 10 % modified forms was in chicken 
for fattening with 2.0 (mean) and 7.8 (95
th
 percentile) µg/kg b.w. per day. This is up to 20 % of the 
LOAEL and not of concern.  
Rabbits 
In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 100 µg/kg b.w. per day for rabbits. In 
rabbits the highest 95
th
 percentile exposure to T2 and HT2 with addition of 10 % modified forms was 
estimated to be 6.5 µg/kg b.w. per day. This corresponds to 7 % of the LOAEL and thus not of concern.  
Fish 
In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 13 µg/kg b.w. per day for fish. No 
exposure data to the parent compound were available for fish. No exposure assessment to T2 and HT2 
with addition of 10 % modified forms could be performed and consequently also no risk can be 
characterised.   
Horses 
No NOAELs/LOAELs have been set for horses. The estimated 95
th
 percentile exposure in horses to T2 
and HT2 with 10 % addition of modified forms was 1.8 µg/kg b.w. per day. This is lower than in sows, 
for which no concern was identified, indicating that exposure to the sum of T2 and HT2 with 10 % 
addition of modified forms is not of concern for horses. 
Cats  
The guidance value for cat food is 50 µg/kg feed. The mean estimated occurrence of T2 and HT2 and its 
modified forms in cat food is below the guidance value, however, the 95
th
 percentile is in the range of 
75 – 82 µg/kg feed exceeding the guidance value. The 95th percentile estimated exposure in cats was 
0.71 µg/kg b.w. per day. No NOAELs/LOAEL is available for cats, but it is known that this species is 
sensitive toward T2 and HT2 induced toxicity. A concern cannot be excluded but is unlikely, based on 
low exposure. 
Dogs 
The indicative value (2013/165/EU) for dog food is 250 µg/kg feed. The estimated mean and 
95
th
 percentile occurrence in dog food based on mean and 95
th
 percentile occurrence in grains possibly 
used for dog food is lower than the indicative value. There are no NOAELs/LOAELs for dogs.  
Estimated exposure to T2 and HT2 and their modified forms is maximally 1.4 µg/kg b.w. per day and 
thus far below the LOAELs and NOAELs derived for other species, and not of concern.  
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10.2.4. Fumonisins and their modified forms 
Pigs 
For fumonisins a LOAEL of 200 µg/kg b.w. per day was derived for pigs by EFSA in 2005. Sows had 
the highest estimated exposure to fumonisins and their modified forms (60 % added to parent 
compound). The estimated mean and 95
th
 percentile UB exposure was 19 and 51 µg/kg b.w. per day, 
respectively. This is up to 25 % of the LOAEL indicating no concern.  
Ruminants 
For ruminants, the lowest NOAEL identified by EFSA in 2005 was 600 µg/kg b.w. per day. In 
ruminants the highest mean exposure to fumonisins and 60 % addition of modified forms was 28 µg/kg 
b.w. per day. This is 5 % of the NOAEL and not of concern. Estimations of high exposure could not be 
done for the ruminant with highest exposure (lactating cows) due to lack of occurrence data, but is not 
expected to exceed the NOAEL. 
Poultry 
For poultry, EFSA identified a LOAEL of 2000 µg/kg b.w. per day in 2005. The highest estimated 
95
th
 percentile exposure to fumonisins and 60 % addition of modified fumonisins was 119 µg/kg b.w. 
per day in chickens for fattening. This is 6 % of the LOAEL, indicating no concern.  
Horses 
For horses the LOAEL identified by EFSA in 2005 was 200 µg/kg b.w. per day. The mean UB exposure 
to fumonisins and 60 % addition of modified fumonisins was 1.7 µg/kg b.w. per day. As this is less than 
1 % of the LOAEL, it is of no concern. 
Rabbits  
For rabbits no NOAELs/LOAELs for fumonisins have been set. Mean UB exposure to fumonisins and 
their modified forms in rabbits is estimated to be 18 µg/kg b.w. per day. The mean occurrence level in 
feed is below the guidance value of 5000 µg/kg.  Estimations of high exposures (P95) is 73 µg/kg b.w. 
per day, and not of concern since it is well below the LOAEL of 200 µg/kg b.w. per day set for the most 
sensitive species, pigs and horses. 
Fish 
In fish (carp) a LOAEL of 10 mg/kg feed was identified by EFSA in 2005. The lack of occurrence data 
for fumonisins and their modified forms in fish feed prevents an exposure assessment and a risk 
characterization in fish.  
Cats and dogs 
For cats and dogs, NOAELs/LOAELs are not available. The guidance value for pet food is 5 mg/kg 
feed. The estimated 95
th
 percentile values for fumonisins and their modified forms are  1.5 and 
1.7 mg/kg feed, respectively.  
Estimated 95
th
 percentile exposures to fumonisins and their modified forms are 22 and 25 µg/kg b.w. 
per day, for cats and dogs respectively and thus far below the LOAEL of 200 µg/kg b.w. per day 
derived for pigs and horses (sensitive to fumonisins) and thus not of concern.  
 Modified mycotoxins in food and feed 
 
EFSA Journal 2014;12(12):3916 70 
10.3. Uncertainty analysis  
The evaluation of the inherent uncertainties in the assessment of the risks for animal and public health 
related to the presence of modified mycotoxins in food and feed has been performed following the 
guidance of the opinion of the Scientific Committee related to Uncertainties in Dietary Exposure 
Assessment (EFSA, 2006). In addition, the report ‘Characterizing and Communicating Uncertainty in 
Exposure Assessment’ has been considered (WHO/IPCS, 2008). In accordance with the guidance 
provided by the EFSA opinion (2006), the following sources of uncertainties have been considered: 
Assessment objectives, exposure scenario, exposure model and model input (parameters). 
10.3.1. Assessment objectives 
The objectives of the assessment were specified in the terms of reference.  
10.3.2. Exposure scenario/model/input parameters 
Based on the fact that insufficient occurrence data for the modified mycotoxins covered by the terms of 
reference were available, exposure assessments have been carried out on the basis of exposure 
assessments for the parent compounds and adding literature derived factors to account for modified 
mycotoxins.  
To establish total exposure levels by combining exposures to parent compound and its respective 
modified form, certain factors have been added to the overall exposures established in recently carried 
out risk assessments (EFSA CONTAM Panel, 2011a, b, 2013) for different consumer groups for ZEN, 
NIV and T2 and HT2, and for the different animal species for NIV, T2 and HT2. The uncertainties 
incurred in the derivation of the exposure levels (for both the different human consumer groups and 
animal species), and that apply also to the present evaluations, are already described in these 
assessments, and are they are therefore not repeated here. 
The factors added to account for modified mycotoxins are based on limited data from the literature. 
Actual exposures to the different modified mycotoxins may well deviate.  
Occurrence data on parent compounds include data generated with ELISA, which potentially detect both 
parent compounds and their modified forms. Adding certain factors to the parent compound to account 
for the modified forms may lead to an overestimation of overall occurrence.  
The extraction methods for fumonisins are hampered by high variability and low accuracy which could 
lead to an underestimation of actual concentrations. Adding 60 % entrapped fumonisins to the reported 
fumonisin exposure levels could lead to an overestimation of actual exposures, since it is unclear to 
what extent these forms were extracted by methods used to generate the data present in the EFSA 
database.  
Since no recent human exposure assessment is available for fumonisins, such an assessment has been 
carried out for the present opinion. The main uncertainty in this assessment is related to the big 
differences between the LB and UB estimates of occurrence and exposure levels owing to high LOQs 
associated with censored data.  
F. verticillioides, which produces fumonisins, is known to grow predominantly on maize. Maize-based 
products are therefore considered to be the main dietary source. However, the fumonisin exposure 
assessment indicated that wheat-based cereals are a major source. This exposure from wheat based 
products is based on a few quantified samples and is associated with a high uncertainty. However, 
recent data in the literature confirm the presence in certain wheat products. 
Overall, the human exposure assessment for fumonisins and consequently that for its modified forms are 
likely to be overestimations.  
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Since no recent animal exposure assessments are available for ZEN and fumonisins, such assessments 
have been carried out for the present opinion. In the preparation of the exposure assessments, the 
occurrence data collated by EFSA on these two substances were considered. The main uncertainty 
related to this dataset is that only a “light” quality procedure was followed (i.e. only checking of 
duplicates and consistency of information related to feed description, harmonisation of the unit of 
expression of the results and expressing fumonisins as total fumonisins equivalents). Normally, an 
outlier analysis is also performed in order to identify potential errors in reporting the results.   
10.3.3. Other uncertainties  
Since neither animal and human risks assessments nor any toxicological data are available for the 
modified mycotoxins covered by the terms of reference, toxicological/guidance values set for their 
parent compounds in previous evaluations have been used for the present risk assessments. 
Consequently, all the uncertainties regarding toxicity assessment identified in these previous 
assessments (EFSA CONTAM Panel, 2011a, b, 2013; FAO/WHO, 2012) and incurred with the 
guidance values set in Commission Recommendation 2006/576/EC are also applicable for the present 
assessment and are therefore not repeated here.  
In the absence of any data, the present assessment is based on the assumption that modified mycotoxins 
have identical toxicological profiles and potencies as their parent compounds. This is based on data 
showing that the modified forms can be hydrolysed to the parent compounds in the GI tract. To what 
extent modified forms per se can exert toxic activity is not known.  
Modified mycotoxins may easily be overlooked because of too high LOQs. This is a result of their 
relatively lower occurrence compared with the parent compound, which may however still be 
substantial, especially when dealing with a set of these compounds. A particular future issue in this 
regard is how to deal with left-censored data in order to arrive at an UB exposure. In the current opinion 
this does not apply, since levels of modified forms were estimated at a fixed contribution to the LB but 
also UB level of the parent compound.  
10.3.4. Summary of uncertainties 
In Table 26, a summary of the uncertainty evaluation is presented, highlighting the main sources of 
uncertainty and indicating an estimate of whether the source of uncertainty leads to 
over/underestimation of the resulting risk. 
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Table 26:  Summary of qualitative evaluation of the impact of uncertainties on the risk assessment of 
the modified mycotoxins in food and feed 
Sources of uncertainty Direction
(a)
  
Absence of occurrence data for animals and human consumer groups for modified 
mycotoxins  
+/- 
Lack of clarity about recovery of methods used for fumonisin analysis + 
Big difference between LB and UB estimates of occurrence and exposure owing to 
high LOQs associated with left censored data for fumonisins 
+ 
Procedure applied for occurrence in feed data collection on zearalenone and 
fumonisins 
+ 
Incomplete animal health NOAELs/LOAELs  +/- 
Factors added to parent compounds to account for modified forms derived from 
limited data  
+/- 
Assumption that modified mycotoxins have similar toxicological profile and potency 
as their parent compounds 
+/- 
 LOQ: limit of quantification; LB lower bound; UB: upper bound. NOAEL; No Observed Adverse Effect Level; LOAEL: 
Lowest Observed Adverse Effect Level. 
(a): + = uncertainty with potential to cause over-estimation of exposure/risk; - = uncertainty with potential to cause under-
estimation of exposure/risk, extent of potential over/underestimation might differ in direction. 
The overall uncertainty incurred with the present assessment is considered as high. The exposure 
assessments to modified mycotoxins are likely to be overestimations. 
 
CONCLUSIONS AND  RECOMMENDATIONS 
CONCLUSIONS 
General 
 Modified mycotoxins are  metabolites of the parent (free) mycotoxin formed in the plant or 
fungus by conjugation with polar compounds. The most common conjugations are with glucose 
and modified glucose and others such as sulphate and glutathione.  
 Modified mycotoxins have up to recently only occasionally been detected when analysing for 
mycotoxins. 
 The present assessment covers modified forms of zearalenone, nivalenol, T-2 and HT-2 toxins 
and fumonisins. Concerning fumonisins, both covalently and non-covalently bound forms have 
been considered as modified forms.  
 
Methods of analysis 
 Protocols for modified mycotoxin analysis are mainly based on water/acetonitrile extraction 
followed by a “dilute & shoot” analysis by liquid chromatography – tandam mass spectrometry.  
 Both targeted and untargeted methods are used and represent the methods of choice for 
modified mycotoxin detection. Immunochemical methods are simple alternatives for routine 
analysis but they are associated with higher uncertainties.  
 Concerning fumonisins and their modified forms, variability due to different extraction 
strategies is high and can significantly affect the occurrence data.  
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 There is a lack of properly validated routine methods due to the lack of commercially available 
calibrants and reference materials.  
Occurrence/Exposure 
 Bran- and fiber-enriched products are more prone to contamination with mycotoxins including 
their modified forms. 
 The EFSA occurrence database contains no data on modified mycotoxins covered by the 
present opinion. Therefore occurrence is based on limited information reported in the literature.  
 Literature data show that modified forms of mycotoxins may add substantially to the overall 
mycotoxin levels, in particular for zearalenone and fumonisins 
 For fumonisins, the major contribution comes from modified parent compound whereas for the 
other compounds, metabolites are the main contributors to modified forms 
 In order to assess occurrence and exposure the Panel on Contaminants in the Food Chain 
(CONTAM Panel) added 100 %, 30 %, 10 % and 60 % to the levels of the parent compounds to 
account for the modified forms of zearalenone, nivalenol, sum of T-2 and HT-2 toxin and 
fumonisins, respectively.  
 Occurrence data about modified mycotoxins in animal products (i.e. milk and dairy, meat, eggs) 
are not available, but occurrence in animal products is expected to be very low, since carry-over 
of Fusarium toxins from feed is considered insignificant for human exposure based on currently 
available data. 
 
Hazard identification and characterisation 
 Modified mycotoxins can be released, hydrolysed, biotransformed and absorbed in the 
gastrointestinal (GI) tract.  
 Although there is no information on toxicity of conjugated mycotoxins addressed in the present 
opinion, literature data show that conjugates of xenobiotics can be of toxicological significance.  
 Based on this the CONTAM Panel assumed equal toxicity of all modified forms as their parent 
compounds as a pragmatic approach. 
 
Human health risk characterisation 
 The risk characterization is performed by comparing the estimated combined exposure to parent 
and modified forms of mycotoxins with the established (provisional maximum) tolerable daily 
intake ((PM)TDI) levels for the respective parent compounds . 
 Using the lower bound (LB) approach, no consumers with mean or 95th percentile exposure 
have combined exposure to zearalenone and modified zearalenone above the TDI set for 
zearalenone, indicating no concern. However, if the concentration of modified and parent 
zearalenone in cereals is closer to the upper bound (UB) level, high consumers (95
th
 percentile) 
may have exposure up to 2.2 fold the TDI for zearalenone of 0.25 µg/kg body weight (b.w.) per 
day, which would be of concern. 
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 Exposure to the sum of nivalenol and modified nivalenol is not of concern, as the highest 
95
th
 percentile UB exposure across studies is less than 20 % of the TDI for nivalenol of 
1.2 µg/kg b.w. per day. 
 Exposure to the sum of T-2 and HT-2 toxin and their modified forms is considered not to be of 
concern since all the LB and UB exposures across studies were lower than the TDI of 0.1 µg/kg 
b.w. per day for the sum of T-2 and HT-2 toxin, with exception of the highest UB exposure 
which was similar as the TDI.  
 The exposure to fumonisins and their modified forms could be of concern, especially in children 
age groups.  In toddlers, 0.2-14 % (LB) to 43-66 % (UB) and in other children 0-38 % (LB) to 
11-59 % (UB) across studies could exceed the PMTDI for fumonisins of 2 µg/kg b.w. per day. 
At high (95
th
 percentile) exposure, the maximal exceedance was 2.5-fold (LB) to 3-fold (UB) 
the PMTDI. 
 
Animal health risk characterisation 
 In order to assess occurrence in feed and exposure of animals, the CONTAM Panel added equal 
factors for masked mycotoxins in feed as in food; 100 %, 30 %, 10 % and 60 % to the levels of 
the parent compounds to account for the modified forms of zearalenone, nivalenol, sum of T-2 
and HT-2 toxin and fumonisins, respectively.  
 Levels in feed have been compared with guidance values for feed, if established, and estimated 
exposures in animals are evaluated in relation to established NOAELs/LOAELs for different 
animals, when available. Furthermore, known differences in sensitivities between different 
species were taken into account when NOAELs/LOAELs were lacking. 
 For fumonisins, contaminated feed has been used in the studies used for derivation of 
NOAELs/LOAELs, with the exception of poultry, for which the pure compound has been added 
to feed. For the other Fusarium toxins, experiments were carried out with application of pure 
compounds. 
 
Zearalenone (ZEN) and its modified forms 
Pigs 
 The reported mean and P95 values for pig feed were below the guidance values in pig feed of 
0.1 mg/kg feed in compound feed for piglets and gilts, and 0.25 mg/kg feed in feed for sows and 
fattening pigs. 
 Risk characterization in pigs was based on the NOEL of 10 µg/kg b.w. per day for oestrogenic 
effects in pigs, which formed the basis for the human risk characterization in EFSA CONTAM 
Panel (2011a). Pigs are more senstitive to ZEN toxicity than other animal species. 
 Based on available data in feed (mean and 95th percentile occurrence), there is no concern for 
exposure to ZEN and modified ZEN in piglets. Exposure in fattening pigs and sows receiving 
feed with average levels is also not of concern. Occurrence data were inadequate to conclude on 
risks regarding fattening pigs and sows receiving feed with higher than average contamination 
level. 
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Ruminants 
 Addition of 100 % modified ZEN to the occurrence of ZEN as parent compound would lead to 
an exceedance of the guidance value of 0.5 mg/kg feed for dairy cattle for maize silage.  
 EFSA has not derived a NOAEL/LOAEL for cattle, but cattle are considered to be less sensitive 
towards ZEN than pigs (EFSA, 2004). The estimated exposure after feeding with mixed feed 
containing 95
th
 percentile concentration of ZEN and modified ZEN was in fattening cows and in 
dairy cows 4-5 fold the NOEL derived for pigs.  The exposure in goats was lower. However, in 
the absence of a NOAEL/LOAEL the risk for cattle and goats cannot be characterised fully.  
 According to EFSA (2004) next to pigs sheep are rather sensitive towards ZEN toxicity. 
Estimated exposure in sheep is lower than in pigs, and therefore not of concern.  
Poultry 
 There are neither NOAELs/LOAELs nor guidance values for poultry. According to EFSA 
(2004) poultry is less susceptible ZEN induced toxicity than pigs.  
 The 95th percentile exposures in poultry to ZEN together with its modified forms are in the 
range of 2-fold the NOEL in pigs of 10 µg/kg b.w. per day, and the CONTAM Panel therefore 
considers exposures of poultry to ZEN and its modified forms not of concern. 
Horses  
 There are neither NOAELs/LOAELs nor guidance values for horses. Estimated exposure to 
ZEN and modified ZEN based on mean occurrence in horse feed is only 2 % of the NOEL in 
pigs of 10 µg/kg b.w. per day and thus not of concern.  
Rabbits 
 There are neither NOAELs/LOAELs nor guidance values for rabbits. Estimated exposure to 
ZEN and modified ZEN based on mean occurrence in rabbit feed is 10 µg/kg b.w. per day and 
thus similar to the no observed effect level (NOEL) derived for pigs. In the absence of 
information on susceptibility of rabbits towards ZEN a concern cannot be excluded. 
Fish 
 No occurrence data were available for fish feed, consequently no exposure assessment and risk 
characterisation could be carried out. 
Cats and dogs 
 There are neither NOAELs/LOAELs nor guidance values for cats and dogs. Exposure to ZEN 
and modified ZEN based on estimated 95
th
 percentile occurrence in grains possibly used for pet 
food is maximally 30 % of the NOEL of 10 µg/kg b.w. per day derived for pigs and thus not of 
concern.  
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Nivalenol (NIV) and its modified forms 
Pigs 
 For NIV the CONTAM Panel established a LOAEL of 100 µg/kg b.w. per day for pigs (EFSA 
CONTAM Panel, 2013). The estimated exposures to NIV with the addition of 30 % modified 
NIV to the parent compound result in a mean exposure which is maximally 3% (95
th
 percentile 
exposure) of the lowest observed adverse effect level (LOAEL), and is therefore not of concern.  
Ruminants 
 No NOAELs/LOAELs have been set for NIV in ruminants. Since EFSA noted in 2013 that the 
susceptibility of ruminants to nivalenol mediated toxicity is likely to be low, and that dairy cows 
had the highest 95
th
 percentile exposure of 13 % of the LOAEL in pigs, the exposure of 
ruminants to NIV and its modified forms is not of concern.  
Poultry 
 For NIV the CONTAM Panel established a LOAEL of 53 µg/kg b.w. per day for poultry (EFSA 
CONTAM Panel, 2013). The highest 95
th
 percentile exposure to NIV with additional 30 % 
modified NIV in poultry was only 7 % of the LOAEL and therefore not of concern.  
Fish 
 No occurrence data were available for fish, consequently no exposure assessment and risk 
characterisation could be carried out. 
 
Other livestock and companion animals 
 No NOAELs/LOAELs have been set for NIV in horses, rabbits, cats and dogs. The 
95
th
 percentile exposures in these species ranged between 0.6 and 2.3 µg/kg b.w. per day. This 
is much lower than the LOAEL of 53 µg/kg b.w. per day derived for poultry, the most sensitive 
species for which a NOAEL/LOAEL has been derived (EFSA CONTAM Panel, 2013). 
Therefore, exposure to NIV and its modified forms is most likely not of concern. 
 
T-2 and HT-2 toxin (T2 and HT2) and their modified forms 
Pigs 
 In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 29 µg/kg b.w. per day for pigs. 
The highest 95
th
 percentile exposure after adding 10 % modified T2 and HT2 to the exposure of 
the parent compound was 9 % of the LOAEL, and not of concern.  
Ruminants 
 In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 300 µg/kg b.w. per day for 
ruminants. In ruminants the highest 95
th
 percentile exposure to T2 and HT2 with addition of 
10 % modified forms was estimated to 3.4 % of the LOAEL, and not of concern. 
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Poultry 
 In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 40 µg/kg b.w. per day for 
poultry. The highest estimated exposure to T2 and HT2 with addition of 10 % modified forms 
was maximally 20 % of the LOAEL and not of concern.  
Rabbits 
 In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 100 µg/kg b.w. per day for 
rabbits. The 95
th
 percentile exposure to T2 and HT2 with addition of 10 % modified forms was 
7 % of the LOAEL and not of concern.  
Fish 
 In 2011 EFSA derived a LOAEL for the sum of T2 and HT2 of 13 µg/kg b.w. per day for fish. 
No exposure data to the parent compound was available for fish. No exposure assessment to T2 
and HT2 with addition of 10 % modified forms could be performed, and consequently the risk 
cannot be characterised. 
Horses 
 No NOAEL/LOAEL has been set for horses. The estimated 95th percentile exposure in horses to 
T2 and HT2 with 10 % addition of modified forms was 1.8 µg/kg b.w. per day. This is lower 
than in pigs (sensitive to T2 and HT2), for which no concern was identified, indicating that 
exposure to the sum of T2 and HT2 with 10 % addition of modified forms is not of concern in 
horses. 
Cats  
 The guidance value for cat food is 50 µg/kg feed. The mean estimated occurrence of T2 and 
HT2 and its modified forms in cat food is below the guidance value, however, the 
95
th
 percentile is in the range of 75 – 82 µg/kg feed exceeding the guidance value. The 
95
th
 percentile estimated exposure in cats was 0.71 µg/kg b.w. per day. No NOAEL/LOAEL is 
available for cats but it is known that this species is sensitive toward T2 and HT2 induced 
toxicity. A concern cannot be excluded but is unlikely based on low exposure. 
Dogs 
 The indicative value (2013/165/EU) for dog food is 250 µg/kg feed. The estimated mean and 
95
th
 percentile occurrence in grains possibly used for dog food is lower than the indicative 
value. There is no NOAEL/LOAEL for dogs. Estimated exposure to T2 and HT2 and their 
modified forms is far below the LOAELs and NOAELs derived in other species and thus not of 
concern.  
 
Fumonisins and their modified forms 
Pigs 
 For fumonisins a LOAEL of  200 µg/kg b.w. per day was derived for pigs by EFSA in 2005. 
The highest estimated 95
th
 percentile exposure to fumonisins with the addition of 60 % modified 
forms to the parent compound was up to 16 % of the LOAEL, indicating no concern in pigs.  
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Ruminants 
 For ruminants, the lowest NOAEL identified by EFSA in 2005 was 600 µg/kg b.w. per day. In 
ruminants the highest mean exposure to fumonisins with addition of 60 % modified forms was 
5 % of the NOAEL and not of concern. Estimations of high exposure could not be done for 
ruminants due to lack of occurrence data, but is not expected to exceed the NOAEL. 
Poultry 
 For poultry, EFSA identified a LOAEL of 2 000 µg/kg b.w. per day in 2005. The highest 
estimated 95
th
 percentile exposure to fumonisins and 60 % addition of modified fumonisins was 
6 % of the LOAEL, indicating no concern.  
Horses 
 For horses the LOAEL identified by EFSA in 2005 was 200 µg/kg b.w. per day. The mean 
exposure to fumonisins with 60 % addition of modified fumonisins was less than 1 % of the 
LOAEL, and of no concern. 
Rabbits  
 The mean occurrence level in feed of fumonisins with addition of 60 % masked forms is below 
the guidance value of 5 000 µg/kg set for fumonisins. For rabbits no NOAELs/LOAELs for 
fumonisins have been set. Estimations of high exposures (P95) is 73 µg/kg b.w. per day, and not 
of concern since it is well below the LOAEL of 200 µg/kg b.w. per day set for the most 
sensitive species, pigs. and horses. 
Fish 
 In fish (carp) a LOAEL of 10 mg/kg feed was identified by EFSA in 2005. The lack of 
occurrence data for fumonisins and their modified forms in fish feed prevents an exposure 
assessment and a risk characterization in fish.  
Cats and dogs 
 The guidance value for fumonisins in pet food is 5 mg/kg feed. The estimated 95th percentile 
values for fumonisins and their modified forms are below the guidance value. 
NOAELs/LOAELs are not available for cats and dogs. Estimated 95
th
 percentile exposures to 
fumonisins and their modified forms for cats and dogs are maximally 12 % of the LOAEL of 
200 µg/kg b.w. per day derived for pigs and horses  and most likely not of concern.  
 
RECOMMENDATIONS  
 There is a need for more information on the chemical structures of modified mycotoxins. 
 There is a need for further work to identify modified mycotoxins not yet characterised. 
 Nomenclature including abbreviations should be standardised for mycotoxins and their 
modified forms. 
 There is a need for properly validated and sensitive routine analytical methods for modified 
mycotoxins. 
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 The fate of modified forms of mycotoxins upon food and feed processing should be further 
investigated. 
 There is a need for more occurrence data on mycotoxins and their modified forms in food and 
feed, in particular for fish and pet food. 
 There is a need for toxicological data on modified mycotoxins. 
 Re-assessments of animal health effects of zearalenone and fumonisins are needed in order to 
set NOAELs/LOAELs for these compounds 
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APPENDICES  
Appendix A. Occurrence data for fumonisins  
The occurrence data correspond to the European data that were considered by the JECFA in its risk 
assessment (FAO/WHO, 2012). The dataset contained 3 654 analytical results obtained on food 
samples, generated with analytical methods based on gas or liquid chromatography and ELISA, 
collected between 2000 and 2010 and reported by 11 European countries. Around 44 % of the 
analytical results corresponded to the sum of fumonisins B1, B2 and B3 whereas the other results 
corresponded to the sum of fumonisins B1 and B2 only. As done in the JECFA evaluation, the results 
corresponding to the sum of fumonisins B1 and B2 were used together with the ones corresponding to 
the sum of fumonisins B1, B2 and B3, without any adjustment.  
Tables A1 and A2 present the mean levels used for the exposure assessment. Two estimates were 
produced depending on the assessment made on the results below the LOD/LOQ: the lower bound 
estimate (LB), replacing all results reported as below the LOD/LOQ by 0, and the upper bound 
estimate (UB), replacing all results reported as below the LOD/LOQ to their respective LOD/LOQ.  
Table A1:  Distribution of fumonisins levels in grains and grain-based products, expressed in µg/kg 
Foodex 
level 
Food groups N
(a)
 LC
(b)
 
Mean  
LB-UB
(c)
 
P95  
LB-UB
(c)
 
1 Grains and grain-based products 2 981 53 170 - 215 811 – 812 
2 Grains for human consumption 186 58 102 - 161 577 – 589 
3 Corn grain 127 46 145 - 186 669 
Ahg Other grains (wheat, barley, maize, rice)  58 84 8 - 106.8 - 
3 Grains unspecified 1 100 0 - 40 - 
2 Grain milling products 1 366 47 279 - 315 1 321 
3 Maize milling products 1 204 41 316 - 349 1 498 
4 Maize flour  535 30 468 - 497 2 302 
4 Maize semolina 589 46 213 - 246 1 018 
4 Maize starch 15 100 0 - 61.7 - 
4 Other and unspecified maize milling products 65 80 64.5 - 119.3 231 – 331 
Ahg Milling products from other grains 106 97 5.3 - 72.7 0 – 260 
Ahg Milling products from unspecified grains 56 89 7.4 - 64.5 - 
2 Bread and rolls 128 70 112 - 199 389 – 404 
4 Maize bread  8 13 1 220 – 1 229 - 
4 Tortilla bread 25 60 93 – 198 - 
Ahg  Bread from other grains  60 80 17.2 - 124.3 111 – 260 
Ahg Bread from unspecified grains 35 71 33.8 - 91 - 
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Table A1: Distribution of fumonisins levels in grains and grain-based products, expressed in µg/kg 
(continued) 
Foodex 
level 
Food groups N 
(a)
 LC 
(b)
 
Mean  
LB-UB
(c)
 
P95  
LB-UB
(c)
 
2 Pasta 112 74 137 - 201 883 
Ahg Pasta from maize grain  4 25 188 - 208 - 
Ahg Pasta from other grain (wheat) 60 95 24.2 - 91.8 26.9 – 200 
Ahg Pasta from unspecified grains  48 52 273 - 336 - 
2 Breakfast cereals 770 58 41.1 - 84.9 176 - 260 
Ahg Breakfast cereals made from corn 556 54 41.9 - 82.7 176 - 247 
Ahg Breakfast cereals made from other grains  43 91 4.8 - 89.8 - 
Ahg 
Breakfast cereals made from grain mixtures 
or unspecified grains  
171 65 47.6 - 91.1 248 - 260 
2 Fine bakery wares 415 52 109 - 164 601 - 638 
3 Pastries and cakes 2 100 0 – 35 - 
3 Biscuits (cookies) 409 51 110 - 165 601 - 638 
4 Biscuits salty 394 49 114 - 162 609 - 639 
4 Biscuits sweet 15 93 20 - 231 - 
3 Fine bakery wares unspecified 4 100 0 - 100 - 
2 Grains and grain-based products unspecified 4 100 0 – 39 - 
(a): N: number of samples.  
(b): LC: percentage of censored results.  
(c): Mean LB-UB, P95 LB-UB, mean and 95th percentile contamination level presented as lower bound estimate - upper 
bound estimate. When the lower and upper bound estimates are equal, only one estimate is given. In case of too few 
observations (less than 60 for the 95th percentile), the estimation may be biased and is not consequently not provided.  
Note: The numbers for the occurrence values are all given with 3 figures, but this does not reflect precision.  
Ahg: ad-hoc food groups created for the purpose of the assessment. In italics: food groups not taken into account in the 
exposure assessment. 
Table A2:  Distribution of fumonisins levels in other food products, expressed in µg/kg 
Foodex 
level 
Food groups N
(a)
 LC
(b)
 
Mean  
LB-UB
(c)
 
P95  
LB-UB
(c)
 
1 Vegetables and vegetable products   
  
3 Sweet corn (Zea mays var. saccharata) 33 76 81 - 104.7 - 
Not taken into account in the exposure assessment: vegetables and vegetable products other than sweet corn (N 
=2) 
1 Foods for infants and young children   
  
Ahg 
Cereal-based food for infants and young 
children 
221 95 2.8 - 99.3 0 - 260 
Ahg Cereals which are or have to be reconstituted 72 94 5.8 - 136.3 28 - 260 
3 Biscuits, rusks and cookies for children 45 89 3.4 - 92.5 - 
3 Cereal-based meals 5 100 0 – 147 - 
3 Cereal-based food unspecified 99 99 0.5 – 73 0 - 230 
Not taken into account in the exposure assessment: foods for infants and young children other than cereal-based 
(N = 16) 
1 Foods for special nutritional use   
  
3 Formulas for metabolic disorder* 181 56 181 - 230 1 027 
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Table A2:  Distribution of fumonisins levels in other food products, expressed in µg/kg (continued) 
Foodex 
level 
Food groups N
(a)
 LC
(b)
 
Mean  
LB-UB
(c)
 
P95  
LB-UB
(c)
 
1 Composite dishes   
  
2 Cereal-based dishes 16 19 307 - 362 - 
Not taken into account in the exposure assessment: composite dishes other than cereal-based (N = 3) 
1 Snacks, desserts and other foods   
  
2 Snack food 181 64 53 - 163 250 - 340 
3 Corn chips 27 67 56 - 212 - 
3 Corn curls 17 88 4.5 - 58.6 - 
3 Tortilla chips 39 49 66 - 173 - 
3 Popcorn 83 61 56 - 165 290 - 340 
3 Snacks unspecified 15 80 49 - 153 - 
Not taken into account in the exposure assessment: desserts (N = 2), other foods (N = 1) and potato and fish-
based snacks. 
1 Other food groups    
   Not taken into account in the exposure assessment: legumes, nuts and oilseeds (N = 1), animal and vegetable 
fats and oils (N = 4), alcoholic beverages (N = 1), products for special nutritional use, juice, water and non 
alcoholic beverages, eggs and egg products, fish and other seafood, fruit and fruit products (N = 2), herbs, 
spices and condiments (N = 1), meat and meat products (N = 1), milk and dairy products (N = 1), starchy 
roots and tubers (N = 6), sugars and confectionary.  
(a): N: number of samples.  
(b): LC: percentage of censored results.  
(c): Mean LB-UB, P95 LB-UB, mean and 95th percentile contamination level presented as lower bound estimate - upper 
bound estimate. When the lower and upper bound estimates are equal, only one estimate is given. In case of too few 
observations (less than 60 for the 95th percentile), the estimation may be biased and is not consequently not provided.  
Note: The numbers for the occurrence values are all given with 3 figures, but this does not reflect precision.  
Ahg: ad-hoc food groups created for the purpose of the assessment.  
* Some occurrence data are available for ‘Formulas for metabolic disorder’, however no consumption evens of such products 
is reported in the Comprehensive European Food Consumption Database. 
In italics: food groups not taken into account in the exposure assessment. 
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Appendix B. Food consumption data for fumonisins 
 
Food consumption data were derived from the EFSA Comprehensive European Food Consumption 
Database (Comprehensive database) which was built in 2010 from existing national information on 
food consumption at the individual level (EFSA, 2011; Huybrechts et al., 2011; Merten et al., 2011). 
The Comprehensive database comprises consumption data of 66,642 individuals from 32 surveys 
carried out in 22 different European countries covering the following age-groups: infants (< 1 year 
old), toddlers (≥ 1 year to < 3 years old), children (≥ 3 years to < 10 years old), adolescents (≥ 10 years 
to < 18 years old), adults (≥ 18 years to < 65 years old), elderly (≥ 65 years to < 75 years old) and very 
elderly (≥ 75 years old). Consumption data were collected with 24h dietary recalls covering one or two 
days, 48 h dietary recalls, or through dietary records covering 3 to 7 days.  
In view of performing a chronic exposure assessment, as suggested by the EFSA Working Group on 
Food Consumption and Exposure (EFSA, 2011), only individuals with at least two days of reporting 
were considered, which represented a total of 53 728 individuals from 28 surveys and 17 European 
countries. The average consumption level was estimated at the individual level for the different food 
groups taken into account in the exposure assessment (see Section 1). 
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Appendix C.  Exposure assessment for fumonisins 
 
Chronic exposure was assessed at the individual level by multiplying the mean consumption for each 
food with the corresponding mean concentration, summing up the respective intakes throughout the 
diet, and finally dividing the results by the individual’s body weight. The mean as well as the 
95
th
 percentile of exposure were then derived for each population group (i.e. [survey and age class] 
combinations). The percentage of individuals with an exposure higher than the provisional maximum 
tolerable daily intake (PMTDI) of 2 µg/kg b.w. per day was also estimated.  
Table C1 presents lower and upper bound estimates of chronic dietary exposure to fumonisins across 
the different population groups. Table C2 summarizes the percentage of individuals with an exposure 
above the PMTDI estimated across the surveys available for each age class. Whereas the mean 
exposure estimates are provided for all surveys and age groups, the 95
th
 percentile and percentage of 
subject above the PMTDI are provided only for those with more than 60 subjects were used to derive 
the ranges of the 95
th
 percentiles and percentages of subjects above the PMTDI.  
Overall, the mean exposure levels estimated are below the PMTDI, but the 95
th
 percentile estimates 
are in the region of the PMTDI for some surveys. Indeed, in the children age groups, the mean 
exposure levels range between 0.04 and 1.17 µg/kg b.w. per day at the LB and 0.34 and 1.77 µg/kg 
b.w. per day at the UB. The 95
th
 percentile of exposure was between 0.24 and 3.14 µg/kg b.w. per day 
at the LB and between 1.43 and 4.05 µg/kg b.w. per day at the UB. In the surveys covering adult age 
groups (including adolescents), the mean exposure levels remain below the HBGV, being between 
0.04 and 0.69 µg/kg b.w. per day at the LB and 0.31 and 1.04 µg/kg b.w. per day at the UB. However, 
the 95
th 
percentile of exposure is in the region of the HBGV for some surveys, being between 0.08 and 
1.58 µg/kg b.w. per day at the LB and 0.53 and 2.19 µg/kg b.w. per day at the UB. The percentage of 
individuals with an exposure above the PMTDI was ranging from 0 % (LB) up to 35 % (UB) in the 
children age groups (infants, toddlers, other children and adolescents), whereas it was ranging from 
0 (LB) up to 0.5 % (UB) in the adults age groups (adults, elderly, very elderly). 
Tables C3 and C4 present for each age group the minimum and maximum percentage contribution of 
main food groups to the total average exposure at the lower and upper bound respectively.   
The two main contributors (i.e. representing more than 10 % of the total exposure in at least one 
population group) identified in all age groups are the ‘Bread other than maize based’ and ‘Pasta’, 
representing respectively up to 98 % and 74 % of the total LB exposure. ‘Cereal based dishes’ is also 
identified as main contributor in all age groups excepted the infants, representing up to 80 % of the 
total LB exposure. They are followed by “Fine bakery wares”, which are representing up to 18 % of 
the total LB exposure. The ‘Breakfast cereals’ (maize based or other than maize based) are also 
identified as a main contributor in some groups of toddlers, other children and adolescents, 
representing up to 12 % of the total LB exposure. 
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Table C1:  Chronic exposure to fumonisins, expressed in µg/kg b.w. per day across population 
groups 
Country Survey acronym N
(a)
 
Mean     
LB-UB
(b)
 
P95       
LB-UB
(c)
 
Percentage 
above PMTDI 
LB-UB
(d)
 
Infants 
Bulgaria NUTRICHILD 860 0.12 - 0.63 0.53 - 1.99 0.1 - 5.0 
Italy INRAN_SCAI_2005_06 16 0.04 - 0.34 -* -* 
  Min 0.04 - 0.34 0.53 - 1.99 0.1 - 5.0 
  Median  - -  -  
  Max 0.12 - 0.63 0.53 - 1.99 0.1 - 5.0 
Toddlers 
Belgium Regional_Flanders 36 0.43 - 1.34 -* -* 
Bulgaria NUTRICHILD 428 0.26 - 1.34 0.58 - 2.32 0 - 9.3 
Finland DIPP_2003_2006 497 0.82 - 1.65 1.61 - 3.26 1.4 - 27 
Germany DONALD_2006_2008 261 0.50 - 1.30 1.36 - 2.39 1.9 - 11 
Italy INRAN_SCAI_2005_06 36 0.36 - 1.32 -* -* 
Netherlands VCP_kids 322 0.53 - 1.32 1.30 - 2.43 1.6 - 13 
Spain enKid 17 0.18 - 0.93 -* -* 
  Min 0.18 - 0.93 0.58 - 2.32 0 - 9.3 
  Median 0.43 - 1.32 1.33 - 2.41 1.5 - 12 
  Max 0.82 - 1.65 1.61 - 3.26 1.9 - 27 
Other children 
Belgium Regional_Flanders 625 0.39 - 1.17 1.05 - 2.16 0.3 - 7.2 
Bulgaria NUTRICHILD 433 0.20 - 1.13 0.45 - 2.01 0 - 5.3 
Czech Republic SISP04 389 0.22 - 0.96 0.50 - 1.83 0.3 - 3.6 
Denmark Danish_Dietary_Survey 490 0.14 - 0.89 0.24 - 1.43 0 - 1.2 
Finland DIPP_2003_2006 933 0.60 - 1.22 1.05 - 2.09 0.1 - 6.3 
Finland STRIP 250 0.69 - 1.41 1.80 - 2.87 4.0 - 18 
France INCA2 482 0.20 - 0.86 0.39 - 1.51 0 - 0.8 
Germany DONALD_2006_2008 660 0.55 - 1.17 1.32 - 2.15 1.1 - 6.2 
Greece Regional_Crete 839 1.17 - 1.77 3.14 - 4.05 18 - 35 
Italy INRAN_SCAI_2005_06 193 0.29 - 1.13 0.87 - 2.31 0 - 9.3 
Latvia EFSA_TEST 189 0.27 - 0.71 0.98 - 1.70 0 - 2.6 
Netherlands VCP_kids 957 0.43 - 1.11 0.94 - 1.94 0.1 - 4.2 
Spain enKid 156 0.29 - 0.88 1.01 - 1.79 1.9 - 3.2 
Spain NUT_INK05 399 0.38 - 1.03 0.95 - 1.85 0 - 2.8 
Sweden NFA 1 473 0.50 - 1.14 1.41 - 2.36 1.8 - 9.2 
  Min 0.14 - 0.71 0.24 - 1.43 0 - 0.8 
  Median 0.38 - 1.13 0.98 - 2.01 0.1 - 5.3 
  Max 1.17 - 1.77 3.14 - 4.05 18 - 35 
Adolescents 
Belgium Diet_National_2004 584 0.12 - 0.50 0.36 - 1.02 0  
Cyprus Childhealth 303 0.69 - 1.04 1.58 - 2.19 1.3 - 6.9 
Czech Republic SISP04 298 0.20 - 0.78 0.64 - 1.52 0.3 - 1 
Denmark Danish_Dietary_Survey 479 0.08 - 0.48 0.14 - 0.87 0  
France INCA2 973 0.13 - 0.52 0.27 - 0.98 0 - 0.1 
Germany National_Nutrition_Survey_II 1 011 0.21 - 0.51 0.60 - 1.11 0.2 - 0.7 
Italy INRAN_SCAI_2005_06 247 0.20 - 0.71 0.58 - 1.37 0 - 0.8 
Latvia EFSA_TEST 470 0.22 - 0.58 0.81 - 1.30 0.2 - 1.3 
Spain AESAN_FIAB 86 0.11 - 0.43 0.24 - 0.91 0  
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Table C1:  Chronic exposure to fumonisins, expressed in µg/kg b.w. per day across population 
groups (continued) 
Country Survey acronym N
(a)
 
Mean     
LB-UB(b) 
P95       
LB-UB(c) 
Percentage 
above PMTDI 
LB-UB
(d)
 
Spain enKid 209 0.18 - 0.62 0.65 - 1.48 0 - 0.5 
Spain NUT_INK05 651 0.25 - 0.70 0.59 - 1.28 0 - 0.2 
Sweden NFA 1 018 0.43 - 0.86 1.18 - 1.75 0.3 - 2.5 
  Min 0.08 - 0.43 0.14 - 0.87 0 
  Median 0.20 - 0.60 0.59 - 1.29 0 - 0.6 
  Max 0.69 - 1.04 1.58 - 2.19 1.3 - 6.9 
Adults 
Belgium Diet_National_2004 1 304 0.10 - 0.40 0.28 - 0.81 0 - 0.2 
Czech Republic SISP04 1 666 0.11 - 0.45 0.35 - 0.92 0.1 - 0.2 
Denmark Danish_Dietary_Survey 2 822 0.05 - 0.34 0.09 - 0.59 0  
Finland FINDIET_2007 1 575 0.28 - 0.53 0.54 - 0.99 0  
France INCA2 2 276 0.09 - 0.37 0.18 - 0.72 0 
Germany National_Nutrition_Survey_II 10 419 0.16 - 0.41 0.44 - 0.86 0 - 0.2 
Hungary National_Repr_Surv 1 074 0.07 - 0.38 0.14 - 0.67 0 
Ireland NSIFCS 958 0.06 - 0.35 0.12 - 0.62 0  
Italy INRAN_SCAI_2005_06 2 313 0.12 - 0.46 0.38 - 0.86 0 
Latvia EFSA_TEST 1 306 0.14 - 0.40 0.58 - 1.03 0.2 - 0.5 
Netherlands DNFCS_2003 750 0.11 - 0.40 0.29 - 0.77 0.1  
Spain AESAN 410 0.11 - 0.36 0.42 - 0.84 0  
Spain AESAN_FIAB 981 0.08 - 0.33 0.19 - 0.64 0  
Sweden Riksmaten_1997_98 1 210 0.33 - 0.63 0.83 - 1.25 0 - 0.3 
United Kingdom NDNS 1 724 0.06 - 0.34 0.14 - 0.63 0 - 0.1 
  Min 0.05 - 0.33 0.09 - 0.59 0 
  Median 0.11 - 0.40 0.29 - 0.81 0 
  Max 0.33 - 0.63 0.83 - 1.25 0.2 - 0.5 
Elderly 
Belgium Diet_National_2004 518 0.07 - 0.31 0.21 - 0.67 0  
Denmark Danish_Dietary_Survey 309 0.05 - 0.31 0.08 - 0.53 0  
Finland FINDIET_2007 463 0.28 - 0.53 0.53 - 0.99 0 
France INCA2 264 0.07 - 0.34 0.15 - 0.67 0  
Germany National_Nutrition_Survey_II 2 006 0.13 - 0.38 0.34 - 0.74 0  
Hungary National_Repr_Surv 206 0.06 - 0.35 0.12 - 0.58 0  
Italy INRAN_SCAI_2005_06 290 0.11 - 0.43 0.26 - 0.86 0  
  Min 0.05 - 0.31 0.08 - 0.53 0 
  Median 0.07 - 0.35 0.21 - 0.67 0 
  Max 0.28 - 0.53 0.53 - 0.99 0 
Very elderly 
Belgium Diet_National_2004 712 0.06 - 0.31 0.18 - 0.64 0  
Denmark Danish_Dietary_Survey 20 0.04 - 0.31 -* -* 
France INCA2 84 0.07 - 0.32 0.14 - 0.55 0  
Germany National_Nutrition_Survey_II 490 0.13 - 0.37 0.34 - 0.73 0.2  
Hungary National_Repr_Surv 80 0.07 - 0.39 0.13 - 0.64 0  
Italy INRAN_SCAI_2005_06 228 0.11 - 0.46 0.22 - 0.84 0  
  Min 0.04 - 0.31 0.13 - 0.55 0 
  Median 0.07 - 0.35 0.18 - 0.64 0 
  Max 0.13 - 0.46 0.34 - 0.84 0.2 
(a): N: number of subjects. (b) mean LB-UB: mean lower bound - upper bound. (c) P95 LB - UB: 95th percentile lower bound 
- upper bound. (d): Percentage above PMTDI: percentage of individuals with an exposure above the PMTDI lower bound - 
upper bound. * P95 and percentage of individuals with an exposure above 1 µg/kg b.w. per day for dietary surveys/age 
classes with less than 60 subjects were not reliable and therefore not presented. Note: The numbers for the exposure values 
(mean, P95) are all given with 3 figures, and the percentage above HBGV with 2 figures, but this does not reflect precision. 
When LB and UB estimates are identical, only one estimate is provided. 
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Table C2: Percentage above the PMTDI across surveys in total population from fumonisins 
Age class 
Percentage above the PMTDI in total population 
Minimum Median Maximum 
LB UB LB UB LB UB 
Infants 0.1 5.0 -* -* 0.1 5.0 
Toddlers 0.0 9.3 1.5 12 1.9 27 
Other children 0.0 0.8 0.1 5.3 18 35 
Adolescents 0.0 0.0 0.0 0.6 1.3 6.9 
Adults  0.0 0.0 0.0 0.0 0.2 0.5 
Elderly 0.0 0.0 0.0 0.0 0.0 0.0 
Very elderly 0.0 0.0 0.0 0.0 0.2 0.2 
*Estimates based on only two dietary surveys. 
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Table C3: Minimum and maximum relative contribution (%) of main food groups to the fumonisins total lower bound exposure  
Food category Infants Toddlers 
Other 
children 
Adolescents Adults Elderly 
Very 
elderly 
Maize grain for human consumption 0 0 - 0.1 0 - 0.6 0 - 0.9 0 - 4.9 0 - 0.3 0 - 1.0 
Other and unspecified grains for human consumption 2.0 - 8.7 0 - 3.5 <0.05 - 3.1 0.3 - 3.0 0.4 - 4.5 0.3 - 2.5 0.6 - 2.0 
Maize milling product 0 - 0.7 0 - 0.8 0 - 3.7 0 - 3.7 0 - 4.4 0 - 7.1 0 - 4.4 
Other and unspecified grain milling products 1.9 - 3.5 0 - 12 0 - 4.1 <0.05 - 6.5 0 - 4.3 0 - 4.6 0.1 - 4.8 
Maize bread and tortilla 0 0 - 0.3 0 - 0.9 0 - 1.3 0 - 21 0 - 4.0 0 
Bread other than maize based 3.3 - 65 18 - 94 13 - 94 11 - 66 8.0 - 97 40 - 98 47 - 86 
Maize based breakfast cereals 0 - 0.1 0 - 0.4 0 - 12 0 - 11 0 - 5.8 0 - 2.9 0 - 2.3 
Breakfast cereals other than maize based 0 - 0.1 <0.05 - 11 0.1 - 7 0 - 5.5 0.6 - 11 0.2 - 3.1 0.1 - 4.7 
Pasta  14 - 74 1.0 - 26 1.0 - 52 0.3 - 52 0 - 42 0.4 - 34 1.9 - 33 
Fine bakery wares  0 – 11 0.3 - 15 0.7 - 24 0.6 - 16 <0.05 - 12 0 - 15 0.6 - 18 
Sweet corn 0 - 0.7 0 - 3.5 0 - 5.8 0 - 7.2 0 - 6.3 <0.05 - 2.0 0.2 - 1.7 
Food for infants and young children 2.0 - 11 0.2 - 4.4 0 - 0.4 0 0 0 0 
Cereal based dishes 0 0 - 41 0 - 76 0 - 76 0 - 80 0 - 19 0 - 18 
Maize based snacks 0 - 3.2 0 - 8.4 <0.05 - 8.2 <0.05 - 1.9 0.1 - 1.3 0 - 0.1 0 
Snacks other than maize based 0 - 0.1 0 - 2.0 0 - 1.7 0 - 2.7 0 - 1.2 0 - 0.4 0 - 0.4 
Note: The numbers for the percentage contributions are all given with 2 figures but this does not reflect precision. A “0” indicates the absence of contribution to the total exposure. 
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Table C4: Minimum and maximum relative contribution (%) of main food groups to the fumonisins total upper bound exposure  
Food category Infants Toddlers 
Other 
children 
Adolescents Adults Elderly 
Very 
elderly 
Maize grain for human consumption 0 0 0 - 0.2 0 - 0.3 0 - 2.0 0 - 0.1 0 - 0.3 
Other and unspecified grains for human consumption 5.2 - 12 0 - 11.2 0.2 - 9.7 2.2 - 9.7 2.4 - 11 1.9 - 7.3 1.7 - 6.1 
Maize milling product 0 - 0.1 0 - 0.2 0 - 1.1 0 - 1.1 0 - 1.2 0 - 1.9 0 - 1.1 
Other and unspecified grain milling products 5.1 - 5.2 0 - 5.9 0 - 9.0 0.1 - 11 0 - 11 0 - 11 0.2 - 11 
Maize bread and tortilla 0 0 - 0.2 0 - 0.8 0 - 1.2 0 - 5.8 0 - 1.0 0 
Bread other than maize based 2.5 - 40.1 23 - 83 23 - 83 27 - 75 28 - 93 53 - 93 57 - 84 
Maize based breakfast cereals 0 0 - 0.2 0 - 3.8 0 - 3.4 0 - 1.9 0 - 0.8 0 - 0.6 
Breakfast cereals other than maize based 0 <0.05- 4.2 0.1 - 12 0 - 5.0 0.4 - 9.6 0.1 - 3.9 0.1 - 5.3 
Pasta  3.8 - 30 1.8 - 23 2.4 - 20 0.7 - 19 0.1 - 16 0.8 - 17 1.0 - 16 
Fine bakery wares  0 - 24 1.8 - 20 2.1 - 30 2.3 - 24 <0.05 - 18 0 - 13 2.9 - 15 
Sweet corn 0 - 0.2 0 - 2.2 0 - 1.2 0 - 1.5 0 - 1.5 <0.05  - 0.4 0.1 - 0.4 
Food for infants and young children 19 - 50 2.4 - 30 0 - 3.9 0 - 0.1 0 - 0.1 0 0 
Cereal based dishes 0 0 - 13 0 - 57 0 - 58 0 - 50 0 - 5.6 0 - 5.0 
Maize based snacks 0 - 2.3 0 - 5.6 <0.05 - 4.8 <0.05 - 2.1 0.1 - 1.0 0 0 
Snacks other than maize based 0 0 - 1.3 0 - 2.0 0 - 2.4 0 - 0.9 0 - 0.2 0 - 0.2 
Note: The numbers for the percentage contributions are all given with 2 figures but this does not reflect precision. A “0” indicates the absence of contribution to the total exposure. 
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Appendix D. Data management and validation of occurrence data on zearalenone and 
fumonisins in feed 
All the data related to the presence of fumonisins (total fumonisins, fumonisin B1, fumonisin B2, 
fumonisin B3) and zearalenone in feed, collected between 2008 and 2014,  submitted to EFSA and 
validated at the date of the 23
rd
 of July 2014 were considered.  
The data control quality procedure consisted in checking for potential duplicates, checking the 
consistency of information related to the feed description, harmonising the unit of expression of the 
results throughout the dataset and expressing the fumonisins as a total fumonisins equivalent. 
The feed description considered in this assessment corresponds to the Commission Regulation (EU) 
No 575/2011 on the Catalogue of food materials22. For sake of consistency, the results were all 
expressed on a 88 % dry matter basis. When the information required to convert the result into this 
unit was missing, the random hot-deck imputation technique, as described in the 2012 EFSA report on 
update of the monitoring of levels of dioxins and PCBs in food and feed (EFSA, 2012) was applied in 
order to approximate the missing value. The total fumonisins was estimated by summing fumonisins 
B1, B2 and B3 when available, by summing fumonisins B1 and B2 when fumonisin B3 was missing, or 
by considering the result provided for total fumonisins when no detailed data was provided for 
fumonisins B1, B2 and B3. Results which were available only for fumonisins B1 or B2 were not further 
considered. As done in the JECFA evaluation, the results corresponding to the sum of fumonisins B1 
and B2 were used together with the ones corresponding to the sum of fumonisins B1, B2 and B3, 
without any adjustment. 
Some high limits of quantification (LOQ) were observed in the zearalenone dataset. In order to 
prevent such LOQs adding a bias to the description of zearalenone levels in feed, the maximum left-
censoring limit accepted was set at 100 µg/kg. It corresponded to the guidance value defined for 
zearalenone in compound feed (Commission Recommendation 2006/576/EC).  
A total of 8 602 analytical results were initially extracted from the EFSA chemical occurrence 
database. The cleaning process led to the exclusion of: 
- 111 analytical results corresponding to duplicate submission, 
- 50 analytical results which were referring to sub-samples, for which an average value at the 
sample level was retained for further analysis, 
- 35 analytical results which were available only for fumonisin B1 or B2, 
- 302 analytical results on zearalenone associated with an LOQ above 100 µg/kg, 
After the adjustment in total fumonisins equivalent, the final dataset contained 5 000 analytical results: 
3 233 for zearalenone and 1 767 for fumonisins.  
 
                                                 
22
  Commission Regulation (EU) No 575/2011 of 16 June 2011 on the Catalogue of feed materials. OJ L159, 17.6.2011, p. 25-
65. 
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Appendix E. Descriptive statistics of of occurrence data on zearalenone and fumonisins in feed 
Table F1 shows the distribution of zearalenone across feed groups. Around 41 % of the results 
available are for ‘Complete feed’, which can allow to assess the exposure levels of a number of animal 
species from the direct consumption of complete feeds, without considering the raw materials. The 
overall quantification rate of zearalenone in complete feed is 52 % with an average MB level at 
28.7 µg/kg 88 % dry matter. Regarding the raw materials, ‘Maize’ is the cereal with the highest 
quantification rate (53 %). The average zearalenone MB level in ‘Maize’ is estimated at 66.7 µg/kg 
88 % dry matter. High levels of zearalenone are also observed in ‘Forages and roughage, and derived 
products’ with average MB level at 252 µg/kg 88 % dry matter. Overall, these results are in line with 
data compiled in Opinion of the CONTAM Panel related to Zearalenone as undesirable substance in 
animal feed (EFSA, 2004).  
Table F2 shows the distribution of fumonisins across feed groups. Around 35 % of the results 
available are for ‘Complete feed’, which can be used to assess the exposure levels from the direct 
consumption of complete feeds. Fumonisins are less frequently detected than zearalenone, the overall 
quantification rate in ‘Complete feed’ being of 22 %. The average MB level is at 206 µg/kg 88 % dry 
matter. A high level of censorship (above 80 %) is also observed in all raw materials, maize excepted. 
Fumonisins are found in almost half the samples, with an average MB level at 571 µg/kg 88 % dry 
matter.  
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Table E1:  Zearalenone concentrations (µg / kg 88 % dry matter) across feed groups  
Feed groups N
(a)
 LC
(b)
 
Mean  Median P95  P97.5 P99 
presented as MB [LB-UB]
(c)
 
Compound feed 1 980 45.3 38.6 [36.1 - 41.9] 9.85 [9.70 - 10.7] 93.4 200 500 
Complete feed 1 316 51.8 28.7 [25.4 - 32.0] 11.4 [0 - 14.1] 82.9 [82.9 - 84.5] 162 310 
Piglets (weaning diets)  262 60.3 16.6 [14.3 - 19.0] 4.93 [0 – 7.00] 47.8 [47.8 - 47.8] 59.1 - 
Growing/Fattening pigs  18 61.1 24.6 [18.4 - 30.8] 12.6 [0 - 22.8] - - - 
Breeding pigs  254 47.2 27.2 [23.3 - 31.1] 14.1 [11.1 - 21.3] 101 150 - 
Lactating sows  29 48.3 77.2 [72.4 - 82.0] 15.0 [2.05 - 25.1] - - - 
Fattening calves (weaning diets) 106 43.4 26.6 [24.0 - 29.1] 14.3 [14.3 - 18.3] 68.2 - - 
Fattening cattle  14 57.1 53.5 [47.3 - 59.7] 15.3 [0 - 20] - - - 
Lactating/dairy  goats  28 64.3 10.8 [8.93 - 12.7] 2.74 [0 - 5.49] - - - 
Lactating/dairy sheep  75 58.7 15.7 [14.2 - 17.2] 2.56 [0 - 5.12] 73.1 - - 
Dairy cows  247 51.4 19.2 [17.0 - 21.5] 7.20 [0 – 10.0] 67.5 80.3 - 
Poultry (starter diets)  54 24.1 59.7 [58.5 - 60.9] 20.6  - - - 
Fattening chickens (broilers)  72 44.4 41.2 [36.5 - 46.0] 15.0 [10.0 – 25.0] 128 - - 
Fattening turkeys  11 45.5 50.8 [44.3 - 57.2] 18.7 [17.7 - 29.6] - - - 
Laying hens  79 55.7 59.5 [54.9 - 64.1] 13.6 [0 - 24.3] 183 - - 
Fattening rabbits  13 84.6 58.8 [50.1 - 67.6] 12.3 [0 - 24.6] - - - 
Pet foods, birds, cats, dogs 4 100.0 9.73 [0 - 19.5] 8.82 [0 - 17.6] - - - 
Other and unspecified complete feed 
(d)
 50 54.0 35.3 [27.9 - 42.8] 19.2 [0 - 29.9] - - - 
Complementary feed (incomplete diet) 224 48.2 139 [136 - 142] 14.4 [7.78 - 17.0] 500 905 - 
Piglets (weaning diets) 17 29.4 10.9 [10.2 - 11.7] 8.20 [8.20 - 9.12] - - - 
Growing/Fattening pigs  66 42.4 129 [127 - 131] 20.1 [20.1 - 20.6] 905 - - 
Fattening cattle  48 35.4 113 [111 - 114] 17.5 [17.5 – 20.0] - - - 
Dairy cows  19 26.3 35.2 [32.8 - 37.5] 19.9 [19.9 - 21.2] - - - 
Other and unspecified complementary feed 
(e)
 74 71.6 221 [215 - 227] 5.04 [0 - 10.1] 221 - - 
Compound feed, unspecified 440 24.1 16.9 [17.2 - 20.5] 5.98 [9.92 - 10.0] 52 83.3 178 
Cereal grains, their products and by-products 981 61.7 46.6 [42.2 - 50.8] 6.20 [0 - 10.3] 164 325 561 
Barley 120 84.2 105 [98.2 - 110] 5.13 [0 - 10.2] 133 - - 
Maize 354 46.6 66.7 [63.7 - 70.8] 10.0 [10.0 – 20.0] 333 510 690 
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Table E1:  Zearalenone concentrations (µg / kg 88 % dry matter) across feed groups (continued) 
Feed groups N
(a)
 LC
(b)
 
Mean  Median P95  P97.5 P99 
presented as MB [LB-UB]
(c)
 
Malt 12 66.7 38.4 [23.6 - 53.2] 25.5 [0 - 51.1] - - - 
Mixed grains 27 48.1 28.7 [22.4 - 35.0] 19.6 [17.5 - 20.2] - - - 
Oats 30 86.7 7.96 [4.42 - 11.8] 2.57 [0 - 5.15] - - - 
Triticale 36 80.6 5.09 [2.76 - 7.86] 3.03 [0 - 6.06] - - - 
Wheat 381 65.9 16.3 [11.5 - 20.1] 6.06 [0 - 10.1] 63.4 91.8 127 
Wheat bran 69 76.8 19.7 [12.9 - 27.0] 5.10 [0 - 10.2] 77.8 - - 
Wheat feed 66 80.3 14.6 [8.46 - 18.2] 5.04 [0 - 10.0] 40.3 - - 
Wheat middlings 88 51.1 15.2 [13.5 - 17.4] 6.04 [0 - 10.07] 50 - - 
Wheat, other and unspecified 158 63.3 16.2 [11.1 - 19.4] 6.11 [0 - 10.2] 70.8 - - 
Cereal grains, other and unspecified 
(f)
 21 57.1 76.7 [74.7 - 79.8] 5.15 [0 - 10.1] - - - 
Forages and roughage, and products derived  160 64.4 252 [240 - 254] 30.7 [0 - 21.7] 1134 - - 
Cereals straw 39 94.9 12.9 [8.18 - 17.7] 5.00 [0 - 10.0] - - - 
Grass, field dried, [Hay] 17 64.7 610 [603 - 611] 19.8 [0 - 20.0] - - - 
Lucerne; [Alfalfa] 10 30.0 552 [550 - 553] 238  - - - 
Maize silage 63 63.5 233 [216 - 235] 45.6 [0 - 32.7] 790 - - 
Forages, other and unspecified 31 38.7 296 [280 - 299] 128 [128 - 134] - - - 
Oil seeds, oil fruits, and products derived  72 76.4 27.3 [22.8 - 31.4] 5.00 [0 - 10.0] 140 - - 
Sunflower seed 45 84.4 16.8 [12.9 - 21.6] 5.00 [0 - 10.0] - - - 
Toasted soya (beans) 20 60.0 55.2 [51.7 - 59.0] 10.0 [0 - 20.0] - - - 
Oil seeds, other and unspecified
(g)
 7 71.4 15.5 [4.28 - 15.3] 12.5 [0 - 16.0] - - - 
Miscellaneous 
(h)
 15 80.0 9.51 [2.46 - 16.6] 8.79 [0 - 10.0] - - - 
Feed, other and unspecified
(i)
 25 36.0 35.6 [34.0 - 38.2] 13.0 [12.0 - 13.0] - - - 
(a) N: number of samples. (b) LC: percentage of left censored results. (c) MB (LB-UB): mean, 95th, 97.5th and 99th percentiles presented as the middle bound estimate (lower bound estimate; 
upper bound estimate). When the middle, lower and upper bound estimates are equal, only one estimate is given. (d) Other and unspecified complete feed: Calves (pre-ruminant) (3), Fattening 
ducks (5), Fattening geese (1), Fattening sheep (1), Fish (1), Lambs (weaning diets) (2), unspecified (37). (e) Other and unspecified complementary feed: Breeding pigs (8), Calves (pre-
ruminant) (8), Fattening calves (weaning diets) (6), Fattening geese (1), Fattening rabbits (3), Horses (2), Lactating sows (1), Lambs (weaning diets) (7), Pet food, birds (1), Pet food, dogs (1), 
Poultry (starter diets) (8), unspecified (28). (f) Cereal grains, other and unspecified: Millet (1), Rice (3), Rye (4), Sorghum; [Milo] (3), Spelt (9), unspecified (1) (g) Other oilseeds: Niger seed 
(1), Palm kernel expeller (1), Rape seed (4), Safflower seed (1). (h) Miscellaneous: Caramelized sugar (2), Feed beer (1), Products from the bakery and pasta industry (6), Products from the 
pastry industry (1), Starch (2), unspecified (4). (i) Feed, other and unspecified: Fermentation (by-)products (3), Land animal products and products derived thereof (2), Legume seeds and 
products derived thereof (2), Milk products and products derived thereof (1), Minerals and products derived thereof (4), Other seeds and fruits, and products derived thereof (3), Tubers, roots, 
and products derived thereof (5), unspecified (5). -: P95, P97.5 and P99 are not reliable when the number of samples is respectively below 60, 180 and 298 and therefore not presented. Note: The 
numbers for the concentration values are all given with 3 figures, but this does not reflect precision 
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Table E2:  Fumonisins concentrations (µg / kg 88 % dry matter) across feed groups  
Feed groups N
(a)
 
LC
(
b)
 
Mean  Median P95  P97.5 P99 
presented as MB [LB-UB]
(c)
 
Compound feed 762 76 202 [133 - 272] 73.9 [0 - 148] 787 [730 - 810] 1549 [1498 - 1549] 2418 [2403 - 2433] 
Complete feed 636 78 206 [135 - 276] 73.9 [0 - 148] 760 [721 - 803] 1549 [1547 - 1549] 2418 [2403 - 2430] 
Piglets (weaning diets)  307 85 139 [73.2 - 205] 73.9 [0 - 148] 400 [351 - 449] 753 [704 - 792] 1557 [1547 - 1568] 
Growing/Fattening pigs  43 60 308 [246 - 369] 150 [0 - 244] - - - 
Breeding pigs  13 92 212 [79.2 - 344] 150 [0 - 300] - - - 
Lactating sows  68 72 274 [152 - 395] 150 [0 - 300] 1020 [970 - 1070] - - 
Fattening cattle  10 60 52.3 [24.0 - 80.6] 32.5 [0 – 55.0] - - - 
Dairy cows  21 81 69.9 [25.6 - 114] 50.0 [0 - 100] - - - 
Poultry (starter diets)  33 18 330 [314 - 345] 117 [92.0 - 120] - - - 
Horses  112 97 91.8 [11.1 - 173] 74.6 [0 - 149] 150 [0 - 300] - - 
Complete, other and unspecified
(d)
 29 34 1043 [993 - 1093] 210 [170 - 310] - - - 
Complementary feed (incomplete diet) 75 59 237 [181 - 292] 80.0 [0 - 151] 1080 - - 
Piglets (weaning diets) 15 93 117 [52.5 - 181] 74.3 [0 - 149] - - - 
Fattening cattle  22 32 198 [187 - 208] 57.5 [50.0 - 89.2] - - - 
Complementary, other and unspecified
(e)
 38 61 307 [229 - 385] 150 [0 - 300] - - - 
Compound feed, unspecified 51 76 110 [34.4 - 185] 50.0 [0 - 100] - - - 
Cereal grains, their products and by-products 537 69 349 [284 - 413] 110 [0 - 151] 1681 [1509 - 1681] 3388 [3388 - 3389] 4860 
Barley 63 81 136 [48.7 - 225] 30.0 [0 - 40.6] 550 [35.0 - 550] - - 
Maize 277 51 571 [516 - 626] 150 [0 - 300] 3388 4750 - 
Mixed grains 18 94 161 [21.1 - 301] 150 [0 - 300] - - - 
Oats 35 97 82.7 [10.8 - 155] 39.1 [0 - 78.1] - - - 
Wheat 124 91 83.5 [28.9 - 138] 50.0 [0 - 100] 150 [30.0 - 300] - - 
Wheat bran 35 100 50.2 [0 - 100] 50.0 [0 - 100] - - - 
Wheat feed 29 100 50.2 [0 - 100] 50.0 [0 - 100] - - - 
Wheat, other and unspecified 60 82 119 [59.7 - 179] 49.3 [0 - 77.8] 582 [532 - 632] - - 
Cereal grains, other and unspecified
(f)
 20 75 220 [118 - 321] 150 [0 - 300] - - - 
Forages and roughage, and products derived  160 99 128 [5.88 - 250] 150 [0 - 300] 150 [0 - 300] - - 
Cereals straw 37 100 50 [0 - 100] 50.0 [0 - 100] - - - 
Forage meal; [Grass meal]; [Green meal] 22 100 150 [0 - 300] 150 [0 - 300] - - - 
Maize silage 38 95 170 [24.7 - 315] 150 [0 - 300] - - - 
Forages, other and unspecified 63 100 141 [0 - 282] 150 [0 - 300] 150 [0 - 300] - - 
Legume seeds and products derived
(g)
 11 100 139 [0 - 278] 150 [0 - 300] - - - 
Oil seeds, oil fruits, and products derived  264 98 137 [7.29 - 268] 150 [0 - 300] 150 [0 - 300] 150 [0 - 300] - 
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Table E2:  Fumonisins concentrations (µg / kg 88 % dry matter) across feed groups (continued) 
Feed groups N 
(a)
 LC 
(b)
 
Mean  Median P95  P97.5 P99 
presented as MB [LB-UB]
(c)
 
Palm kernel expeller 20 100 146 [0 - 292] 150 [0 - 300] - - - 
Rape seed 28 100 147 [0 - 293] 150 [0 - 300] - - - 
Sunflower seed 56 98 85.3 [0.90 - 170] 50.0 [0 - 100] - - - 
Toasted soya (beans) 148 97 154 [12.0 - 296] 150 [0 - 300] 150 [0 - 300] - - 
Soya (bean) meal 32 97 140 [4.47 - 276] 150 [0 - 300] - - - 
Soya beans, extruded 106 97 163 [15.4 - 311] 150 [0 - 300] 150 [0 - 300] - - 
Soya, other and unspecified 
(h)
 10 100 106 [0 - 212] 150 [0 - 300] - - - 
Oil seeds, other and unspecified 
(i)
 12 92 147 [8.33 - 287] 150 [0 - 300] - - - 
Other seeds and fruits, and products derived 
(j)
 16 94 388 [256 - 520] 150 [0 - 300] - - - 
Feed, other and unspecified 
(k)
 17 100 126 [0 - 252] 150 [0 - 300] - - - 
(a) N: number of samples. (b) LC: percentage of left censored results. (c) MB (LB-UB): mean, 95th, 97.5th and 99th percentiles presented as the middle bound estimate (lower bound estimate; 
upper bound estimate). When the middle, lower and upper bound estimates are equal, only one estimate is given. (d) Other and unspecified complete feed: Calves (pre-ruminant) (1), Fattening 
chickens (broilers) (1), Fattening rabbits (2), Fattening sheep (1), Fattening turkeys (2), Fish (2), Lactating/dairy sheep (1), Laying hens (7), Pet food, birds (2), Pet food, dogs (1), unspecified 
(9). (e) Other and unspecified complementary feed: Breeding pigs (1), Calves (pre-ruminant) (4), Dairy cows (9), Fattening calves (weaning diets) (1), Fattening rabbits (3), Growing/Fattening 
pigs (2), Lactating sows (9), Lactating/dairy sheep (1),  Poultry (starter diets) (3), unspecified (5). (f) Cereal grains, other and unspecified: Millet (3), Rice (4), Rye (3), Sorghum; [Milo] (5), 
Spelt 2), Triticale (3). (g) Legume seeds and products derived: Carob, dried (1), Mung beans (1), Peas (2), Sweet lupins (1), Vetches (1), unspecified (5). (h) Soya, other and unspecified: Soya 
(bean) expeller (1Soya (bean) hulls (6), unspecified (3). (i): Oil seeds, other and unspecified: Groundnut expeller, partially decorticated (7), Linseed (2), Niger seed (2), Vegetable oil and fat (1). 
(j): Other seeds and fruits, and products derived: Broken chestnuts (1), Buckwheat (2), Citrus pulp (11), Perilla seed (1), Pine nut (1). (k) Feed, other and unspecified: Fermentation (by-)products 
(3), Minerals and products derived thereof (2), Miscellaneous (5), Other plants, algae and products derived thereof (1), Tubers, roots, and products derived thereof (6). -: P95, P97.5 and P99 are 
not reliable when the number of samples is respectively below 60, 180 and 298 and therefore not presented. Note: The numbers for the concentration values are all given with 3 figures, but this 
does not reflect precision 
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GLOSSARY AND ABBREVIATIONS  
GLOSSARY 
 
 Masked mycotoxins – mycotoxins structurally modified by plants, as living organisms, as part 
of their defence against xenobiotics. Due to this modification, “masked mycotoxins cannot be 
detected by routine analysis”, but can be cleaved in the GI tract of mammals to release their 
parent compound (original definition). 
 Modified mycotoxins – mycotoxins structurally modified as an effect of a metabolic process 
exerted by a living organism (i.e. plants, fungi, mammals), or as an effect of food processing. 
Extractable and not extractable forms are included, as well as matrix entrapped toxins. Masked 
mycotoxins senso strictu are included in this definition. 
 Hidden fumonisins – matrix entrapped fumonisins (see definition). 
 Matrix entrapped mycotoxins – these compounds are strongly associated to the matrix 
macroconstituents, as an effect of specific/aspecific complexation. Although the chemical 
structure of the parent compound is not modified, this physical entrapment may cause an 
underestimation of the mycotoxin content in the food/feed samples.  
 Matrix bound mycotoxins – these forms are covalently bound to the matrix unsoluble 
constituents (i.e. cell walls, fibers, etc.) and, thus, are not directly accessible to the extraction 
solvent. They have to be liberated from the matrix by chemical or enzymatic treatment prior to 
chemical analysis. 
 Extractable conjugated mycotoxins – these forms are directly accessible to the solvent, can be 
extracted and detected by proper analytical methods. Masked mycotoxins senso strictu are 
included in this definition.  
 Targeted analytical methods – any analytical method that is aimed at the determination of a 
specific analyte or of a group of analytes. The analytical procedure should be properly validated 
for the target “known” analytes. 
 Untargeted analytical methods – an analytical method, mainly based on mass spectrometry 
followed by data mining and elaboration, aimed at the acquisition of undefined information 
from a sample (“profiling”). Information about “known” and “unknown” analytes can be 
obtained in the post-acquisition data elaboration. 
 Direct analytical determination – modified mycotoxins are directly extracted from the matrix 
by solvent extraction. The detection method is based on the analyte chemical structure and 
implies a proper validation using calibrators and/or reference materials. The final analysis 
returns the cocnentration of the parent compound together with the concentration of their 
modified forms. 
 Indirect analytical determination – the matrix is chemically or enzymatically treated before 
extraction to release parent mycotoxins from their modified forms. The extraction and detection 
steps are thus aimed at the determination of parent compounds. The final result return the 
mycotoxin concentration as the sum of parent and modified forms. 
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ABBREVIATIONS 
3Ac-DON 3-acetyldeoxynivalenol 
15Ac-DON 15-acetyldeoxynivalenol 
Ac-DON Acetyldeoxynivalenol 
ACN Acetonitrile 
AcOH Acetic acid 
APCI Atmospheric Pressure Chemical Ionization 
b.w. Body weight 
CaCO-2 Heterogeneous human epithelial colorectal adenocarcinoma cells 
CAS Chemical Abstracts Service 
CID Collision-induced dissociation 
CONTAM Panel EFSA Panel on Contaminants in the Food Chain 
DAS Diacetoxyscirpenol 
DAI Daidzein 
DOM-1 Deepoxy-DON 
DON Deoxynivalenol 
EFSA European Food Safety Authority 
ELISA Enzyme-linked immunosorbent assay 
ESI Electrospray ionisation 
FAO/WHO Food and Agriculture Organization of the United Nations/World Health 
Organization 
FB Fumonisin B 
FT-ICR Fourier transform ion-cyclotron resonance 
FUS-X Fusarenon-X 
GC Gas chromatography 
GEMS 
GEN 
Global Environment Monitoring System 
Genistein 
Glc Glucoside 
Glcp Glucopyranoside 
GlcA Glucuronide 
GSH Glutathione 
GST Glutathione-S-transferase 
HBGV Health based guidance value 
HFB Hydrolyzed fumonisin B 
HLB 
HPLC 
Hydrophilic lipophilic balance 
High performance liquid chromatography 
HT2 HT-2 toxin 
IAC Immunoaffinity column 
JECFA Joint FAO/WHO Expert Committee on Food Additives 
KOH Potassium hydroxide 
LB Lower bound 
LC Liquid chromatography/left-censored 
LC-FLD Liquid chromatography – fluorescence detection 
LC-MS/MS Liquid chromatography-tandem mass spectrometry 
LOAEL Lowest observed adverse effect level 
LOD Limit of detection 
LOEL Lowest observed effect level 
LOQ Limit of quantification 
MB (LB-UB): mean 
MCF-7 cells 
MeOH 
Michigan Cancer Foundation-7 cells 
Methanol 
MRM Mutliple reaction monitoring 
MS Mass spectrometry 
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MS/MS Tandem mass spectrometry 
MW 
NCM-FB 
Molecular weight 
N-carboxymethyl fumonisin B 
NDF N-deoxyfructosyl 
NDF-FB N-deoxyfructos-1-yl fumonisin B 
NEO Neosolaniol 
NIV Nivalenol 
NMR Nuclear magnetic resonance 
NOAEL No observed adverse effect level 
NOEL No observed effect level 
OPA Ortho-phthalaldehyde 
OTα Ochratoxin α 
OTA Ochratoxin A 
OTB Ochratoxin B 
P95 95
th
 percentile 
PAT Patulin 
PCB Polychlorinated biphenyl 
PHFB Partially hydrolysed fumonisin B 
PMTDI Provisional maximum tolerable daily intake 
QTL Quantitative trait loci 
Q-TOF Quadrupole and time-of-flight 
QuEChERS Quick, easy, cheap, effective, rugged and safe 
RAL ß-resorcylic acid lactone 
RES Resveratrol 
RP-HPLC/ESI-ITMS Reverse phase high performance liquid chromatography – electrospray – ion 
trap mass spectrometry  
RP-HPLC/ESI-TOFMS Reverse phase high performance liquid chromatography – electrospray – 
time of flight - mass spectrometry 
Sa/So ratio 
SCF 
Sphinganine/sphingosine ratio 
Scientific Committee on Food 
SGLT Sodium-dependent glucose transporter 
SPE Solid-phase extraction 
Sulf Sulphate 
T2 T-2 toxin 
TDI Tolerable daily intake 
TLC Thin layer chromatography 
TOF 
UB 
Time of flight 
Upper bound 
UDP Uridine 5’-diphosphate 
UF Uncertainty factor 
UGT UDP glucosyltransferase 
UV Ultraviolet 
WHO World Health Organization 
ZAL Zearalanol 
ZAN Zearalanone 
ZEL Zearalenol 
ZEN Zearalenone 
 
